{ "generatedAt": "2026-05-31T20:46:57.488Z", "totalRecords": 353, "categories": { "books_bibliographies": 10, "clinical_trials": 15, "clinics": 18, "companies_patents": 9, "culture_stewardship": 9, "documentaries_films": 2, "evidence_pages": 8, "laws_policy": 53, "news_articles_blogs": 65, "podcasts_interviews": 70, "reference_pages": 2, "state_policy_coverage": 51, "studies_papers": 36, "weekly_brief": 5 }, "guardrails": [ "Search results are source leads, not medical or legal advice.", "Ask IbogaBase answers from indexed records and shows citations.", "Ask IbogaBase must refuse dosing, provider referral, self-treatment, individualized medical/legal advice, and treatment instructions." ], "records": [ { "id": "ambio-research-nature-medicine-2024", "title": "Magnesium-ibogaine therapy in veterans with traumatic brain injuries", "category": "studies_papers", "sourceType": "peer_reviewed_observational_study", "sourceName": "Nature Medicine", "url": "https://www.nature.com/articles/s41591-023-02705-w", "summary": "Prospective open-label observational study of 30 male special-operations veterans who independently received magnesium-ibogaine treatment at Ambio Life Sciences in Mexico, with Stanford assessments before and after. The paper reports large short-term improvements and no unexpected serious adverse events, while stating that controlled clinical trials are needed.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [ "Kirsten N. Cherian", "Jackob N. Keynan", "Nolan R. Williams", "Jose Inzunza", "Trevor Millar", "Jonathan Dickinson" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "tbi", "veterans", "ptsd", "depression", "anxiety", "magnesium_ibogaine", "stanford", "conflict_of_interest" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer Reviewed Observational Study", "displaySourceName": "Nature Medicine", "displayDate": "", "whatItIs": "Peer Reviewed Observational Study", "conversationContext": "Covers ambio, ambio life sciences, tbi, veterans.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "magnesium-ibogaine therapy in veterans with traumatic brain injuries prospective open-label observational study of 30 male special-operations veterans who independently received magnesium-ibogaine treatment at ambio life sciences in mexico, with stanford assessments before and after. the paper reports large short-term improvements and no unexpected serious adverse events, while stating that controlled clinical trials are needed. studies_papers peer_reviewed_observational_study nature medicine ambio ambio_life_sciences tbi veterans ptsd depression anxiety magnesium_ibogaine stanford conflict_of_interest cataloged source peer-reviewed source" }, { "id": "ambio-research-nature-mental-health-2025", "title": "Magnesium-ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury", "category": "studies_papers", "sourceType": "peer_reviewed_observational_study", "sourceName": "Nature Mental Health", "url": "https://www.nature.com/articles/s44220-025-00463-x", "summary": "Follow-up Nature Mental Health article on EEG and neural-complexity measures in the same broad magnesium-ibogaine veteran TBI research lane. It reports neurophysiological changes after treatment and states that controlled trials are needed to confirm findings.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [ "Jennifer I. Lissemore", "Anna Chaiken", "Nolan R. Williams" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "tbi", "veterans", "eeg", "neurophysiology", "magnesium_ibogaine", "stanford" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer Reviewed Observational Study", "displaySourceName": "Nature Mental Health", "displayDate": "", "whatItIs": "Peer Reviewed Observational Study", "conversationContext": "Covers ambio, ambio life sciences, tbi, veterans.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "magnesium-ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury follow-up nature mental health article on eeg and neural-complexity measures in the same broad magnesium-ibogaine veteran tbi research lane. it reports neurophysiological changes after treatment and states that controlled trials are needed to confirm findings. studies_papers peer_reviewed_observational_study nature mental health ambio ambio_life_sciences tbi veterans eeg neurophysiology magnesium_ibogaine stanford cataloged source peer-reviewed source" }, { "id": "ambio-research-frontiers-ms-2026", "title": "Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis", "category": "studies_papers", "sourceType": "peer_reviewed_case_report", "sourceName": "Frontiers in Immunology", "url": "https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1535782/full", "summary": "Two-patient case report involving Ambio-affiliated authors and Ambio treatment records. Treat as preliminary case-report evidence with prominent conflict-of-interest and funder-involvement labels, not proof of efficacy.", "confidence": "Case report", "status": "Cataloged source", "people": [ "David Qixiang Chen", "José Adalberto Inzunza Domínguez", "Jonathan E. Dickinson" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "multiple_sclerosis", "neurodegenerative", "case_report", "conflict_of_interest", "clinic_claims" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed case report", "displaySourceName": "Frontiers in Immunology", "displayDate": "", "whatItIs": "Peer-reviewed case report", "conversationContext": "Covers ambio, ambio life sciences, multiple sclerosis, neurodegenerative.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "case report: significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis two-patient case report involving ambio-affiliated authors and ambio treatment records. treat as preliminary case-report evidence with prominent conflict-of-interest and funder-involvement labels, not proof of efficacy. studies_papers peer_reviewed_case_report frontiers in immunology ambio ambio_life_sciences multiple_sclerosis neurodegenerative case_report conflict_of_interest clinic_claims cataloged source case report" }, { "id": "source_radar-SWJvZ2FpbmUgZm", "title": "Ibogaine for the treatment of Parkinson's disease: a case report", "category": "studies_papers", "sourceType": "peer_reviewed_case_report", "sourceName": "source_radar", "url": "https://ourarchive.otago.ac.nz/esploro/outputs/journalArticle/Ibogaine-for-the-treatment-of-Parkinsons/9926827043801891?institution=64OTAGO_INST", "summary": "Track as exciting but very preliminary. One patient, low-dose course, validated PD instruments, no adverse events recorded, sleep worsened; not efficacy proof.", "confidence": "Case report", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-06", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "parkinsons", "neurodegenerative", "case_report", "low_dose", "movement_disorders" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed case report", "displaySourceName": "University of Otago archive", "displayDate": "Jan 6, 2026", "whatItIs": "Peer-reviewed case report", "conversationContext": "Covers parkinsons, neurodegenerative, case report, low dose.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "ibogaine for the treatment of parkinson's disease: a case report track as exciting but very preliminary. one patient, low-dose course, validated pd instruments, no adverse events recorded, sleep worsened; not efficacy proof. studies_papers peer_reviewed_case_report source_radar parkinsons neurodegenerative case_report low_dose movement_disorders cataloged source case report" }, { "id": "source_radar-QWNjZWxlcmF0ZW", "title": "Accelerated recovery using magnesium ibogaine: subjective experience analysis", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "source_radar", "url": "https://www.nature.com/articles/s44184-026-00185-7", "summary": "Qualitative analysis from the 30-person MISTIC veteran cohort; interpret alongside open-label design limits.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [], "publishedAt": "2026", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "tbi", "ptsd", "qualitative", "veterans" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Nature", "displayDate": "2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers tbi, ptsd, qualitative, veterans.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "accelerated recovery using magnesium ibogaine: subjective experience analysis qualitative analysis from the 30-person mistic veteran cohort; interpret alongside open-label design limits. studies_papers peer_reviewed_study source_radar tbi ptsd qualitative veterans cataloged source peer-reviewed source" }, { "id": "source_radar-TXlzdGljYWwgZX", "title": "Mystical experiences during magnesium-Ibogaine associated with PTSD symptom improvements in veterans", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "source_radar", "url": "https://pubmed.ncbi.nlm.nih.gov/41265656/", "summary": "Track as 30-male-veteran secondary analysis from MISTIC; association does not prove mechanism or general efficacy.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "ptsd", "tbi", "veterans", "mental_health", "eeg", "mystical_experience" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "PubMed", "displayDate": "2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers ptsd, tbi, veterans, mental health.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "mystical experiences during magnesium-ibogaine associated with ptsd symptom improvements in veterans track as 30-male-veteran secondary analysis from mistic; association does not prove mechanism or general efficacy. studies_papers peer_reviewed_study source_radar ptsd tbi veterans mental_health eeg mystical_experience cataloged source peer-reviewed paper" }, { "id": "source_radar-TWFnbmVzaXVtLW", "title": "Magnesium-ibogaine therapy effects on cortical oscillations and neural complexity", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "source_radar", "url": "https://www.nature.com/articles/s44220-025-00463-x", "summary": "Track as follow-on analysis from the veteran TBI research line.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [], "publishedAt": "2025", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "tbi", "eeg", "veterans", "mechanism" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Nature", "displayDate": "2025", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers tbi, eeg, veterans, mechanism.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "magnesium-ibogaine therapy effects on cortical oscillations and neural complexity track as follow-on analysis from the veteran tbi research line. studies_papers peer_reviewed_study source_radar tbi eeg veterans mechanism cataloged source peer-reviewed source" }, { "id": "source_radar-RWZmaWNpZW50IG", "title": "Efficient and modular synthesis of ibogaine and related alkaloids", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "source_radar", "url": "https://www.nature.com/nature-index/article/10.1038/s41557-024-01714-7", "summary": "Important for supply, analog research, and non-plant-derived chemistry coverage.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [], "publishedAt": "2025", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "chemistry", "synthesis", "analogs" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Nature", "displayDate": "2025", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers chemistry, synthesis, analogs.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "efficient and modular synthesis of ibogaine and related alkaloids important for supply, analog research, and non-plant-derived chemistry coverage. studies_papers peer_reviewed_study source_radar chemistry synthesis analogs cataloged source peer-reviewed source" }, { "id": "source_radar-QSBzdHVkeSBvZi", "title": "A study of oral ibogaine in opioid withdrawal", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "source_radar", "url": "https://clinicaltrials.gov/study/NCT05029401", "summary": "Track recruitment/status, sponsor, eligibility criteria, and posted results.", "confidence": "Registry record", "status": "Cataloged source", "people": [], "publishedAt": "2024", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "oud", "clinical_trial", "withdrawal" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "2024", "whatItIs": "Trial registry", "conversationContext": "Covers oud, clinical trial, withdrawal.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "a study of oral ibogaine in opioid withdrawal track recruitment/status, sponsor, eligibility criteria, and posted results. studies_papers clinical_trial_registry source_radar oud clinical_trial withdrawal cataloged source registry record" }, { "id": "source_radar_archive-VmV0ZXJhbnMgU2", "title": "Veterans Say an Illegal Psychedelic Drug Is Helping Them. Now Mississippi Wants to Study Ibogaine. - Mississippi Free Press", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Mississippi Free Press", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxORkNGcG1CRjZHa29vNTZ2Qi1yUHJmNzNxRzFXakFFRVY4TEIwNnp1WnNqSjB1M2s4cXJvRGo2R1JTYUpNcUQ3Uk00X2JxMHVuS2VSN3dQSGhSamwxb0RmZnRFQkpNWUhDRWR4c09KWjRfcUJCc2h1MVFHTWV4YXlvUDBWNk9fVGJESEtXRGJ4WHhWUllRMWpiRHFMcllNZk9ZdWliamIyTnE2TjMyY2MxVjlsN2YwNkszdHVoeC1GUlRqX1NSN2FEMmc4N0dxMU0?oc=5", "summary": "Research source from Mississippi Free Press. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 17 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Mississippi Free Press", "displayDate": "Mar 17, 2026", "whatItIs": "Journalism", "conversationContext": "Covers commercial.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "veterans say an illegal psychedelic drug is helping them. now mississippi wants to study ibogaine. - mississippi free press research source from mississippi free press. study design, sample size, limitations, and safety signals matter. studies_papers journalism mississippi free press commercial cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmXigJ", "title": "Ibogaine’s Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course - psychedelicalpha.com", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "psychedelicalpha.com", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPSi04ZE9sOEUzMmh5bDd3cFR3ZnBTTllTRUpmWkl4WWtpQWg4M1dKcG1yQ3pwR3N1TGtEeTUzNXNIa0Y5bHJnaW5qQTRSdXduRTBxaUY5UVJ1YjlaUVh0SUtfeDUxbnpLUTNFenN2Q0NkTFg2a0pQdE04c0ZOQi1XWFl5SWRyWU53UHZ6TTRieGVjNkU2RlhwVHNqdzBPbFVDQkt0OWdabmVsaXJ4Q283MnUyWkdTM3dVam9pR0NGOFgyNWJ3MFFlTXpBWlI?oc=5", "summary": "Culture or stewardship source from psychedelicalpha.com. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 15 Jun 2023 07:00:00 GMT", "foundAt": "2026-05-29T16:41:29.201Z", "sourceOrigin": "source_radar_archive", "tags": [ "culture" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "psychedelicalpha.com", "displayDate": "Jun 15, 2023", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "ibogaine’s surge in popularity could be a huge loss for the gabonese people unless we shift course - psychedelicalpha.com culture or stewardship source from psychedelicalpha.com. outsider summaries require humility and source awareness. culture_stewardship journalism psychedelicalpha.com culture cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgYW", "title": "Ibogaine and 5-MeO-DMT for addiction treatment with Garyth Moxey", "category": "studies_papers", "sourceType": "podcast_interview", "sourceName": "Psychedelic Therapy Frontiers", "url": "https://podcasts.apple.com/us/podcast/ibogaine-and-5-meo-dmt-for-addiction-treatment-with/id1573959330?i=1000659386149&uo=4", "summary": "Research source from Psychedelic Therapy Frontiers. Study design, sample size, limitations, and safety signals matter.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2024-06-18T11:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Studies and papers", "displaySourceType": "Podcast Interview", "displaySourceName": "Psychedelic Therapy Frontiers", "displayDate": "Jun 18, 2024", "whatItIs": "Podcast Interview", "conversationContext": "Covers Ibogaine and 5-MeO-DMT for addiction treatment with Garyth Moxey.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "ibogaine and 5-meo-dmt for addiction treatment with garyth moxey research source from psychedelic therapy frontiers. study design, sample size, limitations, and safety signals matter. studies_papers podcast_interview psychedelic therapy frontiers media cataloged source media metadata" }, { "id": "source_radar_archive-Q2FzZSByZXBvcn", "title": "Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis - Frontiers", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Frontiers", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNVzk1dlFuNzZTUDhXTThfQjUyWlA1c2NvM3VXWmJsWTM3VUZSeG83ZkY4LW1FRkRSZF9UbVpRMzBlcnBad3dRRmhnSWFoVG1IZDZadnZ6SkN1U0l6WTBmQ2lLZWNsbGVBTzlQZmwyaldpV2J0cHdZNjB5X2k0NkNjOWIzWmdiZm9IbWowMjVnNWV4QQ?oc=5", "summary": "Research source from Frontiers. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 05 Feb 2025 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Frontiers", "displayDate": "Feb 5, 2025", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "case report: significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis - frontiers research source from frontiers. study design, sample size, limitations, and safety signals matter. studies_papers journalism frontiers books cataloged source primary-source record" }, { "id": "source_radar_archive-SW5kdWN0aW9uIG", "title": "Induction of insulin secretion by an aqueous extract of Tabernanhte iboga Baill. (Apocynaceae) in rat pancreatic islets of Langerhans - ScienceDirect", "category": "studies_papers", "sourceType": "journalism", "sourceName": "ScienceDirect", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9UREkzaW5NM0JybVlQc29wQzBWV2V4NFJNaXdpX3diSjBNdWlhc25nWnlNbG9uQm53MlRRQWJkcDB2Q3g5LVVCVUdVaWJiUVg4MDZ5LTFGRmtCYmhIYnFkZG5ZZDA3OFBnZ3RqMzFUT1pfSVRvd0M5M2xNNA?oc=5", "summary": "Research source from ScienceDirect. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 30 Jan 2020 08:02:01 GMT", "foundAt": "2026-05-17T22:41:22.106Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "ScienceDirect", "displayDate": "Jan 30, 2020", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "induction of insulin secretion by an aqueous extract of tabernanhte iboga baill. (apocynaceae) in rat pancreatic islets of langerhans - sciencedirect research source from sciencedirect. study design, sample size, limitations, and safety signals matter. studies_papers journalism sciencedirect books cataloged source primary-source record" }, { "id": "source_radar_archive-U3R1ZHkgSWRlbn", "title": "Study Identifies Compounds Similar to Ibogaine That May Improve Treatment of Opioid Addiction - Association of American Universities (AAU)", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Association of American Universities (AAU)", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPb1Y4NTJpYmV6aElFMG1Fa2NVMzJydDVtdmZlNnRKcVlwWldMQXZlVjBNMXpycUlxaldYMERUZHhkR25Ha2VNcmZiSGxFekR3bkF4Wmx4dDVVS0kwT0tnMk95ZkVFMnZUejJSNkdfcDFHVEpiWjhjMXNCWVN5aVBXczBJbVZkd3lrQy0zUElHeTNyWEVUSFNIell0SkdSd3F3M2IyelRjMGM1RGlLeXdQQmhiVQ?oc=5", "summary": "Research source from Association of American Universities (AAU). Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 13 Jun 2023 07:00:00 GMT", "foundAt": "2026-05-18T04:41:30.053Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Association of American Universities (AAU)", "displayDate": "Jun 13, 2023", "whatItIs": "Journalism", "conversationContext": "Covers safety.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "study identifies compounds similar to ibogaine that may improve treatment of opioid addiction - association of american universities (aau) research source from association of american universities (aau). study design, sample size, limitations, and safety signals matter. studies_papers journalism association of american universities (aau) safety cataloged source primary-source record" }, { "id": "source_radar_archive-UmFyZSBidXQgcm", "title": "Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias - Wiley Online Library", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Wiley Online Library", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE52UHRLODh1eXBqaXpRYWpQc094TXgwemZxZU9VS2JHYWhzNVhPSDV0T1ZQNFYteVN4YTZtMnhIVml0TGJTWlE5WWh5c1ItTXR1VlVlYmF0Tjk0SEFmRHQ4UmJXbw?oc=5", "summary": "Research source from Wiley Online Library. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 20 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-18T10:41:39.211Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Wiley Online Library", "displayDate": "Jan 20, 2026", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "rare but relevant: ibogaine and cardiovascular complications—prolonged qt interval and ventricular arrhythmias - wiley online library research source from wiley online library. study design, sample size, limitations, and safety signals matter. studies_papers journalism wiley online library books cataloged source primary-source record" }, { "id": "source_radar_archive-QSBUZXhhcyBoYW", "title": "A Texas hallucinogen hub? $100 million for ibogaine testing brings leading firm to Austin - MSN", "category": "laws_policy", "sourceType": "journalism", "sourceName": "MSN", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbmFMSEV2N3lJUXNpbDM5Q0x6ODBWT2NaTERPMVExX19xd293YlU5dUtuWTBrUVRwNmkwU28ycm8wcmU5Ymd1NFB2c01xaXhQNWh3aHdOUzIzSy1xRmk0bEszbTBSVnpuWkxWUTVCZGJyTTNfbWNRQUIxbU9sdTNsR0RkT0Rla0F4dWlQLWFOQXJfS3JvNThtUHVhZklUZ0NOclNzem1QRDl6RmNIOThEQ0NOX09lSHZCWjhJZXp1YVZYWEd1azg2cXJpRUxqNmVSUUpMRXp4XzNJcHdEQ0JmN2hNQXpkQXNRQy1xNQ?oc=5", "summary": "Law or policy source from MSN. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 13 May 2026 11:07:30 GMT", "foundAt": "2026-05-13T14:41:01.667Z", "sourceOrigin": "source_radar_archive", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "MSN", "displayDate": "May 13, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "a texas hallucinogen hub? $100 million for ibogaine testing brings leading firm to austin - msn law or policy source from msn. read the exact source before drawing legal conclusions. laws_policy journalism msn policy cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgRG", "title": "Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes - Frontiers", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Frontiers", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNYVBjbkhVQ08wQjcxYTNUZHRxZ3ItaVc5RlYxV1k1OWR1NFhIOU9wSXFub3B0SkRVYnBXZTZRdXoxRllUVkU1a1VzMWFCdk56S3l4VHp4bGp4R1FtNlp4SDUzaE5zYXlVSFNYakpyb2lIenZlaHAtTGlwN2YwY0QwcFl0cmFoNVpqUXBZTmZsSHMwUQ?oc=5", "summary": "Research source from Frontiers. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 04 Jun 2018 07:00:00 GMT", "foundAt": "2026-05-21T02:28:34.884Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Frontiers", "displayDate": "Jun 4, 2018", "whatItIs": "Journalism", "conversationContext": "Covers safety.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "ibogaine detoxification transitions opioid and cocaine abusers between dependence and abstinence: clinical observations and treatment outcomes - frontiers research source from frontiers. study design, sample size, limitations, and safety signals matter. studies_papers journalism frontiers safety cataloged source primary-source record" }, { "id": "source_radar_archive-QnVzaDogSWJvZ2", "title": "Bush: Ibogaine saved my family - A Mississippi veteran’s perspective - RedHillsMSNews.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "RedHillsMSNews.com", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOVVlmb2dsbmxoWVVBMjFEaEpPTzVwMTUzZnc1LVFoQmNNT0RWa0RteUdrSUZGNnRxOWlGMUZxUGtOTlBGejN1MERnOTdZNEtVNm50UEdSN21QSVpheHZhWk5FR2d1ODBLd3hEb19FWHh0NEpoZGY1VTFjX25JZGI3d2lzSU02M0JCeGdOSHdTY0d6MG0ycm0xZEVtNnlFeUVEbWszWg?oc=5", "summary": "Law or policy source from RedHillsMSNews.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 26 May 2026 06:02:45 GMT", "foundAt": "2026-05-28T23:19:19.562Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "RedHillsMSNews.com", "displayDate": "May 26, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "bush: ibogaine saved my family - a mississippi veteran’s perspective - redhillsmsnews.com law or policy source from redhillsmsnews.com. read the exact source before drawing legal conclusions. laws_policy journalism redhillsmsnews.com law cataloged source primary-source record" }, { "id": "source_radar_archive-UmVzcG9uc2UgdG", "title": "Response to Luz & Mash on cardiac toxicity of ibogaine - Schellekens - 2022 - Addiction - Wiley Online Library", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Wiley Online Library", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTFBvUzRlZ2JtNXF0Qm13VUtBQW5rVWRvVDc0UFE2NkJRUm1PdGVLQnFCRDdUdEJnMmJlYm8wZXVGQ00zcGNMWUZQVHdYLXZfZ3U4c2JaMWhjNjdSLTd0S2gxa01VdXA2NnlJUGc?oc=5", "summary": "Research source from Wiley Online Library. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 02 Dec 2021 08:00:00 GMT", "foundAt": "2026-05-26T14:37:16.471Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Wiley Online Library", "displayDate": "Dec 2, 2021", "whatItIs": "Journalism", "conversationContext": "Covers safety.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "response to luz & mash on cardiac toxicity of ibogaine - schellekens - 2022 - addiction - wiley online library research source from wiley online library. study design, sample size, limitations, and safety signals matter. studies_papers journalism wiley online library safety cataloged source primary-source record" }, { "id": "latest_scan-T2hpbyBsYXdtYW", "title": "Ohio lawmakers consider joining other states to test psychedelic-assisted treatments - Ohio Capital Journal", "category": "studies_papers", "sourceType": "journalism", "sourceName": "Ohio Capital Journal", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPelJ1c3hVR3BHWDVOaTJLWFBVOXpnN1RlUHp4U0F0WThwQjFZOGVzU2JCRzFVRDNzWEZqTnRZRjlWckZkaXh4aGtGcml1b0t6TlZEQ3BLaTU4TzM4V1M5SHV6RTBBQnlVU0xiX201YUwxQ01IckwxeTNpckEydC0xSG1mWV9nOUR4RDc2ZWR6blFYM2tFWDAzSFNkQjNGQkhOYlhhNzVYRHdFRFNKTVk3MzY4S0pGVjFGY0JvSXkwNlhfcnBYWlE?oc=5", "summary": "Research source from Ohio Capital Journal. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 13 May 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "Ohio Capital Journal", "displayDate": "May 13, 2026", "whatItIs": "Journalism", "conversationContext": "Covers Ohio lawmakers consider joining other states to test psychedelic-assisted treatments.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "ohio lawmakers consider joining other states to test psychedelic-assisted treatments - ohio capital journal research source from ohio capital journal. study design, sample size, limitations, and safety signals matter. studies_papers journalism ohio capital journal research cataloged source primary-source record" }, { "id": "latest_scan-TGVnaXNsYXRpdm", "title": "Legislative updates in Mississippi, West Virginia, Oregon, and New Hampshire; Fast-tracked federal approval of Compass's synthetic psilocybin was vetoed; Federal bill proposes VA study psychedelics - The Microdose", "category": "studies_papers", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9DUmtrSU1jcEdXUEIyVVZmYzBNdUxnb1M0S01PeUZkOVU4XzcwVW1fV0p5MmtHcGMxWFhqbkNKS3l4anhmd291RU9zcHRCQzNUZzF2OUMwUXNWRXNhamsyam95cW03VUxucUVjM3d5UHkwWEN2eHpXWU9B?oc=5", "summary": "Research source from The Microdose. Study design, sample size, limitations, and safety signals matter.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 06 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "blogs" ], "displayCategory": "Studies and papers", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "Feb 6, 2026", "whatItIs": "Journalism", "conversationContext": "Covers blogs.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "legislative updates in mississippi, west virginia, oregon, and new hampshire; fast-tracked federal approval of compass's synthetic psilocybin was vetoed; federal bill proposes va study psychedelics - the microdose research source from the microdose. study design, sample size, limitations, and safety signals matter. studies_papers journalism the microdose blogs cataloged source primary-source record" }, { "id": "latest_scan-UHJvdGVjdGl2ZS", "title": "Protective effect of the aqueous extract of Tabernaemontana stapfiana (Apocynaceae) stem bark against monosodium glutamate-induced neurotoxicity in Swiss albino mice.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "IBRO neuroscience reports", "url": "https://pubmed.ncbi.nlm.nih.gov/42063982/", "summary": "Research source from IBRO neuroscience reports. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Jun", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "IBRO neuroscience reports", "displayDate": "Jun 1, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Protective effect of the aqueous extract of Tabernaemontana stapfiana (Apocynaceae) stem bark against monosodium glutamate-induced neurotoxicity in Swiss albino mice..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "protective effect of the aqueous extract of tabernaemontana stapfiana (apocynaceae) stem bark against monosodium glutamate-induced neurotoxicity in swiss albino mice. research source from ibro neuroscience reports. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study ibro neuroscience reports research cataloged source peer-reviewed paper" }, { "id": "latest_scan-UmFyZSBidXQgcm", "title": "Rare but relevant: Ibogaine and cardiovascular complications-prolonged QT interval and ventricular arrhythmias.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Addiction (Abingdon, England)", "url": "https://pubmed.ncbi.nlm.nih.gov/41560340/", "summary": "Research source from Addiction (Abingdon, England). Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Jun", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Addiction (Abingdon, England)", "displayDate": "Jun 1, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Rare but relevant: Ibogaine and cardiovascular complications-prolonged QT interval and ventricular arrhythmias..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "rare but relevant: ibogaine and cardiovascular complications-prolonged qt interval and ventricular arrhythmias. research source from addiction (abingdon, england). study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study addiction (abingdon, england) research cataloged source peer-reviewed paper" }, { "id": "latest_scan-RXhwbG9yaW5nIH", "title": "Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Journal of psychoactive drugs", "url": "https://pubmed.ncbi.nlm.nih.gov/42171381/", "summary": "Research source from Journal of psychoactive drugs. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 May 22", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Journal of psychoactive drugs", "displayDate": "May 22, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "exploring the use of ibogaine in opioid recovery: insights from lived experience. research source from journal of psychoactive drugs. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study journal of psychoactive drugs research cataloged source peer-reviewed paper" }, { "id": "latest_scan-SWJvZ2FpbmUgaW", "title": "Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT03380728", "summary": "COMPLETED", "confidence": "Registry record", "status": "Completed", "people": [], "publishedAt": "2017-12-15", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Dec 15, 2017", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "ibogaine in the treatment of alcoholism: an open-label escalating-dose trial completed studies_papers clinical_trial_registry clinicaltrials.gov trials completed registry record" }, { "id": "latest_scan-RnJvbSBtb25vdG", "title": "From monotherapy to sequential models: An updated scoping review on ibogaine's role in treatment for psychiatric disorders.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Journal of psychopharmacology (Oxford, England)", "url": "https://pubmed.ncbi.nlm.nih.gov/42117212/", "summary": "Research source from Journal of psychopharmacology (Oxford, England). Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 May 12", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Journal of psychopharmacology (Oxford, England)", "displayDate": "May 12, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers From monotherapy to sequential models: An updated scoping review on ibogaine's role in treatment for psychiatric disorders..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "from monotherapy to sequential models: an updated scoping review on ibogaine's role in treatment for psychiatric disorders. research source from journal of psychopharmacology (oxford, england). study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study journal of psychopharmacology (oxford, england) research cataloged source peer-reviewed paper" }, { "id": "latest_scan-RGV2ZWxvcG1lbn", "title": "Development of Bioisosteres of Iboga Alkaloids: A Step-Economical Synthesis to Enhance the Antinociceptive and Anxiolytic Activity with Neuroprotective Effects.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "ACS pharmacology & translational science", "url": "https://pubmed.ncbi.nlm.nih.gov/42130713/", "summary": "Research source from ACS pharmacology & translational science. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 May 8", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "ACS pharmacology & translational science", "displayDate": "May 8, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Development of Bioisosteres of Iboga Alkaloids: A Step-Economical Synthesis to Enhance the Antinociceptive and Anxiolytic Activity with Neuroprotective Effects..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "development of bioisosteres of iboga alkaloids: a step-economical synthesis to enhance the antinociceptive and anxiolytic activity with neuroprotective effects. research source from acs pharmacology & translational science. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study acs pharmacology & translational science research cataloged source peer-reviewed paper" }, { "id": "latest_scan-QmxpbmRpbmcgSW", "title": "Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "JAMA psychiatry", "url": "https://pubmed.ncbi.nlm.nih.gov/41984443/", "summary": "Research source from JAMA psychiatry. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Apr 15", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "JAMA psychiatry", "displayDate": "Apr 15, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "blinding integrity in psychedelic randomized clinical trials: a systematic review. research source from jama psychiatry. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study jama psychiatry research cataloged source peer-reviewed paper" }, { "id": "latest_scan-T3JhbCAxOC1tZX", "title": "Oral 18-methoxycoronaridine activity in simian and murine Leishmania amazonensis infection.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Frontiers in pharmacology", "url": "https://pubmed.ncbi.nlm.nih.gov/42038284/", "summary": "Research source from Frontiers in pharmacology. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Frontiers in pharmacology", "displayDate": "2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Oral 18-methoxycoronaridine activity in simian and murine Leishmania amazonensis infection..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "oral 18-methoxycoronaridine activity in simian and murine leishmania amazonensis infection. research source from frontiers in pharmacology. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study frontiers in pharmacology research cataloged source peer-reviewed paper" }, { "id": "latest_scan-VW5sb2NraW5nIH", "title": "Unlocking the cytotoxic potential of Apocynaceae monoterpene indole and bis-indole alkaloids: a review.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Natural product research", "url": "https://pubmed.ncbi.nlm.nih.gov/41941660/", "summary": "Research source from Natural product research. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Apr 6", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Natural product research", "displayDate": "Apr 6, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Unlocking the cytotoxic potential of Apocynaceae monoterpene indole and bis-indole alkaloids: a review..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "unlocking the cytotoxic potential of apocynaceae monoterpene indole and bis-indole alkaloids: a review. research source from natural product research. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study natural product research research cataloged source peer-reviewed paper" }, { "id": "latest_scan-VGFiZXJuYWVtb2", "title": "Tabernaemontana catharinensis: A Source of Indole Alkaloids With Potential Activity as Chemotherapeutic Agents.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Chemistry & biodiversity", "url": "https://pubmed.ncbi.nlm.nih.gov/42026976/", "summary": "Research source from Chemistry & biodiversity. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Apr", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Chemistry & biodiversity", "displayDate": "Apr 1, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers Tabernaemontana catharinensis: A Source of Indole Alkaloids With Potential Activity as Chemotherapeutic Agents..", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "tabernaemontana catharinensis: a source of indole alkaloids with potential activity as chemotherapeutic agents. research source from chemistry & biodiversity. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study chemistry & biodiversity research cataloged source peer-reviewed paper" }, { "id": "latest_scan-VVMgc3BlZWRzIH", "title": "US speeds up research into mind-altering drugs - including mysterious 'ibogaine'.", "category": "studies_papers", "sourceType": "peer_reviewed_study", "sourceName": "Nature", "url": "https://pubmed.ncbi.nlm.nih.gov/42020588/", "summary": "Research source from Nature. Study design, sample size, limitations, and safety signals matter.", "confidence": "Peer-reviewed paper", "status": "Cataloged source", "people": [], "publishedAt": "2026 Apr", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Studies and papers", "displaySourceType": "Peer-reviewed paper", "displaySourceName": "Nature", "displayDate": "Apr 1, 2026", "whatItIs": "Peer-reviewed paper", "conversationContext": "Covers US speeds up research into mind-altering drugs.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "us speeds up research into mind-altering drugs - including mysterious 'ibogaine'. research source from nature. study design, sample size, limitations, and safety signals matter. studies_papers peer_reviewed_study nature research cataloged source peer-reviewed paper" }, { "id": "latest_scan-UHN5Y2hlZGVsaW", "title": "Psychedelic Stocks Rally After Trump’s Executive Order - Forbes", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Forbes", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPbk5SMll6cWlyTEpCNUoxNnVHaFBjMGVqOVB0TWVUa2ZmcnFuS3pMc0w0OFNiWVpseWRQOHFNNkxKNl9GeU93d3BfTU5fLWFKTnIxV1hHWWotb1JwMXd6VF9kcjhlUy0tbjJBUGxjcC1wSkhaenRrYjc1ZWZia0VaM3pHTHBPU19ZYU9EQlFodTZCcllLc1hZTzhhUDQtVm1NcElyLTdzWTl2QWF1ODJfX0ZGSVk1Q2NjWGp3a1NiVUZMRUVvUHd3?oc=5", "summary": "News or commentary from Forbes. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 20 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Forbes", "displayDate": "Apr 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "psychedelic stocks rally after trump’s executive order - forbes news or commentary from forbes. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism forbes companies cataloged source primary-source record" }, { "id": "latest_scan-UGVyc29uYWxpdH", "title": "Personality and Drug Use (PDU)", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT05180149", "summary": "WITHDRAWN", "confidence": "Registry record", "status": "Withdrawn", "people": [], "publishedAt": "2021-12-17", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Dec 17, 2021", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "personality and drug use (pdu) withdrawn studies_papers clinical_trial_registry clinicaltrials.gov trials withdrawn registry record" }, { "id": "latest_scan-VHJpZmVjdGEgUm", "title": "Trifecta Research Study", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT06810765", "summary": "WITHDRAWN", "confidence": "Registry record", "status": "Withdrawn", "people": [], "publishedAt": "2025-01-24", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Jan 24, 2025", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "trifecta research study withdrawn studies_papers clinical_trial_registry clinicaltrials.gov trials withdrawn registry record" }, { "id": "latest_scan-UHJlbGltaW5hcn", "title": "Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT04003948", "summary": "COMPLETED", "confidence": "Registry record", "status": "Completed", "people": [], "publishedAt": "2019-06-27", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Jun 27, 2019", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "preliminary efficacy and safety of ibogaine in the treatment of methadone detoxification completed studies_papers clinical_trial_registry clinicaltrials.gov trials completed registry record" }, { "id": "latest_scan-UHJlLXBvc3QgRX", "title": "Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT04313712", "summary": "ACTIVE_NOT_RECRUITING", "confidence": "Registry record", "status": "Active Not Recruiting", "people": [], "publishedAt": "2020-03-16", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Mar 16, 2020", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "pre-post evaluation of the safety and efficacy of ibogaine-magnesium therapy in veterans with repeated blast exposure active_not_recruiting studies_papers clinical_trial_registry clinicaltrials.gov trials active not recruiting registry record" }, { "id": "latest_scan-TWFwcGluZyBJYm", "title": "Mapping Ibogaine Neural Dynamics in Opioid Use Disorder", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT07226570", "summary": "RECRUITING", "confidence": "Registry record", "status": "Recruiting", "people": [], "publishedAt": "2025-10-22", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Oct 22, 2025", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "mapping ibogaine neural dynamics in opioid use disorder recruiting studies_papers clinical_trial_registry clinicaltrials.gov trials recruiting registry record" }, { "id": "latest_scan-TXVsdGlwbGUgQX", "title": "Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers", "category": "studies_papers", "sourceType": "clinical_trial_registry", "sourceName": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/study/NCT06480981", "summary": "COMPLETED", "confidence": "Registry record", "status": "Completed", "people": [], "publishedAt": "2024-06-19", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "trials" ], "displayCategory": "Studies and papers", "displaySourceType": "Trial registry", "displaySourceName": "ClinicalTrials.gov", "displayDate": "Jun 19, 2024", "whatItIs": "Trial registry", "conversationContext": "Covers trials.", "whyListed": "Useful for evidence pages and claim checks. Read the design, sample size, limits, and safety signals.", "searchText": "multiple ascending dose noribogaine pk/pd in healthy volunteers completed studies_papers clinical_trial_registry clinicaltrials.gov trials completed registry record" }, { "id": "source_radar-RkRBIGFsbG93cy", "title": "FDA allows early-phase noribogaine hydrochloride study for alcohol use disorder to proceed", "category": "clinical_trials", "sourceType": "regulatory_or_legal", "sourceName": "source_radar", "url": "https://www.fda.gov/news-events/press-announcements/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order", "summary": "Important policy and research signal. FDA permission to proceed is not approval, safety proof, or efficacy proof.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-24", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "fda", "noribogaine", "aud", "clinical_trial" ], "displayCategory": "Clinical trials", "displaySourceType": "Regulatory Or Legal", "displaySourceName": "FDA", "displayDate": "Apr 24, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers fda, noribogaine, aud, clinical trial.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "fda allows early-phase noribogaine hydrochloride study for alcohol use disorder to proceed important policy and research signal. fda permission to proceed is not approval, safety proof, or efficacy proof. clinical_trials regulatory_or_legal source_radar fda noribogaine aud clinical_trial cataloged source primary-source record" }, { "id": "source_radar-VVRNQiBIZWFsdG", "title": "UTMB Health and UTHealth Houston awarded $50M to lead ibogaine clinical trials", "category": "clinical_trials", "sourceType": "university_release", "sourceName": "source_radar", "url": "https://www.utmb.edu/news/article/utmb-news/2025/12/12/utmb-health--in-collaboration-with-uthealth-houston--awarded--50-million-by-the-state-of-texas-to-lead-ibogaine-clinical-trials", "summary": "Track consortium members, trial registration, matching funds, and protocol publication.", "confidence": "University Release", "status": "Cataloged source", "people": [], "publishedAt": "2025-12-12", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "texas", "impact", "clinical_trials", "public_funding" ], "displayCategory": "Clinical trials", "displaySourceType": "University Release", "displaySourceName": "UTMB", "displayDate": "Dec 12, 2025", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers texas, impact, clinical trials, public funding.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "utmb health and uthealth houston awarded $50m to lead ibogaine clinical trials track consortium members, trial registration, matching funds, and protocol publication. clinical_trials university_release source_radar texas impact clinical_trials public_funding cataloged source university release" }, { "id": "source_radar-SFJBIHN1bW1hcn", "title": "HRA summary for multiple ascending dose noribogaine PK/PD study", "category": "clinical_trials", "sourceType": "clinical_trial_registry", "sourceName": "source_radar", "url": "https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/multiple-ascending-dose-noribogaine-pkpd-study-in-healthy-volunteers/", "summary": "NCT06480981; track trial status, design, endpoints, sponsor, and QT/cardiac monitoring language.", "confidence": "Registry record", "status": "Cataloged source", "people": [], "publishedAt": "2024", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "noribogaine", "aud", "safety", "qt" ], "displayCategory": "Clinical trials", "displaySourceType": "Trial registry", "displaySourceName": "UK Health Research Authority", "displayDate": "2024", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers noribogaine, aud, safety, qt.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "hra summary for multiple ascending dose noribogaine pk/pd study nct06480981; track trial status, design, endpoints, sponsor, and qt/cardiac monitoring language. clinical_trials clinical_trial_registry source_radar noribogaine aud safety qt cataloged source registry record" }, { "id": "source_radar_archive-VGV4YXMgd2lsbC", "title": "Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help - KSAT", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "KSAT", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPU19qUDVrNl9KTTYzdS14YzU4U2stLWhMRGtyZlRVQks3NzMzcW8ycmdYdndzblRodG8xMU8zY2hmcFNuMnpHOE83N1RicXhNNnN2bmJUNHFkSzB4M2tKcXVtaVZEd1NHMXlUVE96dlBuMEx1RktDenItUjRoTEpJOGpaM1B6SU8wejVMaEg0ci1FVWdsV2JMU3BuR1ZhdDN2WVRZN2lUeTF3MVU3Qi0wQkZfakRyNHVMcG9ES1Brd09WVUNhWGpCWjZobG0tQ19xcFNucXdMWTFXX1RkWlIySlVRZXJ5SXlLQ05JOQ?oc=5", "summary": "Research or trial-status source from KSAT. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 31 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "KSAT", "displayDate": "Mar 31, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers law.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help - ksat research or trial-status source from ksat. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism ksat law cataloged source primary-source record" }, { "id": "source_radar_archive-VE4gY2xlYXJzIH", "title": "TN clears way for clinical trials of ibogaine, same drug classification as LSD - WZTV", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "WZTV", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxORnpfOTdMcEZWZEkzczBGZURBcTR4MVlnVTVndm90MEpOSktxVk1taWY3QjNzeGRkN0RwRkJ3emxyTkp6VzVvMXIzc0lEMkpNczdoWjJPczdfcFJOT3E1aTBHUXltWTFkanQtejNqQWxYS2NKM0cyQkp1ZXpBTHJxQTZSSlIxdWcwMlJLSm5ud2Zqak1Ockk2eDdmWVVRVC1hWlo0b2RVTU1CdDg?oc=5", "summary": "Research or trial-status source from WZTV. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 02 May 2026 07:00:00 GMT", "foundAt": "2026-05-22T18:23:44.248Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "WZTV", "displayDate": "May 2, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers TN clears way for clinical trials of ibogaine, same drug classification as LSD.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "tn clears way for clinical trials of ibogaine, same drug classification as lsd - wztv research or trial-status source from wztv. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism wztv research cataloged source primary-source record" }, { "id": "source_radar_archive-VGVubmVzc2VlIG", "title": "Tennessee lawmakers approve HOPE Act to allow ibogaine clinical trials for addiction - WTVC", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "WTVC", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPeVluMFhtVFFoZGpESW1qQ1E4Mzd3dFF2V3BBdk9ReGpiRS1lZklOVlYyMWFFaWIzQi1aNThXcWl0MEZZVExPWk55S0FyMnJXRjhyZTdUUldVeW94TFRwNFBxMGhrbUp5NlprcWc0cWJlbTc2QnNBRU5YU3JIM1BCeDJQTWxzaHRSTk9WWWtsc3dFanl2R1Y0d3FLejNQdnozRVFvVmltel9vNHp5eERQTzF0MDRMdjN5OHU4WA?oc=5", "summary": "Research or trial-status source from WTVC. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "WTVC", "displayDate": "Apr 24, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers Tennessee lawmakers approve HOPE Act to allow ibogaine clinical trials for addiction.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "tennessee lawmakers approve hope act to allow ibogaine clinical trials for addiction - wtvc research or trial-status source from wtvc. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism wtvc research cataloged source primary-source record" }, { "id": "source_radar_archive-V2hhdCB0byBrbm", "title": "What to know about ibogaine as Texas lawmakers eye clinical trial - USA Today", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "USA Today", "url": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxPcEJWbkJES2RoOWhMUGJtNFlGM2ZQajJ6X0JwT00wclJiS2swcUlVcFpySVpzQVFfSHM3MHh3VV96aWRLb1lvaWJxSmlsNzVqQXY2U1o0ZEtvVTkyVVlyNUEyUGZqemtHVUxBRXMydnBER2RpamFtZlRCUFlyV2NKSmJPZ3lmVldySGZLYXB6OGYzbHhNSDVqakQxWm9UT1hEMTRHTVdNSUJXYmhJc0xZNl9RMlpVZDhVVnhCa3ZfY01JZ09EaWR2TFI0ZEZDZHlJVDRDbHZ2T3NBZUtnVnoxUWxwT2dMN2tVQlhRc2Q0bjNBLVVkRFNid3Rpblg?oc=5", "summary": "Research or trial-status source from USA Today. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "USA Today", "displayDate": "Apr 21, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers What to know about ibogaine as Texas lawmakers eye clinical trial.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "what to know about ibogaine as texas lawmakers eye clinical trial - usa today research or trial-status source from usa today. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism usa today research cataloged source primary-source record" }, { "id": "source_radar_archive-T2tsYWhvbWEgU2", "title": "Oklahoma Senate Advances Research-Focused Ibogaine Bill - Filter", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Filter", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1mbUt4WjhqRmxfbFpsanlac1lxajhBZElOWmY1d1RqejMxNmpzS3dJQU9lYlZnOEExS1U5RUdibjJvQklKb1cyVWdoQ2RJa2xoVE5QS2E2TnM?oc=5", "summary": "Law or policy source from Filter. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 04 May 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Filter", "displayDate": "May 4, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "oklahoma senate advances research-focused ibogaine bill - filter law or policy source from filter. read the exact source before drawing legal conclusions. laws_policy journalism filter law cataloged source primary-source record" }, { "id": "source_radar_archive-VGV4YXMgdG8gY2", "title": "Texas to conduct its own ibogaine clinical trials - The Texas Tribune", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "The Texas Tribune", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNM2xyRnZ5dkJjaG9TSlYwVHBRam1lX1NxOXhLWTFGaTQ2RldzRHlyajFfWGxoczN5V2FrQzFmWnhoTTZJdXgyT0hpeEpYa2JIS2JIWC16SnN0ZFdHNFlzZHN0bHloQm5LdnRONTFwa0pKWU0xNXhmMk90WVMtWi1pWEtPczEySk5mRWlCUkdLbWttSFIza2NSSw?oc=5", "summary": "Research or trial-status source from The Texas Tribune. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 31 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-16T22:40:56.064Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "The Texas Tribune", "displayDate": "Mar 31, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers Texas to conduct its own ibogaine clinical trials.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "texas to conduct its own ibogaine clinical trials - the texas tribune research or trial-status source from the texas tribune. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism the texas tribune research cataloged source primary-source record" }, { "id": "source_radar_archive-WmFjaGFyeSBGZW", "title": "Zachary Federico Testimony in Maryland: Funding for Clinical Trials of Ibogaine - American Legislative Exchange Council", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "American Legislative Exchange Council", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOSDJFOHZGYzRETFdjeVVQb1p1bkVMMnFaZFJZNDZyc29HMVJ1QVVaX2lYa3Q0WlBYVjVsbENJSDZkUW9xSHViTklCZVBFQWFPLTFaM0oyYWs4OUN3Z3VIZGc3WVBIUU9samFZSzhzQ1d2N215dU5ia0l2T01RejMzRFI4ZVZxbkE?oc=5", "summary": "Research or trial-status source from American Legislative Exchange Council. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 02 Mar 2026 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "American Legislative Exchange Council", "displayDate": "Mar 2, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers blogs.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "zachary federico testimony in maryland: funding for clinical trials of ibogaine - american legislative exchange council research or trial-status source from american legislative exchange council. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism american legislative exchange council blogs cataloged source primary-source record" }, { "id": "source_radar_archive-TGVnaXNsYXRvcn", "title": "Legislators send bill to Reeves to fund ibogaine mental health clinical trials - Mississippi Today", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "Mississippi Today", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9IWkRkNmtqekoyRzdndHNCME50NTBJNE05eFlxNTlTaVdmVm1JLWY5ZFoyZjJOTWNwRnlXQ2pJMEEzVWk4bWdMa29rZlBJMm5yOGgtMDdFdENvS0NsSGdyeko2S0tTWU1hRndWZWJrOGRRd19hYkE5RE5CaDFmQQ?oc=5", "summary": "Research or trial-status source from Mississippi Today. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 19 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "Mississippi Today", "displayDate": "Mar 19, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers law.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "legislators send bill to reeves to fund ibogaine mental health clinical trials - mississippi today research or trial-status source from mississippi today. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism mississippi today law cataloged source primary-source record" }, { "id": "source_radar_archive-R292ZXJub3Igc2", "title": "Governor signs Ibogaine clinical trial bill into law - magnoliatribune.com", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "magnoliatribune.com", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOR2RCMUVaOVprNkdQTXNQSkYxRU9CbndmNEctNXRhRjROZHotRG12X3RvY0V3SFVTRWxjeTJkTzFYT2FwS201MzVSNDZpWkNzdHotZVZNTHBPRWtjektDbTFzV3pVb2RNM21zZmowTV9VbE03em9TYmVXMUx5R3JGdEl2VlA1RHFHUG1FU1VCWHZEU2U5cW1V?oc=5", "summary": "Research or trial-status source from magnoliatribune.com. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 30 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-29T14:47:14.124Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "magnoliatribune.com", "displayDate": "Mar 30, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers law.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "governor signs ibogaine clinical trial bill into law - magnoliatribune.com research or trial-status source from magnoliatribune.com. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism magnoliatribune.com law cataloged source primary-source record" }, { "id": "source_radar_archive-U2VuYXRlIFB1Ym", "title": "Senate Public Health Committee advances bill to allow Ibogaine trials - Magnolia Tribune", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "Magnolia Tribune", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNQlplZ0Y2NC1sM2ZyN2YyLVFBV0Y2X1prcENjbnBtb0FUSXdMc1F6WXpmN0xRSDZ5eWpnMlJtaE9mejdrTHNXQ3BkRmxOb3NGczU0d0tTWUh6eVVSZEJUUVpIT1Q1RDhHZW40UWE2RlU2czZaTDIxbVp2bjY2WTU2VFprX1BlWk5FclhHdVdJUGZWR242QVlLb2l1R21GcDd1alBKbWRpb2hoUl9tTXc?oc=5", "summary": "Research or trial-status source from Magnolia Tribune. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 27 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "Magnolia Tribune", "displayDate": "Feb 27, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers law.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "senate public health committee advances bill to allow ibogaine trials - magnolia tribune research or trial-status source from magnolia tribune. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism magnolia tribune law cataloged source primary-source record" }, { "id": "source_radar_archive-TG91aXNpYW5hIG", "title": "Louisiana considers supporting clinical trials of ibogaine, MDMA, other psychedelics - Louisiana Illuminator", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "Louisiana Illuminator", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1rNnhqZkFPTXljNmxpNzdvd3IzVU42M21MRlFUemc3Uk9PenYzMEZqU1hjVEFfenBDWnBFS2J0c2tEOHZLeHk5MW9Jek5XZWNqa0I3WmpFX25MdnE0SHM2YncxemlTdTk3RjRFVnBDbUM0UHNqWUxoaFRkOHl1UQ?oc=5", "summary": "Research or trial-status source from Louisiana Illuminator. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 18 May 2026 20:00:52 GMT", "foundAt": "2026-05-18T22:41:55.023Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "Louisiana Illuminator", "displayDate": "May 18, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers Louisiana considers supporting clinical trials of ibogaine, MDMA, other psychedelics.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "louisiana considers supporting clinical trials of ibogaine, mdma, other psychedelics - louisiana illuminator research or trial-status source from louisiana illuminator. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism louisiana illuminator research cataloged source primary-source record" }, { "id": "source_radar_archive-VW5pdmVyc2FsIE", "title": "Universal Ibogaine appoints Julie Dumouchel to lead clinical trial and related projects of ibogaine-centered addiction treatment - Proactive financial news", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "Proactive financial news", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPSk9URnliZnF3d1prSUFzc2dZOGhrelJ4aS1WRVQweXlBdGZ3Z01wRFdta3RxTUotUEs2TWlsbnBCQVZPYXRwbjczMEFKX09DdUxvWGpjLWRJQUVxeE5RMmlYbW5RV1BpZDR2YUtOVEl6bF8wUERHaTM0YzlNTXRrMTdmc2w1b2RkQVVFaGJoTFN4aEdZbFo3NVg2YndrTVI2aGx6U3V1TmJJYUR0RGlUMHRZTEZ5ZmlNRTVDTGlWaHM5VXo5bEVydFE5alR3R0NDTUczdVUwMjFWUGJLMkNxNDB5UjFpOHI0cE9yR0tLb2VtelNJaWFkdnpLY1A0bU82Rzd3T3doTGYzOFh0dEx4NHY5cTBRblQxbmQ3Skp1LWtRWDQ?oc=5", "summary": "Research or trial-status source from Proactive financial news. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 23 Mar 2022 07:00:00 GMT", "foundAt": "2026-05-28T21:24:34.240Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "Proactive financial news", "displayDate": "Mar 23, 2022", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "universal ibogaine appoints julie dumouchel to lead clinical trial and related projects of ibogaine-centered addiction treatment - proactive financial news research or trial-status source from proactive financial news. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism proactive financial news commercial cataloged source primary-source record" }, { "id": "latest_scan-VmV0ZXJhbnMgQW", "title": "Veterans Affairs announces new MDMA clinical trial; Psilocybin’s antidepressant effects are both rapid and long-lasting - The Microdose", "category": "clinical_trials", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBMWXFYUm9aS09FeGtFbTZKU0FtNHplb3AweU4wRWJuQlRGdDd0QkE3LUFDR28yR3Q1bFBnRG5veE9OSkZWRlVaSEdodFRCQUM1YUtCSEFFRDZfallTQTI2cFIwMTdZRnYxclJSRk9EbzNxc1lhd3U1WkZkaw?oc=5", "summary": "Research or trial-status source from The Microdose. A listing or announcement does not prove safety, efficacy, approval, or availability.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 29 May 2026 15:31:11 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "Clinical trials", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "May 29, 2026", "whatItIs": "Trial, registry, agency, or research-status record.", "conversationContext": "Covers Veterans Affairs announces new MDMA clinical trial; Psilocybin’s antidepressant effects are both rapid and long-lasting.", "whyListed": "Useful for tracking research status. A trial listing or announcement is not proof that a treatment works.", "searchText": "veterans affairs announces new mdma clinical trial; psilocybin’s antidepressant effects are both rapid and long-lasting - the microdose research or trial-status source from the microdose. a listing or announcement does not prove safety, efficacy, approval, or availability. clinical_trials journalism the microdose research cataloged source primary-source record" }, { "id": "source_radar-U2NpZW50aWZpYy", "title": "Scientific American evaluates public claims about Ibogaine for PTSD and depression", "category": "laws_policy", "sourceType": "journalism", "sourceName": "source_radar", "url": "https://www.scientificamerican.com/article/rfk-jr-praises-ibogaine-for-depression-treatment-is-the-psychedelic-a-magic-bullet/", "summary": "Use as claim-check context: promise exists, but 'most promising' or magic-bullet language is overstated; cardiac toxicity remains central.", "confidence": "Journalism", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-24", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "mental_health", "ptsd", "depression", "claim_check", "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "scientificamerican.com", "displayDate": "Apr 24, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers mental health, ptsd, depression, claim check.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "scientific american evaluates public claims about ibogaine for ptsd and depression use as claim-check context: promise exists, but 'most promising' or magic-bullet language is overstated; cardiac toxicity remains central. laws_policy journalism source_radar mental_health ptsd depression claim_check policy cataloged source journalism" }, { "id": "source_radar-VGV4YXMgR292ZX", "title": "Texas Governor signs SB 2308 ibogaine research law", "category": "laws_policy", "sourceType": "government_release", "sourceName": "source_radar", "url": "https://gov.texas.gov/news/post/governor-abbott-signs-ibogaine-treatment-research-law-at-texas-capitol", "summary": "Core policy tracker entry; connect to bill text, appropriations, grants, trial requirements, and oversight reports.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2025-06-11", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "texas", "law", "public_funding", "veterans" ], "displayCategory": "Law and policy", "displaySourceType": "Government Release", "displaySourceName": "Texas Governor's Office", "displayDate": "Jun 11, 2025", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers texas, law, public funding, veterans.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "texas governor signs sb 2308 ibogaine research law core policy tracker entry; connect to bill text, appropriations, grants, trial requirements, and oversight reports. laws_policy government_release source_radar texas law public_funding veterans cataloged source primary-source record" }, { "id": "source_radar-MjEgQ0ZSIDEzMD", "title": "21 CFR 1308.11 lists ibogaine as Schedule I", "category": "laws_policy", "sourceType": "regulatory_or_legal", "sourceName": "source_radar", "url": "https://www.law.cornell.edu/cfr/text/21/1308.11", "summary": "Primary U.S. legal-status entry; recheck eCFR/Cornell when making current legal claims.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "current", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "law", "united_states", "schedule_i" ], "displayCategory": "Law and policy", "displaySourceType": "Regulatory Or Legal", "displaySourceName": "Cornell Legal Information Institute", "displayDate": "current", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law, united states, schedule i.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "21 cfr 1308.11 lists ibogaine as schedule i primary u.s. legal-status entry; recheck ecfr/cornell when making current legal claims. laws_policy regulatory_or_legal source_radar law united_states schedule_i cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgZm", "title": "Ibogaine for Alzheimer’s Disease? Why Brain Experts Are Paying Attention - AOL.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "AOL.com", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOdTNjNTBLaGExeW1BWEZsbVBveFBVcFZfVFpLT1dzc1Zubmk5YW8xc25FZVdNUzhHVElGeFgyUEdxUDU0ZmdWdHc4R1c1QXAzR3Uzc3M2YjFWSkVqc29LT0ZKc09XZWN5YkxmU25JMW9ta3ltbnBDTW9sVnZ4RVFmdkl5a2tINU9U?oc=5", "summary": "News or commentary from AOL.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 20 May 2026 10:55:04 GMT", "foundAt": "2026-05-21T08:39:08.526Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "AOL.com", "displayDate": "May 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine for alzheimer’s disease? why brain experts are paying attention - aol.com news or commentary from aol.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism aol.com conditions cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgaX", "title": "Ibogaine is a banned hallucinogenic drug. Scientists believe it can help veterans overcome PTSD - BBC", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "BBC", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOU191SVo5NTJsZ0U1WEtMNEhTaWRwOVlBSFJPTzN5akdrcDkwUmZwbEVIUG84aGZ4VldtMTl4QUd2bmFmbXRHRVRwdW84ZFFUeXFQQndSX0tzTF9qNERiWGNUSE9nOVpvNk51U3hUODY4WG9HaWVlampxM2stTDNhZWduWGt3am1KclFwRzZSa2VTV05FT0ZYVTZKM1A2VFJaNlE?oc=5", "summary": "News or commentary from BBC. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 15 May 2026 10:00:00 GMT", "foundAt": "2026-05-15T14:42:32.563Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "BBC", "displayDate": "May 15, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Ibogaine is a banned hallucinogenic drug. Scientists believe it can help veterans overcome PTSD.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine is a banned hallucinogenic drug. scientists believe it can help veterans overcome ptsd - bbc news or commentary from bbc. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism bbc research cataloged source primary-source record" }, { "id": "source_radar_archive-V2hhdCBpcyBpYm", "title": "What is ibogaine, the psychedelic drug endorsed by Joe Rogan? - NewsNation", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "NewsNation", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPWU5xN3k0cVdna2Qxd01RcDhaRERjT29seTY2Q3hVZm03OXg4eHRkeEtUcDRVOXdsZXQyd2JEMm9lNnNManNiWHdFYmRIOFBxejRtREVLNVdRVjdGNi1RbWRaV1pRODlYaVEyT0pHQkJDLVRpTGRMcGVqbTRIUkMwQ0NVdVBxZknSAYwBQVVfeXFMTW1wdmlBSWx3UTNTQXllZ3ZRZmtaUEdmbmNWd3J5S3FQc2pGa3BrejJIdnJYZHFjMkRtckozSmd1TTBVRUhnc043dzhLbXctcVVfYUgwT2Y2VmRZX2pKeHRfTTE5RG5nanFIMU9kOUZJT0pSYWdreDl0b2pqdW1rU0xPMVZUTTFVMk9kSmg?oc=5", "summary": "News or commentary from NewsNation. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-25T11:35:45.408Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "NewsNation", "displayDate": "Apr 21, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "what is ibogaine, the psychedelic drug endorsed by joe rogan? - newsnation news or commentary from newsnation. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism newsnation conditions cataloged source primary-source record" }, { "id": "source_radar_archive-SG93IElib2dhaW", "title": "How Ibogaine Became the Darling of the Psychedelic Right - rollingstone.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "rollingstone.com", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNSzc5Z09BY29FM01NNVh5RUE5YnVUM0Q5THllZnZOU2pVRGo3dGhRd1dRNDRWQ0pDMExndUdsaC12dWFtM1ZxSklMaXVjOEVZWjhzakZSVkxXcmJpLW1UZVZBZmZPMFNYTHh4QjRSR3FPMGRkblVrNTJtVC1uQUR3ZVB5Y0JpWHZwRjVrS0FYZGxlaWhiTG5TNjYwMi04WUdXRzYybEkwVWVkcGRlN0wtTk43cw?oc=5", "summary": "Law or policy source from rollingstone.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 22 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-29T11:18:33.463Z", "sourceOrigin": "source_radar_archive", "tags": [ "culture" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "rollingstone.com", "displayDate": "Apr 22, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers culture.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "how ibogaine became the darling of the psychedelic right - rollingstone.com law or policy source from rollingstone.com. read the exact source before drawing legal conclusions. laws_policy journalism rollingstone.com culture cataloged source primary-source record" }, { "id": "source_radar_archive-U3VyZU5hbm8gU2", "title": "SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio - newsfilecorp.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "newsfilecorp.com", "url": "https://news.google.com/rss/articles/CBMiqgJBVV95cUxNY2Vnel9yMjhaczJKYWMweXBmZkRvLVJEVF9QWEZDR3h2TC1jOTRpLTVZa3ZhM1hndktJcURLSDRnb2cwM2VvdzJLSlc3SW0zQUNYVVhveFFibVBlWXcxRGFRVWc2VC1NX1duUmpmTUxzNG1MY04yWFh4cnVSTi1FX1hYcEhDQjU1QldJUVVsM1VhTWlNQWk4N2w2YkY0dDNkaFNZSVNzZG84MElaTHh5ZWhPc0VDQ29KemVIb1laczlFZnpuYjlid1pCTUtNbWxXeHVBLVpVbW9rSXBna0RSZnAtMVRiZExfVDJ1Qy1PR2hWeTZjN2RjYkxpckFXRU1sVTZ4YWNwbk5iM2dzNkFJRGhSdnV4ZjZoYWFvQ0w1Q1JLM3FNM1p1UVh3?oc=5", "summary": "Law or policy source from newsfilecorp.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-27T13:36:07.621Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "newsfilecorp.com", "displayDate": "Apr 24, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "surenano science initiates fda stage glp toxicology and pharmacology studies for glp gep-44 and enters discussions to acquire ibogaine formulation ip portfolio - newsfilecorp.com law or policy source from newsfilecorp.com. read the exact source before drawing legal conclusions. laws_policy journalism newsfilecorp.com commercial cataloged source primary-source record" }, { "id": "source_radar_archive-SGVyZSdzIHdoYX", "title": "Here's what to know about they psychedelic drug called ibogaine - Houston Chronicle", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Houston Chronicle", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOdzNiRXV3UTNnLWhZWnI4eEZtOVVGTlNwV0lJNDdfNUVBZE5acEJqX2lDdTJzUXlJWXgwSUxPSXVxMjNFVkotZGQ2V01xc0dYbmgzVmVIQ3NJaWRYYmRTTjhheENiWHh5blpHSl9FLXZYdE9DUEFvZ2FVcWxBSTZaQUFGc3kyNHdHX0FhUU5ENXdWSjN0dzFJWG1JTDdkeU9PNlo4U3hqYw?oc=5", "summary": "Law or policy source from Houston Chronicle. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-11T14:40:37.308Z", "sourceOrigin": "source_radar_archive", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Houston Chronicle", "displayDate": "Apr 18, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "here's what to know about they psychedelic drug called ibogaine - houston chronicle law or policy source from houston chronicle. read the exact source before drawing legal conclusions. laws_policy journalism houston chronicle policy cataloged source primary-source record" }, { "id": "source_radar_archive-TWlzc2lzc2lwcG", "title": "Mississippi Senate panel advances bill for Ibogaine clinical trials - Tippah News", "category": "podcasts_interviews", "sourceType": "journalism", "sourceName": "Tippah News", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPMlh5M1FDR296SmtyNG9EWTk2dUQwRGVoeW0zZDN0Nnl0QlA5UnNaWEVYemVLQnV5dnRyUXMwNEl0RGZOX2JfZUhHejVUYVd0bjlJZGpnanVHa3k2cFAxVHdjRi1VQkxYMHk0eDU2cTlLdUl5LVJ4VFJJM0lBNGo3aDhOT3VWNlhKMTI2TDBNZjJqOFVIOW90N3FaQlZHVnVGdlJKSVRXY2pSSWV4?oc=5", "summary": "Covers Mississippi Senate panel advances bill for Ibogaine clinical trials. This is a media source, not medical evidence.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 28 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Journalism", "displaySourceName": "Tippah News", "displayDate": "Feb 28, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Mississippi Senate panel advances bill for Ibogaine clinical trials.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "mississippi senate panel advances bill for ibogaine clinical trials - tippah news covers mississippi senate panel advances bill for ibogaine clinical trials. this is a media source, not medical evidence. podcasts_interviews journalism tippah news media cataloged source primary-source record" }, { "id": "source_radar_archive-T2tsYWhvbWEgTG", "title": "Oklahoma Lawmakers Pass Ibogaine Bill, Sending Psychedelic Reform To Governor’s Desk - Marijuana Moment", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Marijuana Moment", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOdE5xdlRiemJDNmdrMEJFZWJXc3M3V0Iwd09UTWRyWnRvb0pPdzF0WEdPdEhlWW5pT0t6SE85aWpTUzlnOGJyT0FxSTNWdlpVZ1huS0ZERzhVd3FkamJTZ3JRSTU1VUFIb0ZPb0RGbmdrLVJnbDJSVmNWblhfTGU0eU50RGcyamQ1aFRWQXplX0dvVXIyQ2FxZVl3N2xlZ3JjNEwxcnBEU1lXVkc0QXBhS2hkTTNQZw?oc=5", "summary": "Law or policy source from Marijuana Moment. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 12 May 2026 17:33:45 GMT", "foundAt": "2026-05-12T20:40:52.104Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Marijuana Moment", "displayDate": "May 12, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers Oklahoma Lawmakers Pass Ibogaine Bill, Sending Psychedelic Reform To Governor’s Desk.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "oklahoma lawmakers pass ibogaine bill, sending psychedelic reform to governor’s desk - marijuana moment law or policy source from marijuana moment. read the exact source before drawing legal conclusions. laws_policy journalism marijuana moment research cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgZWFzZW", "title": "Trump eased restrictions on research for ibogaine. Here's what to know about the psychedelic drug - MSN", "category": "laws_policy", "sourceType": "journalism", "sourceName": "MSN", "url": "https://news.google.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?oc=5", "summary": "Law or policy source from MSN. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 30 May 2026 18:09:20 GMT", "foundAt": "2026-05-31T10:09:16.417Z", "sourceOrigin": "source_radar_archive", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "MSN", "displayDate": "May 30, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "trump eased restrictions on research for ibogaine. here's what to know about the psychedelic drug - msn law or policy source from msn. read the exact source before drawing legal conclusions. laws_policy journalism msn policy cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgU2lnbn", "title": "Trump Signs Order to Speed Review of Psychedelics, Including the Controversial Drug Ibogaine - VINnews", "category": "laws_policy", "sourceType": "journalism", "sourceName": "VINnews", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNQk1FZXpkYmhTTGNZcDdYTUpzZTJWQkN0dU1hZC0zci1tWThMWHV1dnR1ZmY5eWN3RHFjVTNZWlNCTFlXRnk2d2RZaDNEOXM3eVNVSDlsRXI5R0xWTjhlaW5ma0R6WTdxT3dISG1aMHRFYTRXRlpNWGpuR2Z5T2h4RFE2amFWMXg4N1lKbjl0dEdGdE1KM1BhbHg3LVdZdVZKQlJPUVZzYmZjVlRhRkxNekMxY3FlUElWUGxCU3k4cUk?oc=5", "summary": "Law or policy source from VINnews. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "VINnews", "displayDate": "Apr 18, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers Trump Signs Order to Speed Review of Psychedelics, Including the Controversial Drug Ibogaine.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "trump signs order to speed review of psychedelics, including the controversial drug ibogaine - vinnews law or policy source from vinnews. read the exact source before drawing legal conclusions. laws_policy journalism vinnews media cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgcm", "title": "Ibogaine research faces supply shortages; Psyence says doses are ready - Stock Titan", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Stock Titan", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPaklZWEZoTEpvZXJXazJNTkotYVpmUzlwMVFmdElhOEpqa2RmbURaUTlLbkJsbzZUSWFvdDRNUDRPQS1LVWhjcHhILWpHR2loNFhfUE5LNDYzdmdnckkybTlKS2xycXNMaldlLXZtQXMxZGpWSDdaYWdFMGU3UDBnOUczVHg4akZMRE5lOVpuamxRMUFiMmg4R3MxSEZ3OU5aaWR2X2t6Q1NMNTFVNnFBVXRqeHZHb0o1ZWY5TQ?oc=5", "summary": "News or commentary from Stock Titan. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 20 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Stock Titan", "displayDate": "Apr 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine research faces supply shortages; psyence says doses are ready - stock titan news or commentary from stock titan. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism stock titan companies cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmU6IF", "title": "Ibogaine: We're Funding Research While the Experiment Runs Unsupervised - celinegounder.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "celinegounder.com", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFBMQUFzNmUzWk9rQlpjODVycG55ZXpfQXNBSWlRcWozOVVzLWV6dWVScVo1Z19iT1ZLWDBPOUNZSEhpdlZBcHo1bDJGOWtZazlmY2FjYS00T2MtRExpSEU2NTZFVUI1eG56dTlnZ2t5SloybDlBSGc?oc=5", "summary": "News or commentary from celinegounder.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 16 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "celinegounder.com", "displayDate": "Apr 16, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers safety.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine: we're funding research while the experiment runs unsupervised - celinegounder.com news or commentary from celinegounder.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism celinegounder.com safety cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgb3JkZX", "title": "Trump orders more access to psychedelics like LSD, psilocybin and ibogaine - The Washington Post", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Washington Post", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPYmFsY0NaTUUzeTdKT1dQeWtELXdIcURPMTZQWGJ4WmlfQm14QnF5eGdXYzhZTExtUm9hTUZVWUJTalEtR1JZdndOZkVnM0duRV9jRnZVd3ZXd3lCYkh5dWtVUmtKejZlVUhxSDdFeXRKLXJuWXlrd1JlMTBIVk1yNTRLcVF3S0g3Qi05a0lhNFBjS3pk?oc=5", "summary": "News or commentary from The Washington Post. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 17 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Washington Post", "displayDate": "Apr 17, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "trump orders more access to psychedelics like lsd, psilocybin and ibogaine - the washington post news or commentary from the washington post. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the washington post blogs cataloged source primary-source record" }, { "id": "source_radar_archive-RXhlY3V0aXZlIG", "title": "Executive order opens door to psychedelic research, including ibogaine - Spectrum News", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Spectrum News", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPNk52RWNOanVyNXY5SUx1ZGIzdnBXUlZyUmtiN2Z1YUtlNXRFMEFTLVViNHRab3h6c19CR3BuZHNXUzBhbFI0dUNIa0dIYXFJd1ZWX0V0SDZLSjhMRW1TSFh3ZlIxcGhRR0xmT2I3YjhRUGp2RmtpXy1BVHlSczN1OXBSaDVMdVVnYmpKS3VlQkk0V3k3MXZVTnM4cmJ6S29CbEowZ1p5WUNXX011U1dseWtn?oc=5", "summary": "Law or policy source from Spectrum News. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 22 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Spectrum News", "displayDate": "Apr 22, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "executive order opens door to psychedelic research, including ibogaine - spectrum news law or policy source from spectrum news. read the exact source before drawing legal conclusions. laws_policy journalism spectrum news law cataloged source primary-source record" }, { "id": "source_radar_archive-QSBib25hbnphIG", "title": "A bonanza of new state psychedelics bills, including ones to fund ibogaine research and new trigger laws for synthetic psilocybin - The Microdose | Substack", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The Microdose | Substack", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9WNHhyQ0Z0VnVockVXVzl1MVhlV2F6WWtZZi1zMmhHSUQ0OXpVLWRKSnlZejQ0a3pSc0xBRkNxZnEyekZFRm1BRm1nOHhjMEZ5Qi16RXNfSmVrZWMzdHpLWmo1UEVObHFRa2J1ek5HcVNYSlhocHBsTmtfYw?oc=5", "summary": "Law or policy source from The Microdose | Substack. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 13 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The Microdose | Substack", "displayDate": "Feb 13, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "a bonanza of new state psychedelics bills, including ones to fund ibogaine research and new trigger laws for synthetic psilocybin - the microdose | substack law or policy source from the microdose | substack. read the exact source before drawing legal conclusions. laws_policy journalism the microdose | substack law cataloged source primary-source record" }, { "id": "source_radar_archive-U2VuYXRlIHBhc3", "title": "Senate passes legislation to fund ibogaine research - Mississippi Today", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Mississippi Today", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQbktzQm9pd3pVMlBHWVpjajV5SmhIOG1Cb29nVVBvRzBuZzd1M3l1TDRXcFlrNW13MjNmb2h2QUU0cTctYjNYTUZOUVdFQ0t3d1kzWFJxa2oyM2pjOXp6SjV0UkdoWUg0LTRpMWp0ZWxIN1E1NjNXUlFtLUJ5Ul9kSWtPaw?oc=5", "summary": "Law or policy source from Mississippi Today. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 05 Mar 2026 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Mississippi Today", "displayDate": "Mar 5, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "senate passes legislation to fund ibogaine research - mississippi today law or policy source from mississippi today. read the exact source before drawing legal conclusions. laws_policy journalism mississippi today law cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gaG", "title": "Colorado has a chance to get ibogaine policy right - Colorado Newsline", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Colorado Newsline", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOTmxwTlVReHpCNTIxbmRTMl9HQi1tWmZHZjJRQ1E3M1ZPd2Q3Z2tlenNuMEVFeGNsVHNJM3VMbGh0b0tXSk5nZXlwT2U4UW9KZnNuUDlfcWxkU0FGX3NOd1Z3eVE5Vld0Uk84bjBhUWtfNklMaGZxRkZKNDVubHpkYw?oc=5", "summary": "Law or policy source from Colorado Newsline. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 17 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Colorado Newsline", "displayDate": "Feb 17, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers safety.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "colorado has a chance to get ibogaine policy right - colorado newsline law or policy source from colorado newsline. read the exact source before drawing legal conclusions. laws_policy journalism colorado newsline safety cataloged source primary-source record" }, { "id": "source_radar_archive-TmV3IGFuYWx5c2", "title": "New analysis: Psychedelics may be no better than SSRIs in treating depression, Kentucky ibogaine bill and New Mexico psilocybin equity fund - The Microdose | Substack", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The Microdose | Substack", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1qdTRpcHdTUFpDLUpWV1hVU010dWVncjNuS1IzcHg3RUJzWWNYTEdNUGhOcGFsZmVzTy1mRXhPc0lTZHMwb1RPTFhTaFh2aF9IbnlwUUVyUGctVlZmUmtubmtHN1dVTUQzUm1uUHkwSFhETHRlQnZJ?oc=5", "summary": "Law or policy source from The Microdose | Substack. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 20 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-17T16:41:12.918Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The Microdose | Substack", "displayDate": "Mar 20, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers blogs.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "new analysis: psychedelics may be no better than ssris in treating depression, kentucky ibogaine bill and new mexico psilocybin equity fund - the microdose | substack law or policy source from the microdose | substack. read the exact source before drawing legal conclusions. laws_policy journalism the microdose | substack blogs cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXDigJlzIG", "title": "Trump’s ibogaine executive order is a big step to solve generational threat - Washington Examiner", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Washington Examiner", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOWGczNnI2ektVQzN6OHF4Yk8wcmpsOXJnYXoySzF4Tl93Q1U3Ymg1ZWVQUFExcmxKVkRBWFVpaVdVTHBhcmdnejZzNkhvLWJkTURkUFZsWlpKLVc5UkctVTZGd2lseWFzY29WYVJwa1JUeDVBeTBjYVpkdU9qSlZDWF9XRDdJRFd4dEVjZnZLVExyWDJnODBmWVlkT2RlVGt5TzE2SG5MdWNlcUh4aUpJ?oc=5", "summary": "Law or policy source from Washington Examiner. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 04 May 2026 07:00:00 GMT", "foundAt": "2026-05-17T22:41:22.106Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Washington Examiner", "displayDate": "May 4, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "trump’s ibogaine executive order is a big step to solve generational threat - washington examiner law or policy source from washington examiner. read the exact source before drawing legal conclusions. laws_policy journalism washington examiner law cataloged source primary-source record" }, { "id": "source_radar_archive-RmVkZXJhbCBJYm", "title": "Federal Ibogaine Research Announcement Comes Weeks After Texas Leaders Tout $50 Million Investment - The Texan", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The Texan", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxORW1NV05DYVJFbF9JQVVYTmdFYkRCbEQzQXpLMloxdU0yQnVCUVpUUUQ1b1ZnaDBsWWNwVngtbjZFRjdTejhjTm0wYVhMUXE1bk9HcU1CSm9Jd3V2TDFEcFlfMEhVZUdvYjJ2RTF1SlFCRGUyWUp0ak5VRDEzVFNOY2pKUTZSdmVqM1JZOWFleldpbThULVdyM2R0UEJoMmJ6YTNkVWRPYXBxeEhnbnlqMmUyYXFSQmlmNkowY1RYMlFlbU05MmR5WWMwckJqT1RaTXF6bFZoU3ZxUy14RDNQU2dHbm1iUTdUbkw0dW9aSExkaXpfcHRjMG5NWDRIMWJ4RUc5ejRpUkFrODBLNXdoRjhfZktqY0ppN01PNzVGY1o5NTQ?oc=5", "summary": "Law or policy source from The Texan. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 23 Apr 2026 19:01:00 GMT", "foundAt": "2026-05-18T04:41:30.053Z", "sourceOrigin": "source_radar_archive", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The Texan", "displayDate": "Apr 23, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "federal ibogaine research announcement comes weeks after texas leaders tout $50 million investment - the texan law or policy source from the texan. read the exact source before drawing legal conclusions. laws_policy journalism the texan policy cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gTG", "title": "Colorado Legislature Passes Landmark Ibogaine Research Bill, Expanding the State's Natural Medicine Framework - Vicente LLP", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Vicente LLP", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPSG1OUEpyX29hZGpaMGZFOEEySy12STJsTHdqQ3FKbkRhS192ak5BdElGaHc2SWNfYjVyNnFNSi0wSUZxM0ZDM2hKNlBYeUY3SWlCdHVudW52SU9HLU1OOGhKVlFmZWxRV2lVTnpja0dBTU4wSnBIYk9WMFlWMjV1T0VwU1R1V3ZIRU5UV3FJa1VlQnZZREg1M0tTNnNrQmFDTDNqSDByM204UmFqZlJXVEtnRFFhRW9lVTltVnZ5b0tLQ2VJaGM4RzViV0oyakMxN3NF?oc=5", "summary": "Law or policy source from Vicente LLP. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 14 May 2026 03:33:28 GMT", "foundAt": "2026-05-21T18:26:29.419Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Vicente LLP", "displayDate": "May 14, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "colorado legislature passes landmark ibogaine research bill, expanding the state's natural medicine framework - vicente llp law or policy source from vicente llp. read the exact source before drawing legal conclusions. laws_policy journalism vicente llp law cataloged source primary-source record" }, { "id": "source_radar_archive-RmVkZXJhbCByZX", "title": "Federal research into psychedelic drug Ibogaine to treat PTSD may soon be reality - cbs8.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "cbs8.com", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPUFB3b1BHX2d2WGR4X0ItaWZ5LWI3TjR5dmpoZHB2TFhrZmhDZDZRTFV0MHZEWFlKTUhScUxJQnI3Mm1KVl9lRUQtNGp4T29jc2V5c19sWm5qLS1PUDA1WmJBWC1WUlVWYVg5OFR0bmQxTnFCS00zOFRTcTlfMTZFX0lLUHFTVE9jZmJBWVRyeHYxUGhfMzJnSGdPTlcydWppbVRJVV9tS2R4VmtWbkpYaDEzMnZ1TkpkenB6ZVRtbEdvSmtKYlFzbE5VdmZnNHE3VFQ4WVh4TlZOTkI2QndNV0xaejlZY3dWZDdaMXVGamM?oc=5", "summary": "Law or policy source from cbs8.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 16 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-19T22:25:42.470Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "cbs8.com", "displayDate": "Apr 16, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "federal research into psychedelic drug ibogaine to treat ptsd may soon be reality - cbs8.com law or policy source from cbs8.com. read the exact source before drawing legal conclusions. laws_policy journalism cbs8.com law cataloged source primary-source record" }, { "id": "source_radar_archive-UHN5Y2hlZGVsaW", "title": "Psychedelic drug ibogaine hailed as healing. U.S. patients ask why it’s illegal. - The Washington Post", "category": "companies_patents", "sourceType": "journalism", "sourceName": "The Washington Post", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPRXhLRDJMdHNUekwwQXMzQWs1MFp1TGRNSndtYVpIbVpXNHZ0amtzZXM0UFI3OEU0RC00YUtLdEo2N2xUV2M1NlZ3S2N0VVFMenV0ZExRZEw0aWFzWGpXdEd4RG05UXhPVjVObV80MEtmMUtlTFBaRUpXeXExZ1VKeDU2allYWjUyRUVZbg?oc=5", "summary": "Company, patent, or biotech-field source from The Washington Post. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 14 Mar 2024 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "The Washington Post", "displayDate": "Mar 14, 2024", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "psychedelic drug ibogaine hailed as healing. u.s. patients ask why it’s illegal. - the washington post company, patent, or biotech-field source from the washington post. commercial claims need independent verification. companies_patents journalism the washington post commercial cataloged source primary-source record" }, { "id": "source_radar_archive-R292ZXJub3IgQW", "title": "Governor Abbott Signs Ibogaine Treatment Research Law At Texas Capitol - Office of the Texas Governor (.gov)", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Office of the Texas Governor (.gov)", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNMUNuWF82M1NwbGxOdnMta0JEUVVsYm54c09xazRDUXRBSkFFTHB1dUJtcnpsVE5ob0loc2N1YmZhZ1d3Y0pwWEI5dVhQblR6bTdJLUpMTXp2endKcWpjdmZ4ZTA0QnBnS21Cak9zYjZjMWY2bGVITnF6d0c4VTZuZldCTkNHaHNDY2ZqaXRfR1ZDZVFiS3hfSmhKYUIxRC1PVVlYRA?oc=5", "summary": "Law or policy source from Office of the Texas Governor (.gov). Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 11 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-20T14:53:32.695Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Office of the Texas Governor (.gov)", "displayDate": "Jun 11, 2025", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "governor abbott signs ibogaine treatment research law at texas capitol - office of the texas governor (.gov) law or policy source from office of the texas governor (.gov). read the exact source before drawing legal conclusions. laws_policy journalism office of the texas governor (.gov) law cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gbG", "title": "Colorado lawmakers approve Ibogaine research bill - CBS News", "category": "laws_policy", "sourceType": "journalism", "sourceName": "CBS News", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQSk4xYkVUUXU4dm5OTmhzeGZtVmdqb3U2aXZLdlY5SHhydGlrWVRYblh1NWp6U3FpTmFGRm9TeW80LXV1eTRjcmJUM3UwZmZETm5WSFBmSk5UVGpYd1p6RXU2azZMM3hJb25wWlptWEU3aDhEcTJMNGFaZGZyVG1kR1BNbUE2a0NnYURCX3p1Q0ctUQ?oc=5", "summary": "Law or policy source from CBS News. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 21 May 2026 14:22:36 GMT", "foundAt": "2026-05-21T16:07:19.987Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "CBS News", "displayDate": "May 21, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers Colorado lawmakers approve Ibogaine research bill.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "colorado lawmakers approve ibogaine research bill - cbs news law or policy source from cbs news. read the exact source before drawing legal conclusions. laws_policy journalism cbs news research cataloged source primary-source record" }, { "id": "source_radar_archive-THQuIEdvdi4gRG", "title": "Lt. Gov. Dan Patrick and Speaker Dustin Burrows Joint Statement on Ibogaine Program Progress - ltgov.texas.gov", "category": "laws_policy", "sourceType": "journalism", "sourceName": "ltgov.texas.gov", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOQXNXUTZCN2pDMklRMEt2dC13alVQTlN4LXEtNEhKRFgzZkRveDlyemVjeXRqZGRCeTJ0cDFvRnZfSG1ySTZUbVRqTzYyRFUwYjhqRWZfNDdScmxVM0R6V3FTMW1kLS1EbXluU2lkTVVYcWpTTUxrajl5OUl1R2JfWW9rN29seWZXVTd1dTFHNkdxaEloRzZicmJ6V1hxMm5Qeks0cGpQT3M2dWJIOWl6QnJvdHo5M2pSc05QWXpaOFc4MmR6alAzM2VB?oc=5", "summary": "Law or policy source from ltgov.texas.gov. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 31 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-21T20:45:24.031Z", "sourceOrigin": "source_radar_archive", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "ltgov.texas.gov", "displayDate": "Mar 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "lt. gov. dan patrick and speaker dustin burrows joint statement on ibogaine program progress - ltgov.texas.gov law or policy source from ltgov.texas.gov. read the exact source before drawing legal conclusions. laws_policy journalism ltgov.texas.gov policy cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gSE", "title": "Colorado HB 26-1325: Ibogaine Takes Center Stage in Colorado's Natural Medicine Program - Vicente LLP", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Vicente LLP", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPa3VFV0w3REFGb3RKV2RlR21KX2hEMTJmdDJpNG82aVBQMEptaXRfclFqMEg1S0lGdXFHSkoxbFRfU3pnTmZfemVCWDQyUDBHZjRSSUtNbTdBN0xIVkdKZWRQVzNNZ3NaWFJVd3RzZC1sRFBRWHZqazVDTnJfOWpqcnJmdGNvWG5OSzFPbzRYendBVGpVWW5BR0lienpGNGwtWG9tcjFmVlBoZ1VHS2UzLTY5aXotOWo0cmc?oc=5", "summary": "Law or policy source from Vicente LLP. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 21 May 2026 16:28:12 GMT", "foundAt": "2026-05-21T22:33:30.581Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Vicente LLP", "displayDate": "May 21, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "colorado hb 26-1325: ibogaine takes center stage in colorado's natural medicine program - vicente llp law or policy source from vicente llp. read the exact source before drawing legal conclusions. laws_policy journalism vicente llp law cataloged source primary-source record" }, { "id": "source_radar_archive-V2l0aCBubyBGRE", "title": "With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Stock Titan", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOWU96RUQzTnMxUUM1cGhGaUVjV1pWcHRoMGpLWi1GeW90XzBwcURWSEhPXzZ1MlFGSk9fMHhlYV85VE9CTUhLcDcwZWlSenpLSnVRZXE0bGxXbFNrWUhDNy1kMzB6UlIzMlA3SlJxSTlNMFhzZkY5MG93V3dqdmZjVXhHMy1Pckx3c0piR01McWgxXzRQYlF0RFh1YVlYX3BrX0RhTXRxdndqWGdEQ1RMU1dWWHBHVlFHQWZvbk05SQ?oc=5", "summary": "Law or policy source from Stock Titan. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 07 May 2026 07:00:00 GMT", "foundAt": "2026-05-22T00:52:28.573Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Stock Titan", "displayDate": "May 7, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "with no fda-approved tbi drugs, silo pursues ibogaine therapy - stock titan law or policy source from stock titan. read the exact source before drawing legal conclusions. laws_policy journalism stock titan commercial cataloged source primary-source record" }, { "id": "source_radar_archive-VGhlIHBzeWNoZW", "title": "The psychedelic ibogaine can treat addiction. The race is on to cash in - theguardian.com", "category": "clinics", "sourceType": "journalism", "sourceName": "theguardian.com", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMTNTTDhNdjJoaVdWZ0JiMWI1SnA1U3VLWlAtNzlIRldRZ3RscFlJaTJVbkJsZHdEdVRHN2I0QXlCeDhEX0ZLNk15Um9CZUNaTFRVeEhsdXotYUlOaG1GNGVTTXJIUEduQVVDNVhlVzhSa1B5akE1dVFXYTJraDJNMFA2LWtDblpxSlR6SFpsZjhId2dlZzF1YzZoZw?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 24 Jan 2023 08:00:00 GMT", "foundAt": "2026-05-30T19:55:58.280Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "theguardian.com", "displayDate": "Jan 24, 2023", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "the psychedelic ibogaine can treat addiction. the race is on to cash in - theguardian.com clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism theguardian.com clinics cataloged source primary-source record" }, { "id": "source_radar_archive-VGV4YXMgaXMgZn", "title": "Texas is funding research into the psychedelic ibogaine. Here's what to know - Dallas News", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Dallas News", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOTTI2QmtZNmFaLWtoWjRCeGp5S29jOGUzb29Gejc5S29FazV0TVBDWkhGS3p3dmpOaVJNWWRPZVExaHpScTNvS1A0U0VfVC1XX01IUW5STGhJaUVwNXpOUVR2dlEwVEVYcFc0dUx1TjAwVHFrRkE4bV9wUHFTTjB0RDgwYUV1eFcyYW84UmlGSDFfd1lRVlgtTlZLOXp2NHo1a0tVS1dYblJmemVHZHVQeWtVVXNob2JFSUNrWWlDSTBpMGdBS05ULWZKTTJoWHNvbWN1Y2VfVFF3dw?oc=5", "summary": "News or commentary from Dallas News. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 11 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Dallas News", "displayDate": "Feb 11, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Texas is funding research into the psychedelic ibogaine. Here's what to know.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "texas is funding research into the psychedelic ibogaine. here's what to know - dallas news news or commentary from dallas news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism dallas news media cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgY2", "title": "Ibogaine could transform public spending on opioid treatment - Reason Foundation", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Reason Foundation", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeVIwLU1nNVVTNzduUWRWQXl6Z2pHWTgybGF6WXUwV2pxOXNVeGdKSzFuVkxNM2FuVV8tRlM1WEQwaWxRNGdIalZUWlUzYjA0X3hjR3ZFenhraDhkRWFScXFzU1QzUUdUNGZSYkpOYm9NNGk2UVQ0ZGpnaFNrOWV0aE84R1p0ZUduNGdWdmdRRFFuakcyWUFrTg?oc=5", "summary": "News or commentary from Reason Foundation. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 05 Nov 2025 08:00:00 GMT", "foundAt": "2026-05-19T13:08:57.214Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Reason Foundation", "displayDate": "Nov 5, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine could transform public spending on opioid treatment - reason foundation news or commentary from reason foundation. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism reason foundation blogs cataloged source primary-source record" }, { "id": "source_radar_archive-U3RhdGUgbGF3bW", "title": "State lawmakers push to fund ibogaine research for veterans, opioid addiction - WZMQ 19 News", "category": "laws_policy", "sourceType": "journalism", "sourceName": "WZMQ 19 News", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPV2YzY3ZqZFEwSlpSOTYyMjZubnFhb2N4ZXNzQy1rR1NsNmFqNUtWMDdvdVN1SUhhNTJBd3VwRF9NUlB1elJIY3plQXVjeldia2pwRldrVno1NmR0SXZfS3RoeHdFMFZGYldiRUdQMTAzSEt1NWdtb3RaRWkxZDNQOU0tT05reW5UcnA2RG1WRHRoblFET1BDeUJpN1NWdmY0NUU1Z0JncklyVnQz?oc=5", "summary": "Law or policy source from WZMQ 19 News. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 25 May 2026 17:23:39 GMT", "foundAt": "2026-05-25T21:54:13.390Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "WZMQ 19 News", "displayDate": "May 25, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers State lawmakers push to fund ibogaine research for veterans, opioid addiction.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "state lawmakers push to fund ibogaine research for veterans, opioid addiction - wzmq 19 news law or policy source from wzmq 19 news. read the exact source before drawing legal conclusions. laws_policy journalism wzmq 19 news research cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgVG", "title": "Ibogaine Therapies in Costa Rica Under Scrutiny After Tourist Death - The Tico Times", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The Tico Times", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOVFU0NzRaTDZVM0x5S2k0ek1WbS1mcU04Q1hVV2pvZ0JOeXFYRzh1YUJtRDBmUG0tVU1yYzNTMXk5V0k0bDF1djFYcmZIMVVJT0NYZXVkdzNjWXd4OW94SlVHbWRyWTdQeW40eHZTX2FVVW9IWkRiclBHSUlIbDlqYjcwSXRSaXV5dVIyNVc0VTVEeDUtdDkyNzFhdUVJbi1acXc?oc=5", "summary": "Law or policy source from The Tico Times. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 26 Aug 2024 07:00:00 GMT", "foundAt": "2026-05-30T14:44:30.468Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The Tico Times", "displayDate": "Aug 26, 2024", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers clinics.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "ibogaine therapies in costa rica under scrutiny after tourist death - the tico times law or policy source from the tico times. read the exact source before drawing legal conclusions. laws_policy journalism the tico times clinics cataloged source primary-source record" }, { "id": "source_radar_archive-W1dlYmluYXJdIE", "title": "[Webinar] Colorado Goes Further: Ibogaine, HB 26-1325 and Key Changes to the Natural Medicine Health Act - Vicente LLP", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Vicente LLP", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNMnpPSTlCNWNhM2M0b0VhWkRMd2xOSGoyNDN1cUszRnNPVTMtVWVuUWNTWWpJSy1qQUlscTVXSUFKZXRQOUV6R09iXzhubmNmdUcwOGxpUEMxLW9JWFZVdXVyMmExMUJmVXFrZkVRRHE0NFJ3M3BZRzZyaW5kOHBCNl9CdXA4WGQ0dkhVWlpKYm41b0l2NEpGS1lFTUJkeWNWVmJhbDRkQXpwcWpEalVaZjBOc0F5RVFFZk9ka0s5dmdPcTdrUFVPekJmeFg?oc=5", "summary": "Law or policy source from Vicente LLP. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 29 May 2026 20:26:17 GMT", "foundAt": "2026-05-31T00:50:43.464Z", "sourceOrigin": "source_radar_archive", "tags": [ "law" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Vicente LLP", "displayDate": "May 29, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers law.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "[webinar] colorado goes further: ibogaine, hb 26-1325 and key changes to the natural medicine health act - vicente llp law or policy source from vicente llp. read the exact source before drawing legal conclusions. laws_policy journalism vicente llp law cataloged source primary-source record" }, { "id": "latest_scan-RGFkIG9mIDIgV2", "title": "Dad of 2 Was on Brink of Divorce and Death When Illegal Hallucinogen Saved Him. Now He's Helping Other Veterans (Exclusive) - People.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "People.com", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNSzRVWkxVUHc2WE9xa1FrcEc5dy1oTU1jRl9xajltQkhrWkxzRTgxTGVFUURsRE42WG82YlN3RzVuSWo3bVBBYkthYWh0ZW1DRC1EemNxTUtPWGdQanFGZ1JuaFhIUmd6NTlpYWI3cTF6N1hKaDE5Z2lpZ0E1YmlkV2g2OEtCVHdCclZmRzNwNlB1T2J0djFOTVEwTEZRQQ?oc=5", "summary": "Law or policy source from People.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 29 May 2026 09:20:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "People.com", "displayDate": "May 29, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "dad of 2 was on brink of divorce and death when illegal hallucinogen saved him. now he's helping other veterans (exclusive) - people.com law or policy source from people.com. read the exact source before drawing legal conclusions. laws_policy journalism people.com policy cataloged source primary-source record" }, { "id": "latest_scan-VHJ1bXDigJlzIG", "title": "Trump’s executive order on psychedelics is the right move. But is my field ready for it? - statnews.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "statnews.com", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNX1BuRFpaaWRDNXFBbTNGWmZ2WXY3aUR6S3I2VEZ4TUVjb2d6UTR0ZllSWU8xbDRNYWc3VVVhTEQwOWZyRWxEOWRiSE1xYWZ5bkFCSTBRSnJNOVVGNnhZcmdXRC1USndDSWZJUEwwOUZuTkhITTlYQnowZXhNUjFETWVEOV9tMUdIbXJuTDlIWE41Q3dMZjlobE1TdlFsYkRITEcyWk9zMnVOai1a?oc=5", "summary": "Law or policy source from statnews.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 06 May 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "statnews.com", "displayDate": "May 6, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "trump’s executive order on psychedelics is the right move. but is my field ready for it? - statnews.com law or policy source from statnews.com. read the exact source before drawing legal conclusions. laws_policy journalism statnews.com policy cataloged source primary-source record" }, { "id": "latest_scan-SG93IFJlcHVibG", "title": "How Republicans came to embrace psychedelic drugs - The Washington Post", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The Washington Post", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNQlNIM3VPX1NXNnE1UGVfZ0xWaWxxN1pSclRZZDdxc0lIcUYwckk5ZUQ1d2dka2daWFBUUlJrVS1lWTdBTXlfTlV0a0xHd0g4dkNuWE1ERWtmQkFZM3BoOGdYQ3JmNk9VWFdQSWJvMElQWlM2SzVWUm5lS29yb2dsN1lRcVFWUHVjbXZfeEVydnB5eWh2OTlZTmln?oc=5", "summary": "Law or policy source from The Washington Post. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 04 May 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "policy" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The Washington Post", "displayDate": "May 4, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "how republicans came to embrace psychedelic drugs - the washington post law or policy source from the washington post. read the exact source before drawing legal conclusions. laws_policy journalism the washington post policy cataloged source primary-source record" }, { "id": "latest_scan-VHJ1bXAgc2lnbn", "title": "Trump signs order to accelerate access to psychedelic drug treatments - The Japan Times", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Japan Times", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbzRxb0FPNDFZNG4zN19BaVEzSFhlUmk0eDUzeTBPa0tLVkw5LUczZk85SWxOVTV0azhZaFBsdXhJWXdSTXZGdVo0Ql9NeUJFZ1lUc2FwNlo3NXFMdGkySzhfak9VYmM4Mkw1ZUV1UEZRMTNxMnliS1huemFlVVZpNEwxVG9qUjI5Y1JRM1JLQ3ZqWUdmNE5OVFZxM1FqUUhhWEE?oc=5", "summary": "News or commentary from The Japan Times. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 19 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Japan Times", "displayDate": "Apr 19, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "trump signs order to accelerate access to psychedelic drug treatments - the japan times news or commentary from the japan times. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the japan times blogs cataloged source primary-source record" }, { "id": "latest_scan-SHV4bGV5IEhlYW", "title": "Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics - TMX Newsfile", "category": "laws_policy", "sourceType": "journalism", "sourceName": "TMX Newsfile", "url": "https://news.google.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?oc=5", "summary": "Law or policy source from TMX Newsfile. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 20 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "commercial" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "TMX Newsfile", "displayDate": "Apr 20, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "huxley health inc. introduces aerasyn biotech division, expands leadership and scalable ip platform, engages capital partner for up to $15m financing and prepares to go public amid growing u.s. policy and public discourse on psychedelics - tmx newsfile law or policy source from tmx newsfile. read the exact source before drawing legal conclusions. laws_policy journalism tmx newsfile commercial cataloged source primary-source record" }, { "id": "latest_scan-QSBMb25nLCBTdH", "title": "A Long, Strange Trip: How the G.O.P. Came to Embrace Psychedelic Drugs - The New York Times", "category": "laws_policy", "sourceType": "journalism", "sourceName": "The New York Times", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOdTFnWXl1M3BORVJpMGQtYVc3TXR0WjVpMy1WU0ZFNDNzNmNqaHZZN21oR1JrSko2X1IxbThFc09YeFQxcnZfV2wwdTZObUM1NVBkVDJFTHdBelYxTHJlaWJwcVNweUZjU0RmVGdGTXdyMjFUTWFaSm1wbnlsTlBZbnBCMElkeHBa?oc=5", "summary": "Law or policy source from The New York Times. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 03 May 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "blogs" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "The New York Times", "displayDate": "May 3, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers blogs.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "a long, strange trip: how the g.o.p. came to embrace psychedelic drugs - the new york times law or policy source from the new york times. read the exact source before drawing legal conclusions. laws_policy journalism the new york times blogs cataloged source primary-source record" }, { "id": "latest_scan-RkRBIGV5ZXMgZX", "title": "FDA eyes expanding testosterone therapy for libido - statnews.com", "category": "laws_policy", "sourceType": "journalism", "sourceName": "statnews.com", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQcGVsRGF4N3dycWY5VkE1aEpXaEhfUk9abk1vYmlmdFMwemNyeWFVQUtYUVJMdkhtM3pWU3ZEY3hHVV9uUkhONlpPSkhvUzRRcEJtTkdRR01DTzBGUE01WFQ3bU1nSVdXc2o0OFpIMkYzcVJiTDdOcXRON09ZVk8wZEsyeEdaRlVaaTBZZkw1QlhIUnRLZUNz?oc=5", "summary": "Law or policy source from statnews.com. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 17 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "companies" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "statnews.com", "displayDate": "Apr 17, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers companies.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "fda eyes expanding testosterone therapy for libido - statnews.com law or policy source from statnews.com. read the exact source before drawing legal conclusions. laws_policy journalism statnews.com companies cataloged source primary-source record" }, { "id": "latest_scan-Q29tcGFzcywgVX", "title": "Compass, Usona and Transcend score FDA national priority vouchers amid Trump administration’s psychedelic push - Fierce Biotech", "category": "laws_policy", "sourceType": "journalism", "sourceName": "Fierce Biotech", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPaGZreG5ONno3a3pKVXRFR3lOYktjSTJhY25ETkQ3NjAtVGtOLXN5N2RodkcwbXhxRFhTb2p6bFVmYnJRR25VdG5sem1Nd3NTMkRvMDlFVjlQZlBLMWtXRy00cExIek5oZm9GQVZEd2tvVzBZaldjQzQwOHFLRi1aMjQ5SU9sMVk5Yk1Ma0NVLW5oclp0dkdRWnljMnFrSmFVMDlybllsRFh3QTJNbW1vZFNvb0N5WFZYaW9DMnZrdzQ4NVVCdmc?oc=5", "summary": "Law or policy source from Fierce Biotech. Read the exact source before drawing legal conclusions.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "companies" ], "displayCategory": "Law and policy", "displaySourceType": "Journalism", "displaySourceName": "Fierce Biotech", "displayDate": "Apr 24, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers companies.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "compass, usona and transcend score fda national priority vouchers amid trump administration’s psychedelic push - fierce biotech law or policy source from fierce biotech. read the exact source before drawing legal conclusions. laws_policy journalism fierce biotech companies cataloged source primary-source record" }, { "id": "podcast-apple-0001", "title": "The Neuropharmacology of Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Foodie Pharmacology Podcast", "url": "https://podcasts.apple.com/us/podcast/the-neuropharmacology-of-ibogaine/id1453126311?i=1000729058142", "summary": "Covers neuropharmacology, addiction. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "neuropharmacology", "addiction", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Foodie Pharmacology Podcast", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: neuropharmacology, addiction.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "the neuropharmacology of ibogaine covers neuropharmacology, addiction. this is a media source, not medical evidence. podcasts_interviews podcast_interview foodie pharmacology podcast ibogaine neuropharmacology addiction podcast cataloged source media metadata" }, { "id": "podcast-apple-0002", "title": "Fair Trade Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Altered States", "url": "https://podcasts.apple.com/us/podcast/fair-trade-ibogaine/id1749548410?i=1000668290837", "summary": "Covers fair trade, culture, clinics. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "fair_trade", "culture", "clinics", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Altered States", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: fair trade, culture, clinics.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "fair trade ibogaine covers fair trade, culture, clinics. this is a media source, not medical evidence. podcasts_interviews podcast_interview altered states ibogaine fair_trade culture clinics podcast cataloged source media metadata" }, { "id": "podcast-apple-0003", "title": "Episode 872: Ibogaine - Inside a Treatment Facility", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Newt's World", "url": "https://podcasts.apple.com/us/podcast/episode-872-ibogaine-inside-a-treatment-facility/id1452065072?i=1000718046062", "summary": "Covers clinic claims, treatment facility. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "clinic_claims", "treatment_facility", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Newt's World", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: clinic claims, treatment facility.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "episode 872: ibogaine - inside a treatment facility covers clinic claims, treatment facility. this is a media source, not medical evidence. podcasts_interviews podcast_interview newt's world ibogaine clinic_claims treatment_facility podcast cataloged source media metadata" }, { "id": "podcast-amazon-0001", "title": "Magic Frogs, Iboga and the Magic of Hallucinogens: a Conversation with Hamilton Morris", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Plants of the Gods", "url": "https://music.amazon.com/podcasts/8b5567d2-27f7-4662-8fad-c0681172385d/episodes/b004e00a-8114-48af-a76e-41fac8805629/the-plants-of-the-gods-podcast-plants-of-the-gods-s3e7-magic-frogs-iboga-and-the-magic-of-hallucinogens-a-conversation-with-hamilton-morris", "summary": "Covers hamilton morris, hallucinogens. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [ "Hamilton Morris" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "hamilton_morris", "iboga", "hallucinogens", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Plants of the Gods", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: hamilton morris, hallucinogens. People named in the record: Hamilton Morris.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "magic frogs, iboga and the magic of hallucinogens: a conversation with hamilton morris covers hamilton morris, hallucinogens. this is a media source, not medical evidence. podcasts_interviews podcast_interview plants of the gods hamilton_morris iboga hallucinogens podcast cataloged source media metadata" }, { "id": "podcast-apple-0004", "title": "Exploring Ibogaine: A Breakthrough in Addiction Therapy with Deborah Mash, PhD", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "NewsRamp Psychedelics Podcast", "url": "https://podcasts.apple.com/us/podcast/exploring-ibogaine-a-breakthrough-in-addiction/id1751642702?i=1000660223474", "summary": "Covers deborah mash, addiction. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [ "Deborah Mash" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "deborah_mash", "addiction", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "NewsRamp Psychedelics Podcast", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: deborah mash, addiction. People named in the record: Deborah Mash.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "exploring ibogaine: a breakthrough in addiction therapy with deborah mash, phd covers deborah mash, addiction. this is a media source, not medical evidence. podcasts_interviews podcast_interview newsramp psychedelics podcast ibogaine deborah_mash addiction podcast cataloged source media metadata" }, { "id": "podcast-apple-0005", "title": "One Dose That Heals Addiction, PTSD and Brain Injury", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Dr. Hyman Show", "url": "https://podcasts.apple.com/us/podcast/one-dose-that-heals-addiction-ptsd-and-brain-injury/id1382804627?i=1000724720623", "summary": "Covers addiction, ptsd, tbi, claim check. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "addiction", "ptsd", "tbi", "podcast", "claim_check" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Dr. Hyman Show", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: addiction, ptsd, tbi, claim check.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "one dose that heals addiction, ptsd and brain injury covers addiction, ptsd, tbi, claim check. this is a media source, not medical evidence. podcasts_interviews podcast_interview the dr. hyman show ibogaine addiction ptsd tbi podcast claim_check cataloged source media metadata" }, { "id": "podcast-apple-0006", "title": "Ibogaine: Safety, Ethics, and Emerging Neuroregenerative Science - A Conversation with Jonathan Dickinson", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Intonicated", "url": "https://podcasts.apple.com/us/podcast/intonicated/id1869470751", "summary": "Covers safety, ethics, neuroregeneration. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [ "Jonathan Dickinson", "Kenneth Tupper" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "safety", "ethics", "neuroregeneration", "podcast" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Intonicated", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: safety, ethics, neuroregeneration. People named in the record: Jonathan Dickinson, Kenneth Tupper.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ibogaine: safety, ethics, and emerging neuroregenerative science - a conversation with jonathan dickinson covers safety, ethics, neuroregeneration. this is a media source, not medical evidence. podcasts_interviews podcast_interview intonicated ibogaine safety ethics neuroregeneration podcast cataloged source media metadata" }, { "id": "ambio-news-cpr-2025", "title": "Psychedelic offers new hope for treating addiction", "category": "podcasts_interviews", "sourceType": "journalism_interview", "sourceName": "Colorado Public Radio", "url": "https://www.cpr.org/2025/07/28/psychedelic-ibogaine-addiction-treatment-interview/", "summary": "CPR News interview with Jonathan Dickinson, identified as founder of Ambio Life Sciences. Useful for public-facing claims and policy context; statements in the interview should be treated as interview claims unless independently supported.", "confidence": "Journalism", "status": "Cataloged source", "people": [ "Andrea Dukakis", "Jonathan Dickinson" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "jonathan_dickinson", "colorado", "addiction", "public_discussion", "clinic_claims" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Journalism Interview", "displaySourceName": "Colorado Public Radio", "displayDate": "", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: ambio, ambio life sciences, jonathan dickinson, colorado. People named in the record: Andrea Dukakis, Jonathan Dickinson.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "psychedelic offers new hope for treating addiction cpr news interview with jonathan dickinson, identified as founder of ambio life sciences. useful for public-facing claims and policy context; statements in the interview should be treated as interview claims unless independently supported. podcasts_interviews journalism_interview colorado public radio ambio ambio_life_sciences jonathan_dickinson colorado addiction public_discussion clinic_claims cataloged source journalism" }, { "id": "source_radar_archive-T25lIERvc2UgVG", "title": "One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Dr. Hyman Show", "url": "https://podcasts.apple.com/us/podcast/one-dose-that-heals-addiction-ptsd-and-brain-injury/id1382804627?i=1000724720623&uo=4", "summary": "Covers One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-09-03T10:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Dr. Hyman Show", "displayDate": "Sep 3, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "one dose that heals addiction, ptsd, and brain injury? dr. nolan williams on the science of ibogaine covers one dose that heals addiction, ptsd, and brain injury? dr. nolan williams on the science of ibogaine. this is a media source, not medical evidence. podcasts_interviews podcast_interview the dr. hyman show media cataloged source media metadata" }, { "id": "source_radar_archive-TWVkaWNhbCBEb2", "title": "Medical Doctor Shares Life Changing Ibogaine Treatment Stories", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Optimal Performance", "url": "https://podcasts.apple.com/us/podcast/medical-doctor-shares-life-changing-ibogaine-treatment/id1004775385?i=1000762434894&uo=4", "summary": "Covers Medical Doctor Shares Life Changing Ibogaine Treatment Stories. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-20T17:04:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Optimal Performance", "displayDate": "Apr 20, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Medical Doctor Shares Life Changing Ibogaine Treatment Stories.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "medical doctor shares life changing ibogaine treatment stories covers medical doctor shares life changing ibogaine treatment stories. this is a media source, not medical evidence. podcasts_interviews podcast_interview optimal performance media cataloged source media metadata" }, { "id": "source_radar_archive-TWFyY3VzICYgQW", "title": "Marcus & Amber Capone: On Ibogaine, Veteran Suicide, PTSD Treatment & Brain Health", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Ultimate Human with Gary Brecka", "url": "https://podcasts.apple.com/us/podcast/marcus-amber-capone-on-ibogaine-veteran-suicide-ptsd/id1709740887?i=1000759991591&uo=4", "summary": "Covers Marcus & Amber Capone: On Ibogaine, Veteran Suicide, PTSD Treatment & Brain Health. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-07T07:30:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Ultimate Human with Gary Brecka", "displayDate": "Apr 7, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Marcus & Amber Capone: On Ibogaine, Veteran Suicide, PTSD Treatment & Brain Health.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "marcus & amber capone: on ibogaine, veteran suicide, ptsd treatment & brain health covers marcus & amber capone: on ibogaine, veteran suicide, ptsd treatment & brain health. this is a media source, not medical evidence. podcasts_interviews podcast_interview the ultimate human with gary brecka media cataloged source media metadata" }, { "id": "source_radar_archive-VGhlIElib2dhaW", "title": "The Ibogaine Experience - Treating Addiction with Alternative Medicine: #289", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Human Upgrade: Biohacking for Longevity & Performance", "url": "https://podcasts.apple.com/us/podcast/the-ibogaine-experience-treating-addiction/id451295014?i=1000364212492&uo=4", "summary": "Covers The Ibogaine Experience. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2016-03-04T20:01:00Z", "foundAt": "2026-05-31T20:30:46.739Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Human Upgrade: Biohacking for Longevity & Performance", "displayDate": "Mar 4, 2016", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: The Ibogaine Experience.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "the ibogaine experience - treating addiction with alternative medicine: #289 covers the ibogaine experience. this is a media source, not medical evidence. podcasts_interviews podcast_interview the human upgrade: biohacking for longevity & performance media cataloged source media metadata" }, { "id": "source_radar_archive-RXAgMjgyIC0gTW", "title": "Ep 282 - Mark Gober | Ibogaine: A Brutal and Evolutionary Experience", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Here For The Truth", "url": "https://podcasts.apple.com/us/podcast/ep-282-mark-gober-ibogaine-a-brutal-and/id1570026970?i=1000749823045&uo=4", "summary": "Covers Ep 282. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-02-15T10:30:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Here For The Truth", "displayDate": "Feb 15, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Ep 282.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ep 282 - mark gober | ibogaine: a brutal and evolutionary experience covers ep 282. this is a media source, not medical evidence. podcasts_interviews podcast_interview here for the truth media cataloged source media metadata" }, { "id": "source_radar_archive-IzM5IC0gRHIuIE", "title": "#39 - Dr. Joseph Barsuglia: Ibogaine, 5-MeO-DMT, and the Future of Trauma Healing", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Uncovered", "url": "https://podcasts.apple.com/us/podcast/39-dr-joseph-barsuglia-ibogaine-5-meo-dmt-and-the/id1656800662?i=1000675098993&uo=4", "summary": "Covers #39 - Dr. Joseph Barsuglia: Ibogaine, 5-MeO-DMT, and the Future of Trauma Healing. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2024-10-30T18:21:25Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Uncovered", "displayDate": "Oct 30, 2024", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #39 - Dr. Joseph Barsuglia: Ibogaine, 5-MeO-DMT, and the Future of Trauma Healing.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#39 - dr. joseph barsuglia: ibogaine, 5-meo-dmt, and the future of trauma healing covers #39 - dr. joseph barsuglia: ibogaine, 5-meo-dmt, and the future of trauma healing. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine uncovered media cataloged source media metadata" }, { "id": "source_radar_archive-TWlrZSBHbG92ZX", "title": "Mike Glover’s Heroic-Dose Psilocybin & Ibogaine Journey and Foreign Involvement in the Charlie Kirk Assassination | Ep. 270 | Pt. 3", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Mike Drop", "url": "https://podcasts.apple.com/us/podcast/mike-glovers-heroic-dose-psilocybin-ibogaine-journey/id1346234726?i=1000741968502&uo=4", "summary": "Covers Mike Glover’s Heroic-Dose Psilocybin & Ibogaine Journey and Foreign Involvement in the Charlie Kirk Assassination | Ep. 270 | Pt. 3. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-12-19T09:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Mike Drop", "displayDate": "Dec 19, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Mike Glover’s Heroic-Dose Psilocybin & Ibogaine Journey and Foreign Involvement in the Charlie Kirk Assassination | Ep. 270 | Pt. 3.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "mike glover’s heroic-dose psilocybin & ibogaine journey and foreign involvement in the charlie kirk assassination | ep. 270 | pt. 3 covers mike glover’s heroic-dose psilocybin & ibogaine journey and foreign involvement in the charlie kirk assassination | ep. 270 | pt. 3. this is a media source, not medical evidence. podcasts_interviews podcast_interview mike drop media cataloged source media metadata" }, { "id": "source_radar_archive-QSBOYXZ5IFNFQU", "title": "A Navy SEAL Goes to Mexico to take Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Altered States", "url": "https://podcasts.apple.com/us/podcast/a-navy-seal-goes-to-mexico-to-take-ibogaine/id1749548410?i=1000674122631&uo=4", "summary": "Covers A Navy SEAL Goes to Mexico to take Ibogaine. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2024-10-23T08:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Altered States", "displayDate": "Oct 23, 2024", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: A Navy SEAL Goes to Mexico to take Ibogaine.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "a navy seal goes to mexico to take ibogaine covers a navy seal goes to mexico to take ibogaine. this is a media source, not medical evidence. podcasts_interviews podcast_interview altered states media cataloged source media metadata" }, { "id": "source_radar_archive-NDgtSG91ciBNaX", "title": "48-Hour Miracle: Ibogaine's CURE For Addiction, Mental Health & Spiritual Crisis | W. Bryan Hubbard & Robert Gallery #496", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Aubrey Marcus Podcast", "url": "https://podcasts.apple.com/us/podcast/48-hour-miracle-ibogaines-cure-for-addiction-mental/id521945322?i=1000703765459&uo=4", "summary": "Covers 48-Hour Miracle: Ibogaine's CURE For Addiction, Mental Health & Spiritual Crisis | W. Bryan Hubbard & Robert Gallery #496. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-04-16T17:14:44Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Aubrey Marcus Podcast", "displayDate": "Apr 16, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: 48-Hour Miracle: Ibogaine's CURE For Addiction, Mental Health & Spiritual Crisis | W. Bryan Hubbard & Robert Gallery #496.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "48-hour miracle: ibogaine's cure for addiction, mental health & spiritual crisis | w. bryan hubbard & robert gallery #496 covers 48-hour miracle: ibogaine's cure for addiction, mental health & spiritual crisis | w. bryan hubbard & robert gallery #496. this is a media source, not medical evidence. podcasts_interviews podcast_interview aubrey marcus podcast media cataloged source media metadata" }, { "id": "source_radar_archive-SGVhbGluZyBWZX", "title": "Healing Veterans Hearts: The Role of Ibogaine Therapy in Overcoming Trauma and Addiction", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "url": "https://podcasts.apple.com/us/podcast/healing-veterans-hearts-the-role-of-ibogaine-therapy/id1781351851?i=1000767999699&uo=4", "summary": "Covers Healing Veterans Hearts: The Role of Ibogaine Therapy in Overcoming Trauma and Addiction. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-15T00:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "displayDate": "May 15, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Healing Veterans Hearts: The Role of Ibogaine Therapy in Overcoming Trauma and Addiction.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "healing veterans hearts: the role of ibogaine therapy in overcoming trauma and addiction covers healing veterans hearts: the role of ibogaine therapy in overcoming trauma and addiction. this is a media source, not medical evidence. podcasts_interviews podcast_interview healing horizons: ibogaine therapy in mexico media cataloged source media metadata" }, { "id": "source_radar_archive-SG93IGlib2dhaW", "title": "How ibogaine could treat depression and anxiety | Nolan Williams", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "TED Talks Daily", "url": "https://podcasts.apple.com/us/podcast/how-ibogaine-could-treat-depression-and-anxiety-nolan/id160904630?i=1000739883625&uo=4", "summary": "Covers How ibogaine could treat depression and anxiety | Nolan Williams. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-12-05T17:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "TED Talks Daily", "displayDate": "Dec 5, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: How ibogaine could treat depression and anxiety | Nolan Williams.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "how ibogaine could treat depression and anxiety | nolan williams covers how ibogaine could treat depression and anxiety | nolan williams. this is a media source, not medical evidence. podcasts_interviews podcast_interview ted talks daily media cataloged source media metadata" }, { "id": "source_radar_archive-V2hhdCBUcnVtcO", "title": "What Trump’s New Ibogaine Order Means for Veterans, PTSD, and the Future of Healing", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "url": "https://podcasts.apple.com/us/podcast/what-trumps-new-ibogaine-order-means-for-veterans-ptsd/id1781351851?i=1000766523662&uo=4", "summary": "Covers What Trump’s New Ibogaine Order Means for Veterans, PTSD, and the Future of Healing. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-30T00:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "displayDate": "Apr 30, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: What Trump’s New Ibogaine Order Means for Veterans, PTSD, and the Future of Healing.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "what trump’s new ibogaine order means for veterans, ptsd, and the future of healing covers what trump’s new ibogaine order means for veterans, ptsd, and the future of healing. this is a media source, not medical evidence. podcasts_interviews podcast_interview healing horizons: ibogaine therapy in mexico media cataloged source media metadata" }, { "id": "source_radar_archive-V2VuZGkgUmVlcy", "title": "Wendi Rees on Psychedelic PTSD Therapy, Faith-Based Healing, and Trump’s Ibogaine Push", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Marc Cox Morning Show", "url": "https://podcasts.apple.com/us/podcast/wendi-rees-on-psychedelic-ptsd-therapy-faith-based/id1213933085?i=1000766630051&uo=4", "summary": "Covers Wendi Rees on Psychedelic PTSD Therapy, Faith-Based Healing, and Trump’s Ibogaine Push. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-07T14:09:05Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Marc Cox Morning Show", "displayDate": "May 7, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Wendi Rees on Psychedelic PTSD Therapy, Faith-Based Healing, and Trump’s Ibogaine Push.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "wendi rees on psychedelic ptsd therapy, faith-based healing, and trump’s ibogaine push covers wendi rees on psychedelic ptsd therapy, faith-based healing, and trump’s ibogaine push. this is a media source, not medical evidence. podcasts_interviews podcast_interview the marc cox morning show media cataloged source media metadata" }, { "id": "source_radar_archive-VGhlIFNjaWVuY2", "title": "The Science of Ibogaine: How It Affects the Brain's Wiring in Recovery of Veterans Journeys", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "url": "https://podcasts.apple.com/us/podcast/the-science-of-ibogaine-how-it-affects-the-brains/id1781351851?i=1000748506739&uo=4", "summary": "Covers The Science of Ibogaine: How It Affects the Brain's Wiring in Recovery of Veterans Journeys. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-02-06T09:42:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Healing Horizons: Ibogaine Therapy in Mexico", "displayDate": "Feb 6, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: The Science of Ibogaine: How It Affects the Brain's Wiring in Recovery of Veterans Journeys.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "the science of ibogaine: how it affects the brain's wiring in recovery of veterans journeys covers the science of ibogaine: how it affects the brain's wiring in recovery of veterans journeys. this is a media source, not medical evidence. podcasts_interviews podcast_interview healing horizons: ibogaine therapy in mexico media cataloged source media metadata" }, { "id": "source_radar_archive-IzYwIC0gQ2xhaX", "title": "#60 - Claire Weber: Re-mothering with Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Uncovered", "url": "https://podcasts.apple.com/us/podcast/60-claire-weber-re-mothering-with-ibogaine/id1656800662?i=1000759880131&uo=4", "summary": "Covers #60 - Claire Weber: Re-mothering with Ibogaine. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-06T17:40:56Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Uncovered", "displayDate": "Apr 6, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #60 - Claire Weber: Re-mothering with Ibogaine.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#60 - claire weber: re-mothering with ibogaine covers #60 - claire weber: re-mothering with ibogaine. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine uncovered media cataloged source media metadata" }, { "id": "source_radar_archive-V2hhdCBzaG91bG", "title": "What should I know about ibogaine?", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Dose", "url": "https://podcasts.apple.com/us/podcast/what-should-i-know-about-ibogaine/id1498259551?i=1000764659937&uo=4", "summary": "Covers What should I know about ibogaine?. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-30T09:10:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Dose", "displayDate": "Apr 30, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: What should I know about ibogaine?.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "what should i know about ibogaine? covers what should i know about ibogaine?. this is a media source, not medical evidence. podcasts_interviews podcast_interview the dose media cataloged source media metadata" }, { "id": "source_radar_archive-IzkgLSBJcyBJYm", "title": "#9 - Is Iboga Right For Me? | Readiness, Risks, and the Truth About Iboga", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/9-is-iboga-right-for-me-readiness-risks-and-the/id1861195577?i=1000765913441&uo=4", "summary": "Covers #9. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-03T16:52:37Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "May 3, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #9.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#9 - is iboga right for me? | readiness, risks, and the truth about iboga covers #9. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "source_radar_archive-IzMgLSBJYm9nYS", "title": "#3 - Iboga or Ayahuasca", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/3-iboga-or-ayahuasca/id1861195577?i=1000744509140&uo=4", "summary": "Covers #3. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-09T22:10:30Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Jan 9, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #3.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#3 - iboga or ayahuasca covers #3. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "source_radar_archive-IzEgLSBCYXNpYy", "title": "#1 - Basic Questions about Iboga", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/1-basic-questions-about-iboga/id1861195577?i=1000741169814&uo=4", "summary": "Covers #1. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-12-13T23:32:58Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Dec 13, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #1.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#1 - basic questions about iboga covers #1. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "source_radar_archive-TWV0YSBNeXN0ZX", "title": "Meta Mysteries| The Real Experiences Of Iboga w/ Jonathan of Iboga Talk", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Cult of Conspiracy", "url": "https://podcasts.apple.com/us/podcast/meta-mysteries-the-real-experiences-of-iboga-w/id1527152965?i=1000715087783&uo=4", "summary": "Covers Meta Mysteries| The Real Experiences Of Iboga w/ Jonathan of Iboga Talk. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-06-30T05:05:07Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Cult of Conspiracy", "displayDate": "Jun 30, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Meta Mysteries| The Real Experiences Of Iboga w/ Jonathan of Iboga Talk.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "meta mysteries| the real experiences of iboga w/ jonathan of iboga talk covers meta mysteries| the real experiences of iboga w/ jonathan of iboga talk. this is a media source, not medical evidence. podcasts_interviews podcast_interview cult of conspiracy media cataloged source media metadata" }, { "id": "source_radar_archive-RVAwMjogQWxsIE", "title": "EP02: All About Iboga, with Bwiti Initiated Medicine Woman, Pamela", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Plant-Allied Recovery Podcast", "url": "https://podcasts.apple.com/us/podcast/ep02-all-about-iboga-with-bwiti-initiated-medicine/id1715862854?i=1000634268632&uo=4", "summary": "Covers EP02: All About Iboga, with Bwiti Initiated Medicine Woman, Pamela. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2023-05-19T12:01:30Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Plant-Allied Recovery Podcast", "displayDate": "May 19, 2023", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: EP02: All About Iboga, with Bwiti Initiated Medicine Woman, Pamela.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ep02: all about iboga, with bwiti initiated medicine woman, pamela covers ep02: all about iboga, with bwiti initiated medicine woman, pamela. this is a media source, not medical evidence. podcasts_interviews podcast_interview plant-allied recovery podcast media cataloged source media metadata" }, { "id": "source_radar_archive-IzggLSBJYm9nYS", "title": "#8 - Iboga vs. Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/8-iboga-vs-ibogaine/id1861195577?i=1000763714092&uo=4", "summary": "Covers #8. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-26T21:54:54Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Apr 26, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #8.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#8 - iboga vs. ibogaine covers #8. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "source_radar_archive-Izcg4oCUIEh5cG", "title": "#7 — Hyperdimensional Healing, Ibogaine and Parkinson's Disease with Tobias Erny", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Iboga Leadership Summit Podcast", "url": "https://podcasts.apple.com/us/podcast/7-hyperdimensional-healing-ibogaine-and-parkinsons/id1873572601?i=1000754022354&uo=4", "summary": "Covers #7 — Hyperdimensional Healing, Ibogaine and Parkinson's Disease with Tobias Erny. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-03-09T13:56:05Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Iboga Leadership Summit Podcast", "displayDate": "Mar 9, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #7 — Hyperdimensional Healing, Ibogaine and Parkinson's Disease with Tobias Erny.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#7 — hyperdimensional healing, ibogaine and parkinson's disease with tobias erny covers #7 — hyperdimensional healing, ibogaine and parkinson's disease with tobias erny. this is a media source, not medical evidence. podcasts_interviews podcast_interview the iboga leadership summit podcast media cataloged source media metadata" }, { "id": "source_radar_archive-VGhlIEhlYXJ0IG", "title": "The Heart of Iboga: Ancient Healing, Modern Maladies—PTSD, TBI, & Addiction w/ Tricia Eastman", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Life Stylist", "url": "https://podcasts.apple.com/us/podcast/the-heart-of-iboga-ancient-healing-modern-maladies/id1121467751?i=1000718445708&uo=4", "summary": "Covers The Heart of Iboga: Ancient Healing, Modern Maladies—PTSD, TBI, & Addiction w/ Tricia Eastman. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-07-22T10:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Life Stylist", "displayDate": "Jul 22, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: The Heart of Iboga: Ancient Healing, Modern Maladies—PTSD, TBI, & Addiction w/ Tricia Eastman.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "the heart of iboga: ancient healing, modern maladies—ptsd, tbi, & addiction w/ tricia eastman covers the heart of iboga: ancient healing, modern maladies—ptsd, tbi, & addiction w/ tricia eastman. this is a media source, not medical evidence. podcasts_interviews podcast_interview the life stylist media cataloged source media metadata" }, { "id": "source_radar_archive-TGFuYSBQcmliaW", "title": "Lana Pribic - Getting to the Root: Iboga, Kanna, and Africa's Primordial Medicines", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Psychedelic Podcast", "url": "https://podcasts.apple.com/us/podcast/lana-pribic-getting-to-the-root-iboga-kanna-and/id1200537009?i=1000726870786&uo=4", "summary": "Covers Lana Pribic. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-09-15T08:00:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Psychedelic Podcast", "displayDate": "Sep 15, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Lana Pribic.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "lana pribic - getting to the root: iboga, kanna, and africa's primordial medicines covers lana pribic. this is a media source, not medical evidence. podcasts_interviews podcast_interview the psychedelic podcast media cataloged source media metadata" }, { "id": "source_radar_archive-SWJvZ2FpbmUgIk", "title": "Ibogaine \"Iboga\": Healing PTSD, Addiction, and the Soul with Clayton Smith | Gateways to Awakening", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Gateways to Awakening", "url": "https://podcasts.apple.com/us/podcast/ibogaine-iboga-healing-ptsd-addiction-and-the/id1529629262?i=1000722675796&uo=4", "summary": "Covers Ibogaine \"Iboga\": Healing PTSD, Addiction, and the Soul with Clayton Smith | Gateways to Awakening. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-08-19T16:07:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Gateways to Awakening", "displayDate": "Aug 19, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Ibogaine \"Iboga\": Healing PTSD, Addiction, and the Soul with Clayton Smith | Gateways to Awakening.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ibogaine \"iboga\": healing ptsd, addiction, and the soul with clayton smith | gateways to awakening covers ibogaine \"iboga\": healing ptsd, addiction, and the soul with clayton smith | gateways to awakening. this is a media source, not medical evidence. podcasts_interviews podcast_interview gateways to awakening media cataloged source media metadata" }, { "id": "source_radar_archive-IzEg4oCUIEJ3aX", "title": "#1 — Bwiti, Iboga and Gabon: It's Happening Now with Patrick Moughenda Mikala", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Iboga Leadership Summit Podcast", "url": "https://podcasts.apple.com/us/podcast/1-bwiti-iboga-and-gabon-its-happening-now-with/id1873572601?i=1000747466873&uo=4", "summary": "Covers #1 — Bwiti, Iboga and Gabon: It's Happening Now with Patrick Moughenda Mikala. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-31T01:38:12Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Iboga Leadership Summit Podcast", "displayDate": "Jan 31, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #1 — Bwiti, Iboga and Gabon: It's Happening Now with Patrick Moughenda Mikala.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#1 — bwiti, iboga and gabon: it's happening now with patrick moughenda mikala covers #1 — bwiti, iboga and gabon: it's happening now with patrick moughenda mikala. this is a media source, not medical evidence. podcasts_interviews podcast_interview the iboga leadership summit podcast media cataloged source media metadata" }, { "id": "source_radar_archive-UGxhbnRzIG9mIH", "title": "Plants of the Gods: S3E7. Magic Frogs, Iboga and the Magic of Hallucinogens: a Conversation with Hamilton Morris", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Plants of the Gods: Hallucinogens, Healing, Culture and Conservation podcast", "url": "https://podcasts.apple.com/us/podcast/plants-of-the-gods-s3e7-magic-frogs-iboga/id1549464922?i=1000574855131&uo=4", "summary": "Covers Plants of the Gods: S3E7. Magic Frogs, Iboga and the Magic of Hallucinogens: a Conversation with Hamilton Morris. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2022-08-03T06:05:12Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Plants of the Gods: Hallucinogens, Healing, Culture and Conservation podcast", "displayDate": "Aug 3, 2022", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Plants of the Gods: S3E7. Magic Frogs, Iboga and the Magic of Hallucinogens: a Conversation with Hamilton Morris.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "plants of the gods: s3e7. magic frogs, iboga and the magic of hallucinogens: a conversation with hamilton morris covers plants of the gods: s3e7. magic frogs, iboga and the magic of hallucinogens: a conversation with hamilton morris. this is a media source, not medical evidence. podcasts_interviews podcast_interview plants of the gods: hallucinogens, healing, culture and conservation podcast media cataloged source media metadata" }, { "id": "source_radar_archive-IzUgLSBJYm9nYS", "title": "#5 - Iboga Leadership Summit w/ Ryan \"Ghenigho\" Rich", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/5-iboga-leadership-summit-w-ryan-ghenigho-rich/id1861195577?i=1000747576589&uo=4", "summary": "Covers #5. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-02-01T16:18:24Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Feb 1, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #5.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#5 - iboga leadership summit w/ ryan \"ghenigho\" rich covers #5. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "source_radar_archive-IzUwMiAtIEF3YW", "title": "#502 - Awaken Your Soul Iboga retreat with Amber and Anthony. Bwiti tradition and shamanic healing", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Grimerica Show", "url": "https://podcasts.apple.com/us/podcast/502-awaken-your-soul-iboga-retreat-with-amber-and/id653314424?i=1000527840289&uo=4", "summary": "Covers #502. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2021-07-05T05:32:00Z", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Grimerica Show", "displayDate": "Jul 5, 2021", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #502.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#502 - awaken your soul iboga retreat with amber and anthony. bwiti tradition and shamanic healing covers #502. this is a media source, not medical evidence. podcasts_interviews podcast_interview the grimerica show media cataloged source media metadata" }, { "id": "source_radar_archive-RXAgNjY6IFRoZS", "title": "Ep 66: The Psychedelic Explorer's Guide - Risks, Micro-Dosing, Ibogaine, and More", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Tim Ferriss Show", "url": "https://podcasts.apple.com/us/podcast/ep-66-the-psychedelic-explorers-guide-risks-micro/id863897795?i=1000338101375&uo=4", "summary": "Covers Ep 66: The Psychedelic Explorer's Guide - Risks, Micro-Dosing, Ibogaine, and More. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2015-03-21T01:59:52Z", "foundAt": "2026-05-19T04:42:04.594Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Tim Ferriss Show", "displayDate": "Mar 21, 2015", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Ep 66: The Psychedelic Explorer's Guide - Risks, Micro-Dosing, Ibogaine, and More.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ep 66: the psychedelic explorer's guide - risks, micro-dosing, ibogaine, and more covers ep 66: the psychedelic explorer's guide - risks, micro-dosing, ibogaine, and more. this is a media source, not medical evidence. podcasts_interviews podcast_interview the tim ferriss show media cataloged source media metadata" }, { "id": "source_radar_archive-MTEwIHwgRGlzY3", "title": "110 | Discussing Ibogaine w Trevor Millar", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Operator With Rob O’Neill", "url": "https://podcasts.apple.com/us/podcast/110-discussing-ibogaine-w-trevor-millar/id1637203087?i=1000671599262&uo=4", "summary": "Covers 110 | Discussing Ibogaine w Trevor Millar. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2024-10-02T20:00:00Z", "foundAt": "2026-05-19T04:42:04.594Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Operator With Rob O’Neill", "displayDate": "Oct 2, 2024", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: 110 | Discussing Ibogaine w Trevor Millar.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "110 | discussing ibogaine w trevor millar covers 110 | discussing ibogaine w trevor millar. this is a media source, not medical evidence. podcasts_interviews podcast_interview the operator with rob o’neill media cataloged source media metadata" }, { "id": "source_radar_archive-MTE5IHwgSWJvZ2", "title": "119 | Ibogaine & Iboga Treatment: Safety, Ethics, and A New Approach to Addiction w/ Juliana Mulligan", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Modern Psychedelics", "url": "https://podcasts.apple.com/us/podcast/119-ibogaine-iboga-treatment-safety-ethics-and-a/id1553826157?i=1000698239348&uo=4", "summary": "Covers 119 | Ibogaine & Iboga Treatment: Safety, Ethics, and A New Approach to Addiction w/ Juliana Mulligan. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-03-07T09:00:00Z", "foundAt": "2026-05-19T04:42:04.594Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Modern Psychedelics", "displayDate": "Mar 7, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: 119 | Ibogaine & Iboga Treatment: Safety, Ethics, and A New Approach to Addiction w/ Juliana Mulligan.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "119 | ibogaine & iboga treatment: safety, ethics, and a new approach to addiction w/ juliana mulligan covers 119 | ibogaine & iboga treatment: safety, ethics, and a new approach to addiction w/ juliana mulligan. this is a media source, not medical evidence. podcasts_interviews podcast_interview modern psychedelics media cataloged source media metadata" }, { "id": "source_radar_archive-UG9kY2FzdGVycy", "title": "Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine - Mother Jones", "category": "podcasts_interviews", "sourceType": "journalism", "sourceName": "Mother Jones", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdjlLQUlCUFpLVnNNc001T1A4dGxHWjJyVjNvMGxlTDJRdjNLQUZoRjZRM0NQRUJwT2dXTHR4VThaNkxpUVlUTFVfcGNJN1ZrSVhDX1ZNNE15eGtIbW1rZk0tZHMxcWVMb2Nsb1V3cVdUR1lULU0xMUpNMjgtZkJQZTZNRE14NmR5M2ViZ0hkS0MyZU9NZHlsMjg1NU1JdjZpaTNOQi1jdDhYMEFlUFA5bDRjRjFfMU9BMUhTV0NvZUhDcTFXXy02Z3ozdUhsZHcyT3dDWkE4ekVyQQ?oc=5", "summary": "Covers Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine. This is a media source, not medical evidence.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-21T03:30:23.330Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Journalism", "displaySourceName": "Mother Jones", "displayDate": "Apr 18, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "podcasters, presidents, and psychedelics: how joe rogan got trump into ibogaine - mother jones covers podcasters, presidents, and psychedelics: how joe rogan got trump into ibogaine. this is a media source, not medical evidence. podcasts_interviews journalism mother jones media cataloged source primary-source record" }, { "id": "source_radar_archive-VGhpcyBQbGFudC", "title": "This Plant Is Making People Go Crazy! Iboga", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "IBOGA WELLNESS", "url": "https://podcasts.apple.com/us/podcast/this-plant-is-making-people-go-crazy-iboga/id1780548160?i=1000677481086&uo=4", "summary": "Covers This Plant Is Making People Go Crazy! Iboga. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2024-11-19T08:47:59Z", "foundAt": "2026-05-21T23:04:22.041Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "IBOGA WELLNESS", "displayDate": "Nov 19, 2024", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: This Plant Is Making People Go Crazy! Iboga.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "this plant is making people go crazy! iboga covers this plant is making people go crazy! iboga. this is a media source, not medical evidence. podcasts_interviews podcast_interview iboga wellness media cataloged source media metadata" }, { "id": "source_radar_archive-Izkg4oCUIEJlY2", "title": "#9 — Becoming Hunters of Ourselves: Bwiti, Iboga and Decolonizing Mental Health with Sarah Siegel", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Iboga Leadership Summit Podcast", "url": "https://podcasts.apple.com/us/podcast/9-becoming-hunters-of-ourselves-bwiti-iboga/id1873572601?i=1000767055918&uo=4", "summary": "Covers #9 — Becoming Hunters of Ourselves: Bwiti, Iboga and Decolonizing Mental Health with Sarah Siegel. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-10T14:10:34Z", "foundAt": "2026-05-21T23:04:22.041Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Iboga Leadership Summit Podcast", "displayDate": "May 10, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #9 — Becoming Hunters of Ourselves: Bwiti, Iboga and Decolonizing Mental Health with Sarah Siegel.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#9 — becoming hunters of ourselves: bwiti, iboga and decolonizing mental health with sarah siegel covers #9 — becoming hunters of ourselves: bwiti, iboga and decolonizing mental health with sarah siegel. this is a media source, not medical evidence. podcasts_interviews podcast_interview the iboga leadership summit podcast media cataloged source media metadata" }, { "id": "source_radar_archive-T1BJT0lEIEFERE", "title": "OPIOID ADDICTION AND IBOGAINE FOR TREATMENT", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Podcast", "url": "https://podcasts.apple.com/us/podcast/opioid-addiction-and-ibogaine-for-treatment/id1582622594?i=1000544409590&uo=4", "summary": "Covers OPIOID ADDICTION AND IBOGAINE FOR TREATMENT. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2021-12-09T09:29:57Z", "foundAt": "2026-05-22T18:39:11.260Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Podcast", "displayDate": "Dec 9, 2021", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: OPIOID ADDICTION AND IBOGAINE FOR TREATMENT.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "opioid addiction and ibogaine for treatment covers opioid addiction and ibogaine for treatment. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine podcast media cataloged source media metadata" }, { "id": "source_radar_archive-SWJvZ2E6IEJlZm", "title": "Iboga: Before vs. After (14 Years in the Making)", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Medicine for These Times with Beth Weinstein", "url": "https://podcasts.apple.com/us/podcast/iboga-before-vs-after-14-years-in-the-making/id1562920606?i=1000745944267&uo=4", "summary": "Covers Iboga: Before vs. After (14 Years in the Making). This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-03-31T04:00:00Z", "foundAt": "2026-05-23T18:42:34.408Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Medicine for These Times with Beth Weinstein", "displayDate": "Mar 31, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Iboga: Before vs. After (14 Years in the Making).", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "iboga: before vs. after (14 years in the making) covers iboga: before vs. after (14 years in the making). this is a media source, not medical evidence. podcasts_interviews podcast_interview medicine for these times with beth weinstein media cataloged source media metadata" }, { "id": "source_radar_archive-TGV2aSBCYXJrZX", "title": "Levi Barker - Iboga Wellness - Bwiti Shamanism - Addiction Recovery - Releasing Emotions", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Grimerica Show", "url": "https://podcasts.apple.com/us/podcast/levi-barker-iboga-wellness-bwiti-shamanism-addiction/id653314424?i=1000610773152&uo=4", "summary": "Covers Levi Barker - Iboga Wellness - Bwiti Shamanism - Addiction Recovery. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2023-04-26T19:26:15Z", "foundAt": "2026-05-23T18:42:34.408Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Grimerica Show", "displayDate": "Apr 26, 2023", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Levi Barker - Iboga Wellness - Bwiti Shamanism - Addiction Recovery.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "levi barker - iboga wellness - bwiti shamanism - addiction recovery - releasing emotions covers levi barker - iboga wellness - bwiti shamanism - addiction recovery. this is a media source, not medical evidence. podcasts_interviews podcast_interview the grimerica show media cataloged source media metadata" }, { "id": "source_radar_archive-IzQ3IC0gU2phbm", "title": "#47 - Sjana Elise: Ayahuasca vs. Ibogaine: Different Paths, Different Lessons", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Uncovered", "url": "https://podcasts.apple.com/us/podcast/47-sjana-elise-ayahuasca-vs-ibogaine-different-paths/id1656800662?i=1000712462187&uo=4", "summary": "Covers #47. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-06-11T16:35:50Z", "foundAt": "2026-05-24T14:07:23.035Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Uncovered", "displayDate": "Jun 11, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #47.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#47 - sjana elise: ayahuasca vs. ibogaine: different paths, different lessons covers #47. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine uncovered media cataloged source media metadata" }, { "id": "source_radar_archive-VGhlIFNhZmV0eS", "title": "The Safety and Efficacy of Ibogaine Treatment for Trauma and Addiction", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "How To Heal Your Trauma with David Dardashti", "url": "https://podcasts.apple.com/us/podcast/the-safety-and-efficacy-of-ibogaine-treatment/id1716614797?i=1000640346803&uo=4", "summary": "Covers The Safety and Efficacy of Ibogaine Treatment for Trauma and Addiction. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2023-12-12T18:38:57Z", "foundAt": "2026-05-24T14:07:23.035Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "How To Heal Your Trauma with David Dardashti", "displayDate": "Dec 12, 2023", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: The Safety and Efficacy of Ibogaine Treatment for Trauma and Addiction.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "the safety and efficacy of ibogaine treatment for trauma and addiction covers the safety and efficacy of ibogaine treatment for trauma and addiction. this is a media source, not medical evidence. podcasts_interviews podcast_interview how to heal your trauma with david dardashti media cataloged source media metadata" }, { "id": "source_radar_archive-IzYyIC0gVG9iaW", "title": "#62 - Tobias Erny: Ibogaine for Parkinson's?", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Uncovered", "url": "https://podcasts.apple.com/us/podcast/62-tobias-erny-ibogaine-for-parkinsons/id1656800662?i=1000769256250&uo=4", "summary": "Covers #62. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-23T19:57:44Z", "foundAt": "2026-05-24T15:55:36.068Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Uncovered", "displayDate": "May 23, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #62.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#62 - tobias erny: ibogaine for parkinson's? covers #62. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine uncovered media cataloged source media metadata" }, { "id": "source_radar_archive-MzYuIFNoIXR0aW", "title": "36. Sh!tting Yourself for Enlightenment. What is Ibogaine?", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Wrong Way Forward", "url": "https://podcasts.apple.com/us/podcast/36-sh-tting-yourself-for-enlightenment-what-is-ibogaine/id1834728665?i=1000768852451&uo=4", "summary": "Covers 36. Sh!tting Yourself for Enlightenment. What is Ibogaine?. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-21T04:00:00Z", "foundAt": "2026-05-25T12:40:08.214Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Wrong Way Forward", "displayDate": "May 21, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: 36. Sh!tting Yourself for Enlightenment. What is Ibogaine?.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "36. sh!tting yourself for enlightenment. what is ibogaine? covers 36. sh!tting yourself for enlightenment. what is ibogaine?. this is a media source, not medical evidence. podcasts_interviews podcast_interview wrong way forward media cataloged source media metadata" }, { "id": "source_radar_archive-RGF2aWQgUnV0aG", "title": "David Rutherford Show: Trump Legalizes Ibogaine - Navy SEAL Tommy Aceto On Why This Changes Everything", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The David Rutherford Show", "url": "https://podcasts.apple.com/us/podcast/david-rutherford-show-trump-legalizes-ibogaine-navy/id1807090449?i=1000764260372&uo=4", "summary": "Covers David Rutherford Show: Trump Legalizes Ibogaine. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-29T08:00:00Z", "foundAt": "2026-05-25T12:40:08.214Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The David Rutherford Show", "displayDate": "Apr 29, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: David Rutherford Show: Trump Legalizes Ibogaine.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "david rutherford show: trump legalizes ibogaine - navy seal tommy aceto on why this changes everything covers david rutherford show: trump legalizes ibogaine. this is a media source, not medical evidence. podcasts_interviews podcast_interview the david rutherford show media cataloged source media metadata" }, { "id": "source_radar_archive-SWJvZ2FpbmUgTW", "title": "Ibogaine Meets Justice: Bryan Hubbard’s Mission to Transform the System", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Gabby Reece Show", "url": "https://podcasts.apple.com/us/podcast/ibogaine-meets-justice-bryan-hubbards-mission-to-transform/id1492179907?i=1000739092312&uo=4", "summary": "Covers Ibogaine Meets Justice: Bryan Hubbard’s Mission to Transform the System. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-12-01T08:00:00Z", "foundAt": "2026-05-26T11:32:25.621Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Gabby Reece Show", "displayDate": "Dec 1, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Ibogaine Meets Justice: Bryan Hubbard’s Mission to Transform the System.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ibogaine meets justice: bryan hubbard’s mission to transform the system covers ibogaine meets justice: bryan hubbard’s mission to transform the system. this is a media source, not medical evidence. podcasts_interviews podcast_interview the gabby reece show media cataloged source media metadata" }, { "id": "source_radar_archive-V2hpc3BlcnMgb2", "title": "Whispers of Iboga with Troy Valencia, iboga provider and co-founder of Root & Wisdom and Sacred Roots Foundation #88", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The School of Whispers Podcast", "url": "https://podcasts.apple.com/us/podcast/whispers-of-iboga-with-troy-valencia-iboga-provider/id1619554570?i=1000769526166&uo=4", "summary": "Covers Whispers of Iboga with Troy Valencia, iboga provider and co-founder of Root & Wisdom and Sacred Roots Foundation #88. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-25T14:00:00Z", "foundAt": "2026-05-26T21:50:01.828Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The School of Whispers Podcast", "displayDate": "May 25, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Whispers of Iboga with Troy Valencia, iboga provider and co-founder of Root & Wisdom and Sacred Roots Foundation #88.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "whispers of iboga with troy valencia, iboga provider and co-founder of root & wisdom and sacred roots foundation #88 covers whispers of iboga with troy valencia, iboga provider and co-founder of root & wisdom and sacred roots foundation #88. this is a media source, not medical evidence. podcasts_interviews podcast_interview the school of whispers podcast media cataloged source media metadata" }, { "id": "source_radar_archive-SWJvZ2FpbmU6IE", "title": "Ibogaine: A Psychedelic for Addiction Treatment and Brain Health - Mark Hyman, MD", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Mark Hyman, MD", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxORmpScVVGT2o1YXcwczJvbW1XVHR5dFV3cjZneEtBS1RsUzJTcW1LbC1iYjl0NHRpSE9CSm5BdGxtNXlyTGM4blhlMmpaaVlMOTc5OUdVVFFkeWQ0QW1GUXppdUdwVlk3bUtldHFKWGpOZ2ZUeVRLSkFGdFJyTXN4UDJrRDI0MlNGYjFXQWhGaw?oc=5", "summary": "Book or bibliography source from Mark Hyman, MD. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 10 Feb 2025 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Mark Hyman, MD", "displayDate": "Feb 10, 2025", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "ibogaine: a psychedelic for addiction treatment and brain health - mark hyman, md book or bibliography source from mark hyman, md. interpret claims according to source type and evidence quality. books_bibliographies journalism mark hyman, md books cataloged source primary-source record" }, { "id": "source_radar_archive-IzU4IC0gTWlrZS", "title": "#58 - Mike Stratton: Is Ibogaine an Performance Enhancer?", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Ibogaine Uncovered", "url": "https://podcasts.apple.com/us/podcast/58-mike-stratton-is-ibogaine-an-performance-enhancer/id1656800662?i=1000753675645&uo=4", "summary": "Covers #58. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-03-06T17:12:22Z", "foundAt": "2026-05-29T02:03:11.801Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Ibogaine Uncovered", "displayDate": "Mar 6, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #58.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#58 - mike stratton: is ibogaine an performance enhancer? covers #58. this is a media source, not medical evidence. podcasts_interviews podcast_interview ibogaine uncovered media cataloged source media metadata" }, { "id": "source_radar_archive-SW5zaWRlIE15ID", "title": "Inside My 72-Hour Psychedelic Iboga Therapy With Julie Piatt", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Rich Roll Podcast", "url": "https://podcasts.apple.com/us/podcast/inside-my-72-hour-psychedelic-iboga-therapy-with-julie/id582272991?i=1000768893880&uo=4", "summary": "Covers Inside My 72-Hour Psychedelic Iboga Therapy With Julie Piatt. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-21T09:00:00Z", "foundAt": "2026-05-29T05:05:09.380Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Rich Roll Podcast", "displayDate": "May 21, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Inside My 72-Hour Psychedelic Iboga Therapy With Julie Piatt.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "inside my 72-hour psychedelic iboga therapy with julie piatt covers inside my 72-hour psychedelic iboga therapy with julie piatt. this is a media source, not medical evidence. podcasts_interviews podcast_interview the rich roll podcast media cataloged source media metadata" }, { "id": "source_radar_archive-TmF0ZSBNb3JnYW", "title": "Nate Morgans (Ibogaine in the Fire Service, Overcoming Addiction and the True Cost of War) - Episode 1245", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Behind The Shield", "url": "https://podcasts.apple.com/us/podcast/nate-morgans-ibogaine-in-the-fire-service-overcoming/id1178831764?i=1000769740947&uo=4", "summary": "Covers Nate Morgans (Ibogaine in the Fire Service, Overcoming Addiction and the True Cost of War). This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-27T01:17:01Z", "foundAt": "2026-05-31T20:30:46.739Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Behind The Shield", "displayDate": "May 27, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Nate Morgans (Ibogaine in the Fire Service, Overcoming Addiction and the True Cost of War).", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "nate morgans (ibogaine in the fire service, overcoming addiction and the true cost of war) - episode 1245 covers nate morgans (ibogaine in the fire service, overcoming addiction and the true cost of war). this is a media source, not medical evidence. podcasts_interviews podcast_interview behind the shield media cataloged source media metadata" }, { "id": "source_radar_archive-RXBpc29kZSAxNj", "title": "Episode 1620 - The Truth About Ibogaine", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Drinkin‘ Bros Podcast", "url": "https://podcasts.apple.com/us/podcast/episode-1620-the-truth-about-ibogaine/id1061361026?i=1000755473127&uo=4", "summary": "Covers Episode 1620. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-03-16T00:00:36Z", "foundAt": "2026-05-31T20:30:46.739Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Drinkin‘ Bros Podcast", "displayDate": "Mar 16, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Episode 1620.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "episode 1620 - the truth about ibogaine covers episode 1620. this is a media source, not medical evidence. podcasts_interviews podcast_interview drinkin‘ bros podcast media cataloged source media metadata" }, { "id": "source_radar_archive-RXBpc29kZSA4NT", "title": "Episode 858: Ibogaine – A Breakthrough Treatment for Addiction", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Newt's World", "url": "https://podcasts.apple.com/us/podcast/episode-858-ibogaine-a-breakthrough-treatment-for/id1452065072?i=1000714995986&uo=4", "summary": "Covers Episode 858: Ibogaine – A Breakthrough Treatment for Addiction. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-06-29T09:00:00Z", "foundAt": "2026-05-31T20:30:46.739Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Newt's World", "displayDate": "Jun 29, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Episode 858: Ibogaine – A Breakthrough Treatment for Addiction.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "episode 858: ibogaine – a breakthrough treatment for addiction covers episode 858: ibogaine – a breakthrough treatment for addiction. this is a media source, not medical evidence. podcasts_interviews podcast_interview newt's world media cataloged source media metadata" }, { "id": "latest_scan-QXRhaUJlY2tsZX", "title": "AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills - The Microdose", "category": "podcasts_interviews", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9aZzYxVXc0OG9FM0xIZXMwMXY0T0JfSmJGb25DUE9LM0hqbW9kX014YjJZVUtWODA0dUcwYUFTMTd1MWpjOWxpZDNjV0h4dFZxaWJnTEpEYWpsQ2FDR2VjeGZpa3hHYTJaa0dpajNudWR6ZzdKUVhQV1F3YkxLdw?oc=5", "summary": "Covers commercial. This is a media source, not medical evidence.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 06 Mar 2026 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "commercial" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "Mar 6, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Main topics: commercial.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "ataibeckley’s mdma product could treat social anxiety; hhs secretary kennedy talks psychedelics on rogan podcast; wv senate and sd legislature pass compass trigger bills - the microdose covers commercial. this is a media source, not medical evidence. podcasts_interviews journalism the microdose commercial cataloged source primary-source record" }, { "id": "latest_scan-IzIzODUgLSBSaW", "title": "#2385 - Rick Strassman", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Joe Rogan Experience", "url": "https://podcasts.apple.com/us/podcast/2385-rick-strassman/id360084272?i=1000728601890&uo=4", "summary": "Covers #2385. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-09-26T17:00:00Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Joe Rogan Experience", "displayDate": "Sep 26, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #2385.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#2385 - rick strassman covers #2385. this is a media source, not medical evidence. podcasts_interviews podcast_interview the joe rogan experience media cataloged source media metadata" }, { "id": "latest_scan-IzI0NzcgLSBSaW", "title": "#2477 - Rick Perry & W. Bryan Hubbard", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Joe Rogan Experience", "url": "https://podcasts.apple.com/us/podcast/2477-rick-perry-w-bryan-hubbard/id360084272?i=1000758690096&uo=4", "summary": "Covers #2477. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-04-01T17:00:00Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Joe Rogan Experience", "displayDate": "Apr 1, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #2477.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#2477 - rick perry & w. bryan hubbard covers #2477. this is a media source, not medical evidence. podcasts_interviews podcast_interview the joe rogan experience media cataloged source media metadata" }, { "id": "latest_scan-IzIgLSBQcmVwYX", "title": "#2 - Preparation and Choosing a Provider", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/2-preparation-and-choosing-a-provider/id1861195577?i=1000743562564&uo=4", "summary": "Covers #2. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-02T22:02:50Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Jan 2, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #2.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#2 - preparation and choosing a provider covers #2. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "latest_scan-IzMg4oCUIEhlYW", "title": "#3 — Healing, Acceptance and Orientation with Spencer “Missambo” Burton", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Iboga Leadership Summit Podcast", "url": "https://podcasts.apple.com/us/podcast/3-healing-acceptance-and-orientation-with-spencer/id1873572601?i=1000747682200&uo=4", "summary": "Covers #3 — Healing, Acceptance and Orientation with Spencer “Missambo” Burton. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-02-02T09:55:51Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Iboga Leadership Summit Podcast", "displayDate": "Feb 2, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #3 — Healing, Acceptance and Orientation with Spencer “Missambo” Burton.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#3 — healing, acceptance and orientation with spencer “missambo” burton covers #3 — healing, acceptance and orientation with spencer “missambo” burton. this is a media source, not medical evidence. podcasts_interviews podcast_interview the iboga leadership summit podcast media cataloged source media metadata" }, { "id": "latest_scan-IzQgLSBBbSBJIF", "title": "#4 - Am I Ready?", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/4-am-i-ready/id1861195577?i=1000747479162&uo=4", "summary": "Covers #4. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-31T17:01:15Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Jan 31, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #4.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#4 - am i ready? covers #4. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "latest_scan-IzcgLSBCZSBZb3", "title": "#7 - Be Your Own Witness", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/7-be-your-own-witness/id1861195577?i=1000753836046&uo=4", "summary": "Covers #7. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-03-08T02:30:36Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Mar 8, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #7.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#7 - be your own witness covers #7. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "latest_scan-QWZyaWNhbiBQc3", "title": "African Psychoactive Plants: Dreams, Ancestors, and Healing - Jean-Francois Sobiecki", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "The Psychedelic Podcast", "url": "https://podcasts.apple.com/us/podcast/african-psychoactive-plants-dreams-ancestors-and/id1200537009?i=1000745717474&uo=4", "summary": "Covers African Psychoactive Plants: Dreams, Ancestors, and Healing - Jean-Francois Sobiecki. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-01-19T09:00:00Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "The Psychedelic Podcast", "displayDate": "Jan 19, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: African Psychoactive Plants: Dreams, Ancestors, and Healing - Jean-Francois Sobiecki.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "african psychoactive plants: dreams, ancestors, and healing - jean-francois sobiecki covers african psychoactive plants: dreams, ancestors, and healing - jean-francois sobiecki. this is a media source, not medical evidence. podcasts_interviews podcast_interview the psychedelic podcast media cataloged source media metadata" }, { "id": "latest_scan-IzYgLSBUcnVzdC", "title": "#6 - Trust yourself in Motherhood/Fatherhood", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Get To The Root Iboga", "url": "https://podcasts.apple.com/us/podcast/6-trust-yourself-in-motherhood-fatherhood/id1861195577?i=1000751949347&uo=4", "summary": "Covers #6. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2026-02-27T16:38:43Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Get To The Root Iboga", "displayDate": "Feb 27, 2026", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: #6.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "#6 - trust yourself in motherhood/fatherhood covers #6. this is a media source, not medical evidence. podcasts_interviews podcast_interview get to the root iboga media cataloged source media metadata" }, { "id": "latest_scan-UHNpbG9jeWJpbi", "title": "Psilocybin Therapy for Depression, Trauma, Cancer Support and Life Clarity: Healing with Magic Mushrooms", "category": "podcasts_interviews", "sourceType": "podcast_interview", "sourceName": "Healing with Psychedelics: Plant Medicine, Ayahuasca, Psilocybin, San Pedro, Iboga & Trauma Recovery", "url": "https://podcasts.apple.com/us/podcast/psilocybin-therapy-for-depression-trauma-cancer-support/id1825996943?i=1000717309181&uo=4", "summary": "Covers Psilocybin Therapy for Depression, Trauma, Cancer Support and Life Clarity: Healing with Magic Mushrooms. This is a media source, not medical evidence.", "confidence": "Media metadata", "status": "Cataloged source", "people": [], "publishedAt": "2025-07-15T08:00:00Z", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "Podcasts and interviews", "displaySourceType": "Podcast Interview", "displaySourceName": "Healing with Psychedelics: Plant Medicine, Ayahuasca, Psilocybin, San Pedro, Iboga & Trauma Recovery", "displayDate": "Jul 15, 2025", "whatItIs": "Podcast or interview.", "conversationContext": "Topic from title: Psilocybin Therapy for Depression, Trauma, Cancer Support and Life Clarity: Healing with Magic Mushrooms.", "whyListed": "Useful for hearing how people discuss Iboga/Ibogaine. Do not treat episode claims as medical evidence unless supported by stronger sources.", "searchText": "psilocybin therapy for depression, trauma, cancer support and life clarity: healing with magic mushrooms covers psilocybin therapy for depression, trauma, cancer support and life clarity: healing with magic mushrooms. this is a media source, not medical evidence. podcasts_interviews podcast_interview healing with psychedelics: plant medicine, ayahuasca, psilocybin, san pedro, iboga & trauma recovery media cataloged source media metadata" }, { "id": "documentary-wiki-0001", "title": "Hamilton's Pharmacopeia episode on natural tramadol and synthetic ibogaine", "category": "documentaries_films", "sourceType": "documentary_reference", "sourceName": "Hamilton's Pharmacopeia", "url": "https://en.wikipedia.org/wiki/Tabernanthe_iboga", "summary": "Covers hamilton morris, documentary, voacanga. This is media context, not medical evidence.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [ "Hamilton Morris" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "hamilton_morris", "documentary", "iboga", "voacanga", "ibogaine" ], "displayCategory": "Documentaries and films", "displaySourceType": "Documentary Reference", "displaySourceName": "Hamilton's Pharmacopeia", "displayDate": "", "whatItIs": "Film, documentary, or video.", "conversationContext": "Covers hamilton morris, documentary, voacanga.", "whyListed": "Useful for understanding public narratives. Separate storytelling from clinical evidence.", "searchText": "hamilton's pharmacopeia episode on natural tramadol and synthetic ibogaine covers hamilton morris, documentary, voacanga. this is media context, not medical evidence. documentaries_films documentary_reference hamilton's pharmacopeia hamilton_morris documentary iboga voacanga ibogaine cataloged source primary-source record" }, { "id": "documentary-wiki-0002", "title": "Dangerous with Love", "category": "documentaries_films", "sourceType": "documentary_reference", "sourceName": "Documentary reference", "url": "https://en.wikipedia.org/wiki/Dimitri_Mobengo_Mugianis", "summary": "Covers documentary, addiction, culture. This is media context, not medical evidence.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [ "Dimitri Mugianis" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ibogaine", "documentary", "addiction", "culture" ], "displayCategory": "Documentaries and films", "displaySourceType": "Documentary Reference", "displaySourceName": "Documentary reference", "displayDate": "", "whatItIs": "Film, documentary, or video.", "conversationContext": "Covers documentary, addiction, culture.", "whyListed": "Useful for understanding public narratives. Separate storytelling from clinical evidence.", "searchText": "dangerous with love covers documentary, addiction, culture. this is media context, not medical evidence. documentaries_films documentary_reference documentary reference ibogaine documentary addiction culture cataloged source primary-source record" }, { "id": "source_radar_archive-Rm9ybWVyIEdvdi", "title": "Former Gov. Rick Perry pushes for legalizing ibogaine to aid veterans at SXSW - spectrumlocalnews.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "spectrumlocalnews.com", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOTHc1UVRXRUFJUHZ3QkV5OGM4LXZ2TVJxOUllUDlNRk9iOFZrMFNFYzJPbnBvNURzekxMVEpJbFZGeU1XMk9xQUVmT2c5b0NuQjhkSGM2emcyZFRzb2lNNnRVd2cxOEpJcmtxVWF6V1dHcTBEMTN4dVRHNjhfZnR4bzRfcnQ5SEd5LW1UcndhazNqZ21QTE9WXzU0U3F2Nm5oNTZSMTdXUHhqR1lHWDhfUk9Cb1ljLV9fVTJQQ2FrelBUSTRu?oc=5", "summary": "News or commentary from spectrumlocalnews.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 18 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-21T17:55:34.887Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "spectrumlocalnews.com", "displayDate": "Mar 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Former Gov. Rick Perry pushes for legalizing ibogaine to aid veterans at SXSW.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "former gov. rick perry pushes for legalizing ibogaine to aid veterans at sxsw - spectrumlocalnews.com news or commentary from spectrumlocalnews.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism spectrumlocalnews.com media cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgdGFrZX", "title": "Trump takes page out of Texas lawmakers' book, signs executive order on Ibogaine - Austin American-Statesman", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Austin American-Statesman", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUzR5bUVpbGtpbHFzY1Y2Y05GTVExMG9CTXZjMWdZOW5LU1lGTkRkQzZVSnZfTks2MnRfa2s0UEluNzBoazM1X2hTUU9ic0hjSmFrVXdpTXpIOEJ5MUZzS1pKWFB5YUZZVXQ0RnlCc0ZsbjAxSDNJMWowdFFrQzFvNjdUb1otdEVmOWFiWlV1ZXZXUzdJYVFvVmRhZWluejQ?oc=5", "summary": "Book or bibliography source from Austin American-Statesman. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Austin American-Statesman", "displayDate": "Apr 18, 2026", "whatItIs": "Journalism", "conversationContext": "Covers Trump takes page out of Texas lawmakers' book, signs executive order on Ibogaine - Austin American-Statesman.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "trump takes page out of texas lawmakers' book, signs executive order on ibogaine - austin american-statesman book or bibliography source from austin american-statesman. interpret claims according to source type and evidence quality. books_bibliographies journalism austin american-statesman media cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG_igJ", "title": "Colorado’s governor wants to legalize an African psychedelic, but there's a conflict over where ibogaine is sourced - The Colorado Sun", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "The Colorado Sun", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPVHVqYVZFeVBhR1FkNmVxSHFhaXdVNmFoSzdEeTJLVXZvNnR5eDdJZlJ2TkdoVXBZeklUdHpZTFRRbDJIOFFtZGZ5cHpzSkg2WkFsTGVZYnBFU3BXalJsYmRtLVNfZjZMODhJbnFTYVNsV0xINjV5VFNVa185VGVReXdxbzJielk?oc=5", "summary": "Book or bibliography source from The Colorado Sun. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 07 Nov 2025 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "The Colorado Sun", "displayDate": "Nov 7, 2025", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "colorado’s governor wants to legalize an african psychedelic, but there's a conflict over where ibogaine is sourced - the colorado sun book or bibliography source from the colorado sun. interpret claims according to source type and evidence quality. books_bibliographies journalism the colorado sun books cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgc3BvdG", "title": "Trump spotlights ibogaine in his recent executive order supporting psychedelics. - Psychology Today", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Psychology Today", "url": "https://news.google.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?oc=5", "summary": "Book or bibliography source from Psychology Today. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 19 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Psychology Today", "displayDate": "Apr 19, 2026", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "trump spotlights ibogaine in his recent executive order supporting psychedelics. - psychology today book or bibliography source from psychology today. interpret claims according to source type and evidence quality. books_bibliographies journalism psychology today books cataloged source primary-source record" }, { "id": "source_radar_archive-T3hhLUlib2dhIG", "title": "Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models - Nature", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Nature", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE1GSFNSZTFOWXVXYkdwVFJGV0FONDhTRGVreFVQSldVclc1aDhiTXZxTVZJN0JEUlVkeHBySjdNVC1meXgtbHlLQ3VCUWxjZXRQemVUUzYzNlAtLWJzYkEw?oc=5", "summary": "Book or bibliography source from Nature. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 20 Sep 2024 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Nature", "displayDate": "Sep 20, 2024", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "oxa-iboga alkaloids lack cardiac risk and disrupt opioid use in animal models - nature book or bibliography source from nature. interpret claims according to source type and evidence quality. books_bibliographies journalism nature books cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gcG", "title": "Colorado plans for rollout of ibogaine as the next regulated psychedelic plant medicine in healing centers - The Colorado Sun", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "The Colorado Sun", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQV2xIWlJzWUZlM3oxMEg2NXdzYWM0UUdMNjVYQS1mV0dXbEJNOHhlRHFza1BlY2ZRUFdlcEpVZmtPbEdfSHY2a0ZYaHNaRlVIOGtNd2JfOGRkR01QRkdoM1h2WmVRMTAxOXVYVGxPbndfUG1sWVFqMVdSV0RzTnlfN01Pa2xJZi1m?oc=5", "summary": "Book or bibliography source from The Colorado Sun. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 21 Jul 2025 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "The Colorado Sun", "displayDate": "Jul 21, 2025", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "colorado plans for rollout of ibogaine as the next regulated psychedelic plant medicine in healing centers - the colorado sun book or bibliography source from the colorado sun. interpret claims according to source type and evidence quality. books_bibliographies journalism the colorado sun books cataloged source primary-source record" }, { "id": "source_radar_archive-TmVpdGhlciBTbm", "title": "Neither Snake Oil Nor Silver Bullet: Ibogaine for Opioid Use Disorder - Filter", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Filter", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE1aY25wZW1DZWVlZUlaN29nazlmYzJsVUxvQlo1eER5UUwwT0xoczJQdTRXaVBSWDlWYTBrejNIUUxTSloxcXFkRExtM0g5YWFuRXBtaFB1MUlIV2EybVREcw?oc=5", "summary": "Book or bibliography source from Filter. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 15 Dec 2023 08:00:00 GMT", "foundAt": "2026-05-21T17:24:39.369Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Filter", "displayDate": "Dec 15, 2023", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "neither snake oil nor silver bullet: ibogaine for opioid use disorder - filter book or bibliography source from filter. interpret claims according to source type and evidence quality. books_bibliographies journalism filter books cataloged source primary-source record" }, { "id": "source_radar_archive-QSBjdXJlIGZvci", "title": "A cure for fentanyl addiction? San Francisco should help test ibogaine - San Francisco Chronicle", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "San Francisco Chronicle", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaFRZOWthdmNtbXJveXU3d0RUR3dWWUY5NzBXSDd3MFNzVDlEc2VsLThrNEowd2RqdV9GSC1nNjR3czM1VUpsbFFfS1A0ZXJSQXVtTnJwejdUTHd1YTRpSDduNDY5dkNBYUVtSjhMYW5ZWFFFaDR1eXJzTzAweF9rUmI5UmdCdF9YX1pVY2ZYdktwUDhMSjM2M1h6NHBfR0hOanR1WmZQTFBkZw?oc=5", "summary": "Book or bibliography source from San Francisco Chronicle. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 22 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-23T01:08:23.729Z", "sourceOrigin": "source_radar_archive", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "San Francisco Chronicle", "displayDate": "Jan 22, 2026", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "a cure for fentanyl addiction? san francisco should help test ibogaine - san francisco chronicle book or bibliography source from san francisco chronicle. interpret claims according to source type and evidence quality. books_bibliographies journalism san francisco chronicle books cataloged source primary-source record" }, { "id": "latest_scan-QSBwb3dlcmZ1bC", "title": "A powerful psychedelic plant medicine is gaining federal and state backing. - Psychology Today", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "Psychology Today", "url": "https://news.google.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?oc=5", "summary": "Book or bibliography source from Psychology Today. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 26 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "Psychology Today", "displayDate": "Apr 26, 2026", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "a powerful psychedelic plant medicine is gaining federal and state backing. - psychology today book or bibliography source from psychology today. interpret claims according to source type and evidence quality. books_bibliographies journalism psychology today books cataloged source primary-source record" }, { "id": "latest_scan-R3JhbS1TY2FsZS", "title": "Gram-Scale Total Synthesis of (±)-Ibogamine - ACS Publications", "category": "books_bibliographies", "sourceType": "journalism", "sourceName": "ACS Publications", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFA1VEhQU0pBSmVfQm1ic0hzdlFBZ1h3SWtHU3VJOFl3bkxLQ0dFeWtiSzBObmVoaWhtWmxDTnBERTE5N3VtTHNrb1FaMWJBVVBpdHRfSTE4S0tOMXluNk1fcUN3?oc=5", "summary": "Book or bibliography source from ACS Publications. Interpret claims according to source type and evidence quality.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 13 Jun 2023 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "books" ], "displayCategory": "Books and bibliographies", "displaySourceType": "Journalism", "displaySourceName": "ACS Publications", "displayDate": "Jun 13, 2023", "whatItIs": "Journalism", "conversationContext": "Covers books.", "whyListed": "Useful as background. Do not rely on it as standalone proof of a claim.", "searchText": "gram-scale total synthesis of (±)-ibogamine - acs publications book or bibliography source from acs publications. interpret claims according to source type and evidence quality. books_bibliographies journalism acs publications books cataloged source primary-source record" }, { "id": "archive-0001", "title": "News Articles on Eboga & Ibogaine", "category": "news_articles_blogs", "sourceType": "article_archive", "sourceName": "MyEboga document archive", "url": "https://www.myeboga.com/docs/articles.pdf", "summary": "News or commentary from MyEboga document archive. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Article Archive", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "news_archive", "history", "ibogaine", "articles" ], "displayCategory": "News and commentary", "displaySourceType": "Article Archive", "displaySourceName": "MyEboga document archive", "displayDate": "", "whatItIs": "News or commentary.", "conversationContext": "Covers news archive, history, articles.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "news articles on eboga & ibogaine news or commentary from myeboga document archive. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs article_archive myeboga document archive news_archive history ibogaine articles cataloged source article archive" }, { "id": "source_radar_archive-QWNjZWxlcmF0ZW", "title": "Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders - Nature", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Nature", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE1oRHlhOWFYdm1xNDVBeUpLSm81bTNNZzZPczZ2a2ViR0tVcGhqWUVzMDBmNUVfQkhCQnk4WkU2WUhwbktxZlEzWnhwYUZkNmdYWlhQXzVpUm5Yb0lxNk1F?oc=5", "summary": "News or commentary from Nature. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 31 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Nature", "displayDate": "Jan 31, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders - nature news or commentary from nature. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism nature research cataloged source primary-source record" }, { "id": "source_radar_archive-VVMgc3BlZWRzIH", "title": "US speeds up research into mind-altering drugs — including mysterious ‘ibogaine’ - Nature", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Nature", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE8xTXBJVDQydmg2aHVIWVBwMmRoV1FrcFF2NFprMXZqaDdNMWN5RVRQZU1wdFFmdDFYalRXTW50dDlMdmJfVTNjS0ZCLTktNnRyNmt1ekdKeUEwV3duQTJ3?oc=5", "summary": "News or commentary from Nature. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-11T20:40:40.329Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Nature", "displayDate": "Apr 21, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers US speeds up research into mind-altering drugs — including mysterious ‘ibogaine’.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "us speeds up research into mind-altering drugs — including mysterious ‘ibogaine’ - nature news or commentary from nature. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism nature research cataloged source primary-source record" }, { "id": "source_radar_archive-V2hhdCBpcyB0aG", "title": "What is the psychedelic drug ibogaine that Trump wants fast-tracked? - nbcnews.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "nbcnews.com", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWE1qNkxIY2lGQ0tzM0xpRXNHa0k0NGVyclRVYWU4WG9Rb3VwRU5tbEhkaHRZYzFfa0dfeDQtNG1HeUc3czVDVGo0OFh1TEU1UTlINmpLYlA1SGk0d1BtazNfQ0NYbWxGMzU4QUlUSnRqSU53cEtYTkMzMnU0YXZ6Zl9LR3UwTy1uTjBqbUFkaWtYb3VOTnNEd3NZRTdwTVJTODZKSVJpV0tXZw?oc=5", "summary": "News or commentary from nbcnews.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 20 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-28T12:43:41.853Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "nbcnews.com", "displayDate": "Apr 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "what is the psychedelic drug ibogaine that trump wants fast-tracked? - nbcnews.com news or commentary from nbcnews.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism nbcnews.com conditions cataloged source primary-source record" }, { "id": "source_radar_archive-UHN5ZW5jZSBCaW", "title": "Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine - GlobeNewswire", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "GlobeNewswire", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOYVRoTjNTRUFjRnRUcVh4ODhBbUtzd3Zhay1rNDNEbEFObGlRdFA4N25ra0p4VHRzZDdpZnVaUWc3a2pRNW5mam8xVEtxYkRva2JkYVVJVTNHdXM1dEUzcGVYV2s2Q2loamxaTXlSYlNCTjNsQm9qM08yd243UVByYzF2YklfMEJjVUhmZFlyTXFnMkVZTU5LdmRSeVBzdGZCX3hQbW9OLW16dXJYQVpoUEZWOHVMMTRHRFRabGVSQjFKcVJfVG9tLVoxYzJHdnJDdWpnM01teEZGT296R19uZW12Q1A?oc=5", "summary": "News or commentary from GlobeNewswire. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 17 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T22:41:22.106Z", "sourceOrigin": "source_radar_archive", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "GlobeNewswire", "displayDate": "Apr 17, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "psyence biomed welcomes u.s. executive action to advance research into ibogaine - globenewswire news or commentary from globenewswire. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism globenewswire companies cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gbW", "title": "Colorado man's federal drug sentence comes months before expected state approval of ibogaine use - CBS News", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "CBS News", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOUjI5S2xPY3NEdjM2S1o1WUVqNnZEMlUzak1jNEx1MmR0NUpkNlVPaURKLWZPZUlLYVUzaWV0WF9SQWVlQTRQWVc0RE4yYVd1S010ZDdubm56VGs4RW5xclhpeVZIcTZKakxpRnphTUJ1bEdKS29oTDltcURWUHhWX3ZQZ29IOUNyQnJPMVI0M3l4WUk0SzdRMGZtTGh5QQ?oc=5", "summary": "News or commentary from CBS News. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 02 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "CBS News", "displayDate": "Feb 2, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Colorado man's federal drug sentence comes months before expected state approval of ibogaine use.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "colorado man's federal drug sentence comes months before expected state approval of ibogaine use - cbs news news or commentary from cbs news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism cbs news media cataloged source primary-source record" }, { "id": "source_radar_archive-SW1wYWN0OiBJYm", "title": "Impact: Iboga trafficking - Interpol", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Interpol", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQcklHTTJkNU9fTlBnWTdxQTU0WGxydzloVjduTXZQcnhDb0FLVnU4MGJnRjQtbThCaXNCXzk5RzA3c1dLanpkQnFqNXJ3UWtaU0drVEQ2aXdfajJOODllOTJjU0czOUctRjFfdFlsTnJmaFJNS0Y5M1ZQaDluLWVZMXcya0hWcHlnYUtFVjMwbi1KQVZhTUpaaWV5aC05OHNabWVZR2prZmdFM0RUckp3MlRB?oc=5", "summary": "News or commentary from Interpol. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 22 Dec 2025 12:12:25 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Interpol", "displayDate": "Dec 22, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers Impact: Iboga trafficking.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "impact: iboga trafficking - interpol news or commentary from interpol. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism interpol media cataloged source primary-source record" }, { "id": "source_radar_archive-UHN5Y2hvYWN0aX", "title": "Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets - Stanford Medicine", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Stanford Medicine", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE5BaTd5UWJUTzZkY21IM2huNkt3eWZteDJEWW5LcTg5Xy00LVlNVDJ1QWtxeFdraURKZ284bF9obzVpMk1idDJlT2RMdXFjdWZjb3E3ZUwwclJCeHJ5Zi1laXpvRkpJOVlHWTVWV3NZeVUzOFU?oc=5", "summary": "News or commentary from Stanford Medicine. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 05 Jan 2024 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Stanford Medicine", "displayDate": "Jan 5, 2024", "whatItIs": "News or commentary.", "conversationContext": "Covers Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets - stanford medicine news or commentary from stanford medicine. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism stanford medicine media cataloged source primary-source record" }, { "id": "source_radar_archive-SGlnaCBvbiBJYm", "title": "High on Ibogaine: Vice's Hamilton Morris Goes Back to Africa - CelebStoner.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "CelebStoner.com", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxORTV3d2hzUkM3c3paOUxrTjNiVEx5NU9MN0hRd3d0dXB5V2Y2LWhsR0RGTV9ha05rZXN2LUh2RVNKNlFjaGZMZ1FMN3NRUEVMallyaGhVNnlBallZXzJzWHJDMFhaNzJoWFBhbjFXTlNvSUxCU19TMFZjdmkzd05TN0pkY3I0LTlrUHljTWhpaThrS2RJWUY5VFB5SDUwUmNVcmJQM0V3aVJEX195SlRsUg?oc=5", "summary": "News or commentary from CelebStoner.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 02 Feb 2021 08:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "CelebStoner.com", "displayDate": "Feb 2, 2021", "whatItIs": "News or commentary.", "conversationContext": "Covers High on Ibogaine: Vice's Hamilton Morris Goes Back to Africa.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "high on ibogaine: vice's hamilton morris goes back to africa - celebstoner.com news or commentary from celebstoner.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism celebstoner.com media cataloged source primary-source record" }, { "id": "source_radar_archive-RnJvbSBjb21iYX", "title": "From combat to calm: One veteran’s ibogaine journey - DAV : Disabled American Veterans", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "DAV : Disabled American Veterans", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQZW43MGw4NTBOUVZuZjdJUzZJdTJjRVVmb0tpblRGUnQ5b3pqcnN1TmtrNkIyU1hBZnd5ekwyV3dzcnN5ZnhQX21VUEJsUnpCdEdIMzFQMDE2djhldnQwQk1JaW9OaG9sTWhMSk01R2RBbGVkMk1od2N2TW5pY1NwZUpGTV9zUlN6VlE0SjFNOUN6TkdtSlE?oc=5", "summary": "News or commentary from DAV : Disabled American Veterans. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 14 May 2026 12:36:06 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "DAV : Disabled American Veterans", "displayDate": "May 14, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "from combat to calm: one veteran’s ibogaine journey - dav : disabled american veterans news or commentary from dav : disabled american veterans. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism dav : disabled american veterans conditions cataloged source primary-source record" }, { "id": "source_radar_archive-RXhwbG9yaW5nIH", "title": "Exploring the treatment potential of the psychedelic ibogaine. - Psychology Today", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Psychology Today", "url": "https://news.google.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?oc=5", "summary": "News or commentary from Psychology Today. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 28 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Psychology Today", "displayDate": "Apr 28, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "exploring the treatment potential of the psychedelic ibogaine. - psychology today news or commentary from psychology today. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism psychology today conditions cataloged source primary-source record" }, { "id": "source_radar_archive-VmV0ZXJhbjogRX", "title": "Veteran: Executive Order a Win for Ibogaine, But More Research Needed - Military.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Military.com", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPdy1BUG5ZOUxhUXVLckRYZGxtbHcxUmE4LUpYZHdRX09SVkdpMGFSODk2bDJLQkxEODFwbV9OaG5ST0lYdmtTd3RNMDk2MFhQVi1JWjIzU3BXdWMyaTdKNDZjcDNPaldObHRiSWtNRlYzSnlLZ3NqRHlqTmFrY2o1QjFWOWFjcmxmNXpmTm1waEUwck5QSGpv?oc=5", "summary": "News or commentary from Military.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 03 May 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Military.com", "displayDate": "May 3, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "veteran: executive order a win for ibogaine, but more research needed - military.com news or commentary from military.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism military.com conditions cataloged source primary-source record" }, { "id": "source_radar_archive-UM6xKyBQc3ljaG", "title": "Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to Cover IV Ketamine for Depression; Inside the Plan to Make Lykos MAPS Again - Psychedelic Alpha", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Psychedelic Alpha", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxPakZJTF9DTzNhRGdWLVdEZDA2cTZmUjNmMG9IWEExOUs1VUFYYm5zSlcxUnpBOGlfRG9sX2pmeENnaTBFVnJUaEJ6V2hUU2Fxazk2TXRXbndhSy1XNWpIOEg2eG9WTlgxYTZIUi0xUWpEdlMxSU9nQS1ma2FaM3hxRnhjSl9lVUVVQlBDNXNvcXFpd0tIT05TSzZTRngxdS1ERUk0NV93VjE3YmFjaVpScnNjWnZteVFVcWJNV0V0LUdydk1aTExhT0ZuQUJPWG1CLUlKNEozRUdLSVRzWlRaOFdrU2FLYklhZUxTQmd1ZTMxbGQweTRlWG9WVXBOWlIxRV8wckVBeF8zY0puakluUC01QQ?oc=5", "summary": "News or commentary from Psychedelic Alpha. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 11 Jan 2025 08:00:00 GMT", "foundAt": "2026-05-17T04:40:59.131Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Psychedelic Alpha", "displayDate": "Jan 11, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to Cover IV Ketamine for Depression; Inside the Plan to Make Lykos MAPS Again.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "pα+ psychedelic bulletin #185: joe rogan on ibogaine; wisconsin medicaid to cover iv ketamine for depression; inside the plan to make lykos maps again - psychedelic alpha news or commentary from psychedelic alpha. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism psychedelic alpha media cataloged source primary-source record" }, { "id": "source_radar_archive-VHJ1bXAgc2lnbn", "title": "Trump signs executive order urging more research into ibogaine and other psychedelics - CNN", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "CNN", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOTklIbkpZS2VNYUVOVF9aX3pPRU9uSUdxb3Qzd1NkZ0RWV2ZHRGVDWkdyVUVYdHk3TUtJQjRLTUdSVGsyTXFWOXhUR0tpTzRFWUN6Z2tRRzBNRUFZbUlXcXo0enNBeGZKd3BjUzFTUHBoMXVHeW9CakZZa2I3TUwwMW92MGdfTHI4R0g0d3RXTU9MLVRzenFzRE5RVkR4RFFKYmpSWm1jcHJRcHMxRDFhbGlSemI?oc=5", "summary": "News or commentary from CNN. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-21T21:47:10.035Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "CNN", "displayDate": "Apr 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "trump signs executive order urging more research into ibogaine and other psychedelics - cnn news or commentary from cnn. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism cnn conditions cataloged source primary-source record" }, { "id": "source_radar_archive-QSBWZXRlcmFu4o", "title": "A Veteran’s Search for Healing Led to an Ibogaine Trip and an Epiphany: ‘I’ve Got to Let It Go’ - thewarhorse.org", "category": "clinics", "sourceType": "journalism", "sourceName": "thewarhorse.org", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFA1bF9JSEVPVkJHT0IzeXdfZTAzNmUwaTBaN1BGcVA2ZHI4d3JWbUJuS0J6dmZiVXB2dmNKd0ZwNWJMOXVCb21JdmdZVTNUNDN5eWo2cWpKWEQtZ1NVOGlnNFQzcw?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 08 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-21T15:20:47.421Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "thewarhorse.org", "displayDate": "Jan 8, 2026", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "a veteran’s search for healing led to an ibogaine trip and an epiphany: ‘i’ve got to let it go’ - thewarhorse.org clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism thewarhorse.org clinics cataloged source primary-source record" }, { "id": "source_radar_archive-VEhFIENSVUNJRk", "title": "THE CRUCIFIXION OF AMEEN ALAI:Or is it REALLY about Ibogaine? - Artvoice", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Artvoice", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNOFBfNERoLUFBTUJJdDdOUElOUktnZDk3bUU0T2xsNldjam5nNjFBck4zMXYwWXAtdU9sUTRZX1psTEVyRms0d01EY2JrQjB0MGJwMy1mRXVpRXpkaGE4bFh0dGtxQVF2dS1TMFZpQURMelN3S1UtcV8tNEl6TERjWHNNZS1sbGlFOS1oajZFS3JqVG1LOXR3?oc=5", "summary": "News or commentary from Artvoice. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 17 Feb 2026 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Artvoice", "displayDate": "Feb 17, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers safety.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "the crucifixion of ameen alai:or is it really about ibogaine? - artvoice news or commentary from artvoice. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism artvoice safety cataloged source primary-source record" }, { "id": "source_radar_archive-SXMgaWJvZ2Fpbm", "title": "Is ibogaine really a magic bullet for depression and PTSD? Not exactly - Scientific American", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Scientific American", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPMjBZdU56aVVxTHRYb3lIaXE4UVZsNEtFcUZZaUdtTWlFUk5QRkpXMXN5aEhSQlJVUzNRR294bFlwMEJlQ1paQ19aR3A2LXg5dTl6VmxMSVlsXzd0UGQ0eXp4bmN2akxBT0RaU01BZHZKTmM1LWFsRTJBV3ZXdXAtYzdvZ1FjOFBNMzdNLVRzbjNzU1NSUlU0eTVTN0M5MzdOenJUWHRYVlZCNlc0Yk9ZTzBBRW4tT1hSNDlzejQ3dXBjNnRx?oc=5", "summary": "News or commentary from Scientific American. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Scientific American", "displayDate": "Apr 24, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers safety.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "is ibogaine really a magic bullet for depression and ptsd? not exactly - scientific american news or commentary from scientific american. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism scientific american safety cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgdH", "title": "Ibogaine treatment for opioid use disorder: What you need to know - Healio", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Healio", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQZzg0aGhxb3g4SkFtU3dpb3BXdGpsMmJlalRqS0NXVkU0NkFWNWJHX3RpRHFsT2g1WjRPM0JRbF92X1JGZldabzNBR05lMDV3cFd5Z3J6Z3RkOVd0bEJNRm9UMG0yQXlCc3VtSGtaMHl5TVVHTU1hazBiZ2g1Z3E1V2J5Vml6WHZvR0ZGYUFtcm4xNWY1TGppcDFna1Q4clFWYmhKRDJKUEdjdk4yYjV4c0F6LU0?oc=5", "summary": "News or commentary from Healio. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 05 Dec 2019 08:00:00 GMT", "foundAt": "2026-05-31T02:55:06.883Z", "sourceOrigin": "source_radar_archive", "tags": [ "safety" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Healio", "displayDate": "Dec 5, 2019", "whatItIs": "News or commentary.", "conversationContext": "Covers safety.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine treatment for opioid use disorder: what you need to know - healio news or commentary from healio. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism healio safety cataloged source primary-source record" }, { "id": "source_radar_archive-T3B0aW1pIEhlYW", "title": "Optimi Health launches ibogaine initiative in response to Trump’s executive order - Mugglehead Investment Magazine", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Mugglehead Investment Magazine", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPYXNHQVM4NGtqSWFFMFJJUXh3QWhWZG5DQkwzbWVwbDE0M2RBdWhmOTFBTUZNQ1UzUXRXNXZVS3VEMy1UZVl4SUUycTJZLWRVblplTm1VOC1oeXJmVFM5VC1ydUhHN1VtbEVGX3h1TnpSem55QnBXMC16WHVGSTFieDhMaTNtcjRkS0FPdmd3cUlFMEx2UWZmZ1l0VTRvM2ZxR3dLckZxdw?oc=5", "summary": "News or commentary from Mugglehead Investment Magazine. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T22:41:22.106Z", "sourceOrigin": "source_radar_archive", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Mugglehead Investment Magazine", "displayDate": "Apr 21, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "optimi health launches ibogaine initiative in response to trump’s executive order - mugglehead investment magazine news or commentary from mugglehead investment magazine. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism mugglehead investment magazine companies cataloged source primary-source record" }, { "id": "source_radar_archive-MjAyNTogVGhlIF", "title": "2025: The Year of Ibogaine Therapy - lucid.news", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "lucid.news", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE1ZelRmVDl3dXhsVXhiUWNhMkY3Z1d5LTdnd1JjeVRIT3JXRFdzdUFERWY2ZFVtSDd0aExBV0dEOEdaVXZMOGNFLWNSX1hLRWlkc2tnUFpPODJkYVNiaUE?oc=5", "summary": "News or commentary from lucid.news. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 05 Aug 2025 07:00:00 GMT", "foundAt": "2026-05-18T04:41:30.053Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "lucid.news", "displayDate": "Aug 5, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers 2025: The Year of Ibogaine Therapy.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "2025: the year of ibogaine therapy - lucid.news news or commentary from lucid.news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism lucid.news media cataloged source primary-source record" }, { "id": "source_radar_archive-Q29sb3JhZG8gUH", "title": "Colorado Psychedelics Board Votes To Recommend Adding Ibogaine To Regulated Healing Centers - Marijuana Moment", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Marijuana Moment", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPbmtEYU1CWnVnUUc1cGNoTUhhTEtJSXV6amZQdzk2NFNuZXkzb0paa1htV1cyWTBVRTd0ZktjblBSRW1TNnlFVWl1bDVwd25na1lVWnd3TGhYdnBQNllqVDlwZGdCX3ZGVHg2OV9Jdk9ZQWwyVUNhQkxPdVVicE40bktwYjhndklDdUxleksxWTdwT3RIYmhpaDU2U3VJTjNJV2NmbzM3Xzd6UmxRTDI5UU1DREZQR3J1cXp0VjZEZ3h3UQ?oc=5", "summary": "News or commentary from Marijuana Moment. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 19 Sep 2025 07:00:00 GMT", "foundAt": "2026-05-18T04:41:30.053Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Marijuana Moment", "displayDate": "Sep 19, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers Colorado Psychedelics Board Votes To Recommend Adding Ibogaine To Regulated Healing Centers.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "colorado psychedelics board votes to recommend adding ibogaine to regulated healing centers - marijuana moment news or commentary from marijuana moment. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism marijuana moment media cataloged source primary-source record" }, { "id": "source_radar_archive-Q29tbWVudGFyeT", "title": "Commentary: Ibogaine hype is outpacing the science - bendbulletin.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "bendbulletin.com", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdkxxeUpGaE9CS2FmYjFIa21LaUREdllQMGNtWnZKbXdXYnB1TVl1b3NaMkx0c2JhZ2xjY3JubnhRZEgydjlTZ0ZSdUdUU2c4cmNYeHhkdHFZQUVqczR1YmxvMkc0MzFtamxqbExxaWdyc3VnMW9KdHdPaTNLd3d4dndhN2h6dFBBZTg3WF9tTQ?oc=5", "summary": "News or commentary from bendbulletin.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 04 May 2026 07:00:00 GMT", "foundAt": "2026-05-19T12:38:02.773Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "bendbulletin.com", "displayDate": "May 4, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "commentary: ibogaine hype is outpacing the science - bendbulletin.com news or commentary from bendbulletin.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism bendbulletin.com conditions cataloged source primary-source record" }, { "id": "source_radar_archive-QnJhaW4gc2Nhbn", "title": "Brain scans reveal how ibogaine alters neural networks in veterans with head trauma - psypost.org", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "psypost.org", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNak5ndHY1ODJfVkN1NVVtOVBORU5aeGZURzFYZHU1dzVMQVV2eWNLVUVCZ0VESElpQ0FwTkd1ZXA5ckVoYkd4cXFnaWZSV2MwWTBZQ1hFSi1wVXFRSUFpeU15bDk4MGlKVlQ3cVdWX3R1RHMzLXY2SllqYWQtanB0VmtZanE1SVhsV0FxblpmcUtxTWJsUnNLY1U1dmxQV1FzVWo5XzNvOEg?oc=5", "summary": "News or commentary from psypost.org. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 19 May 2026 14:12:09 GMT", "foundAt": "2026-05-20T07:41:27.986Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "psypost.org", "displayDate": "May 19, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "brain scans reveal how ibogaine alters neural networks in veterans with head trauma - psypost.org news or commentary from psypost.org. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism psypost.org conditions cataloged source primary-source record" }, { "id": "source_radar_archive-V2hhdCBJcyBJYm", "title": "What Is Ibogaine? How Psychedelic Could Help Treat Veterans’ Depression - Newsweek", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Newsweek", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxORlZoTU8xbktwNi1QUDdUclYtX2I3OWNaY2JTRXZnRmhVV2pHZjA5eTlRV3Q0UGE0U1lEVHB3bkpYdjFSVTVlN3BMMWFGSVdxTnZRTExBS1d4ZHk0R1lvS3h6RVZCdTN2eldVeFQxcWNidFlJRkt3dEZFLUh2QTByTzhfQkFjSjljeDZVSHQ2dzliUUQ0bXR6amJRa1FwWkhsZUdSVUFn?oc=5", "summary": "News or commentary from Newsweek. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-19T19:35:40.661Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Newsweek", "displayDate": "Apr 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers What Is Ibogaine? How Psychedelic Could Help Treat Veterans’ Depression.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "what is ibogaine? how psychedelic could help treat veterans’ depression - newsweek news or commentary from newsweek. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism newsweek media cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgQX", "title": "Ibogaine Appears to Help Veterans with Brain Injuries - Psychiatrist.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Psychiatrist.com", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPX0czdFdiRnljTjlnUnMzanBHd3NqLWZSODNCWkZrZThOTjNNbF9LOU9rTmFvTlVUR2g5NmM0Y283UGttbXQ5SGJpSlBXSWxDbjhTRTZIN0JLX2ljOGk1RzN6aUNXMklERVBaU1dVSlliUFVqczB6LTVXTXllWUJnR3NzSm9BY05jTmxPSU5oZGhNdw?oc=5", "summary": "News or commentary from Psychiatrist.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 05 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-20T09:13:58.782Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Psychiatrist.com", "displayDate": "Jan 5, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine appears to help veterans with brain injuries - psychiatrist.com news or commentary from psychiatrist.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism psychiatrist.com conditions cataloged source primary-source record" }, { "id": "source_radar_archive-TmV3IFRoZW9yaW", "title": "New Theories and Findings From The Frontier of Ibogaine Research - lucid.news", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "lucid.news", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPNzhCejl3NzE1a1BHNmpwckxvRnpZZkVaVDRXaHpEcjR2WUZfRVBaU1FUR1FuWUp6ejM4QXdpS2l1cGZFaG5JTjJLS1ZQSUdBZ2tETU4zd2I3MUVOUWd5TkhucTZlSUl6MnJUT3V2UXU2cTJPeGpRNm5UcGYyeW90dXBfVkVHS3NlNWdGSmRrajljQQ?oc=5", "summary": "News or commentary from lucid.news. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 30 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-20T11:48:14.083Z", "sourceOrigin": "source_radar_archive", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "lucid.news", "displayDate": "Jan 30, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "new theories and findings from the frontier of ibogaine research - lucid.news news or commentary from lucid.news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism lucid.news companies cataloged source primary-source record" }, { "id": "source_radar_archive-Rm9ybWVyIEdPUC", "title": "Former GOP House Speaker Pledges To Advance Access To Psychedelic Ibogaine That Could 'Save Several Million Lives' - Marijuana Moment", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Marijuana Moment", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNUjZ0aWxnNGNRZ0NYUEo3MDV3eEJkWGhKdDh1WWJna1Z0dXdxN2RrOHhFN0x3RHVHU0VEaTZXOThKdHJrcTRnd2xjZEZSYW1XbnpzMkZIREh2NW5raDU3dEZvZlByVDRqd0YwU3RzSkhlWTktM1ptX0RJb1dCMnZhai1VM1hoSmI5clV3cFozNU5NOTVLMUdSa21hbnhySEZERUowc1puZko2VGtQMkJsNWdnMUN4eGp3Mm1kTnhTNHNWWi1ERjVnZ3hEZXMxdzJPNVg1V2ZNNkpFUFhXZ2c?oc=5", "summary": "News or commentary from Marijuana Moment. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 10 Jul 2025 07:00:00 GMT", "foundAt": "2026-05-22T21:29:07.174Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Marijuana Moment", "displayDate": "Jul 10, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers Former GOP House Speaker Pledges To Advance Access To Psychedelic Ibogaine That Could 'Save Several Million Lives'.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "former gop house speaker pledges to advance access to psychedelic ibogaine that could 'save several million lives' - marijuana moment news or commentary from marijuana moment. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism marijuana moment media cataloged source primary-source record" }, { "id": "source_radar_archive-UmVwcy4gR3JlZW", "title": "Reps. Greene, McFall Lead the Way in Promoting Ibogaine Research in Michigan - Michigan House Republicans", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Michigan House Republicans", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUGZHdFplNDVjQ3RpRTlPWjRWX090Z2g0WHgzTUtJVDZqZldteFRJZmRvcFNtOUhlWE5vQV9jV21tenl3d0VydGlsSVB2SjlWQ1hvMHZPWHhqMlgtVHV2V0pIMS1Ra0p5aTlkSnM0eG8xa3RFQ29LdWFsN0FmeGNUeUpfMDBxZUVMTTA3RkVnMlJvUE5mcVBLV3YxSG9pYnIxR2VN?oc=5", "summary": "News or commentary from Michigan House Republicans. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 22 May 2026 21:37:08 GMT", "foundAt": "2026-05-23T00:37:03.753Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Michigan House Republicans", "displayDate": "May 22, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Reps. Greene, McFall Lead the Way in Promoting Ibogaine Research in Michigan.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "reps. greene, mcfall lead the way in promoting ibogaine research in michigan - michigan house republicans news or commentary from michigan house republicans. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism michigan house republicans research cataloged source primary-source record" }, { "id": "source_radar_archive-VXNlciBDbGlwOi", "title": "User Clip: President Trump Signs Executive Order on Ibogaine Research - C-SPAN", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "C-SPAN", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNSmRydkdZaGVBQ3MtM3QwbmpMeDdHY3FHb09mbHN2ZDNUWktwcDJhSWJWRWdONkIzVjFpejAxZjJQR3BIVGtGRU10blZ3NlpnS21XNk94dkpIWHBZTHVCWUJFNTdVemZhRVVzcWpLWEdTd0ozX2dxblVDWVFYcU9xOVVlRGRhYTk3eHZfWGpJOHFuTFQ5dGI4YkF1NXptZmVyNTgzcE1sMjh1OUtfemZRYlZ0XzMycmxGZmJzT1E3RQ?oc=5", "summary": "News or commentary from C-SPAN. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-24T04:35:52.410Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "C-SPAN", "displayDate": "Apr 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "user clip: president trump signs executive order on ibogaine research - c-span news or commentary from c-span. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism c-span conditions cataloged source primary-source record" }, { "id": "source_radar_archive-QSB0cmFuc2NyaX", "title": "A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets - Nature", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Nature", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE10WTQ1SnAzTFR1NkFoRzdVSjZ4S05wb0FLSTJKdmttU0FUcmwxX3JXSkpiM2s4ZlRmZVVURTJKaUJYTWFMck0tdzVPWE9fZFI5NjBjeVZxamQ0cmN5QXZJ?oc=5", "summary": "News or commentary from Nature. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 19 Jan 2024 08:00:00 GMT", "foundAt": "2026-05-24T10:00:10.404Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Nature", "displayDate": "Jan 19, 2024", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "a transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets - nature news or commentary from nature. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism nature blogs cataloged source primary-source record" }, { "id": "source_radar_archive-QW5hbHl6aW5nIE", "title": "Analyzing Joe Rogan's effectiveness claims of psychedelic ibogaine - WBAL-TV", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "WBAL-TV", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNendIVDl6dTE2eVlNa3V2NVYxSndBd3RLNjdDeU1tTkJxaUtVZlZsYXQzNldiN0hvVHpTaVgyQTlBNjlsZlZKOWY0Yl9HM294MHhRUFUtQjV0Y1d0VDMxWWZ2VDFRV251ZG9KMGFHRzZQLUdkWW15Mi1MU1dRbFg1dFpNVFJZc0dHYWt6Z1hGX2dlRFA0UVB1NmdxRENrYm1YWVotOQ?oc=5", "summary": "News or commentary from WBAL-TV. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-30T04:01:48.622Z", "sourceOrigin": "source_radar_archive", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "WBAL-TV", "displayDate": "Apr 24, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "analyzing joe rogan's effectiveness claims of psychedelic ibogaine - wbal-tv news or commentary from wbal-tv. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism wbal-tv conditions cataloged source primary-source record" }, { "id": "source_radar_archive-TWFnbmVzaXVtLU", "title": "Magnesium-Ibogaine Therapy Could Offer Treatment Option for TBI - U.S. Medicine", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "U.S. Medicine", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSTFMTWZUWVZlR05jS1hFdEExMnZudmU4NWliUVd2V2h5RXVyVWlQTVdFNERNdDZxcWQ3Z01mcWVZbWpRcEJvdlAtbkJJZUFVam53RUpaeE5HblNZb28wRjJMNDdxMXlsSHNfUUNrV0h0cWNVR0pJVl84TXpqV3piaXBLdW82WDA3MjVyTWZEUlNBWUhzcHZhRG1VQUZGbnktdm43WVRtSDl3SG1GeGlMVQ?oc=5", "summary": "News or commentary from U.S. Medicine. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 22 Sep 2025 07:00:00 GMT", "foundAt": "2026-05-24T17:28:18.785Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "U.S. Medicine", "displayDate": "Sep 22, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "magnesium-ibogaine therapy could offer treatment option for tbi - u.s. medicine news or commentary from u.s. medicine. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism u.s. medicine blogs cataloged source primary-source record" }, { "id": "source_radar_archive-U291cmNpbmcgQ2", "title": "Sourcing Challenges for Ibogaine May Slow US Veterans’ Psychedelic Therapy Push - Hemp Gazette", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Hemp Gazette", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNQXl3Z2NiQ0lNQ0FnSEN3OEYwSUFZWGh0a3Iyb1drN2p1eDRtTWhmMUVKM2NRWTRmQkp6ejI5N0tWTTVQbTZGOHRYaE5mSXgxZGJMN2xuVmpQQmpPbm9Ub0dGZGd0RjJ6aHRrYzRkWWJfNUwwN19IdEUxS29ybHNZakVnU0ZVQkZ4RlJYYWFWOUQ?oc=5", "summary": "News or commentary from Hemp Gazette. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 27 May 2026 00:12:06 GMT", "foundAt": "2026-05-27T00:24:36.909Z", "sourceOrigin": "source_radar_archive", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Hemp Gazette", "displayDate": "May 27, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Sourcing Challenges for Ibogaine May Slow US Veterans’ Psychedelic Therapy Push.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "sourcing challenges for ibogaine may slow us veterans’ psychedelic therapy push - hemp gazette news or commentary from hemp gazette. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism hemp gazette research cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUsIG", "title": "Ibogaine, of all things - Larchmont Chronicle", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Larchmont Chronicle", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE8wMUFWWlZrODFfWU9IT1lQaVJEcHlrcnd2ZXZCREQ0cjBkNFRtODBGU3I4aFJTQ1J3c0lyaXBRZTY5Rl9GajkwMlpIVlRoeGxVMnFSQjFETmxodElaVUpPSU4wMm5DbXc?oc=5", "summary": "News or commentary from Larchmont Chronicle. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 28 May 2026 16:23:31 GMT", "foundAt": "2026-05-28T16:31:31.181Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Larchmont Chronicle", "displayDate": "May 28, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Ibogaine, of all things.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "ibogaine, of all things - larchmont chronicle news or commentary from larchmont chronicle. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism larchmont chronicle media cataloged source primary-source record" }, { "id": "source_radar_archive-4oCcSeKAmW0gQW", "title": "“I’m All About the Data”: Dr. Charles Nemeroff on Psychedelics, Ibogaine, and Scientific Rigour - Psychedelic Alpha", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Psychedelic Alpha", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOeGdwN2V6a2xRc2hDd3FBZnZUbHdwbVQ4WVV4QTY5SmhhWVM0NVdtVXBKWFpTdkEyOUtyYzNKdzBJQUhvM2VMc2tmaUFJai1XQXZtdi1iWGlFeHV4TFdpRXN1TGRpNW1HbXJKc1BLUEdkekU3NDhLN21La3RaVUE0a0pWSFl1RHk0YkdRNmp0T2trTHNUM3RSNnlKTVlOSEw4LUtURHhMaUFXZERuN2lVaFAtZGhFeE5GS3RxOGxoZGM?oc=5", "summary": "News or commentary from Psychedelic Alpha. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 17 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-30T01:18:18.737Z", "sourceOrigin": "source_radar_archive", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Psychedelic Alpha", "displayDate": "Mar 17, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "“i’m all about the data”: dr. charles nemeroff on psychedelics, ibogaine, and scientific rigour - psychedelic alpha news or commentary from psychedelic alpha. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism psychedelic alpha blogs cataloged source primary-source record" }, { "id": "latest_scan-VGhlIE1hbiBCZW", "title": "The Man Behind the Trump Administration’s Favorite Psychedelic - The Atlantic", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Atlantic", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQWXBkYXBQLVFEWkZmU3pwT1d4UjA4d2tJeVdneGVEUnhpeGp6b3U4Nm5KVkFTQ01PZDhLckIteWRwYlFrWlRIZzJneXV0VXFLbmJ4WXJtQ2lZd0p5WERkUU44NG5tTGNKcDFOQUpCMUFMcUdfNWFNUktDUVNGUUdTVE9UaFVlclJsNzlkcV9rLVVobmNhYXl4YU9jZXJaQQ?oc=5", "summary": "News or commentary from The Atlantic. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 24 May 2026 12:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Atlantic", "displayDate": "May 24, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers The Man Behind the Trump Administration’s Favorite Psychedelic.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "the man behind the trump administration’s favorite psychedelic - the atlantic news or commentary from the atlantic. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the atlantic research cataloged source primary-source record" }, { "id": "latest_scan-TWljaGlnYW4gY2", "title": "Michigan can lead the nation in healing addiction, veteran trauma | Opinion - The Detroit News", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Detroit News", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxORXZtNENncGxNTUgxSjJiZVBBc214RkRXVzY3aWwxSjJlci1zOHZXZVprX3l6R05YcVJOXzVuRDc3NjBmdDBCMlB0aWk5UFY3dGFlbWtLZmtURDlicnVUQjJWX01CdkVXVjBHdTdEQzA0RmMyUzFDbEdKdzQ1d2szRW52TmJfbzFtbGVrRjIxNl9PRExoWFY4M2lKejlaanp6OHVmdXU2cTlzT3B3WTFvS1V0OEx3RTFzUU9SMk5JYmE?oc=5", "summary": "News or commentary from The Detroit News. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 20 May 2026 23:40:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "research" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Detroit News", "displayDate": "May 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Michigan can lead the nation in healing addiction, veteran trauma | Opinion.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "michigan can lead the nation in healing addiction, veteran trauma | opinion - the detroit news news or commentary from the detroit news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the detroit news research cataloged source primary-source record" }, { "id": "latest_scan-SXTigJlzIGFuIE", "title": "It’s an Obscure Psychedelic Used to Treat Trauma. Could It Help Me? - The New York Times", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The New York Times", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNY1hjUElaY0t5Z1ZhYWFsdzQ3RkF2ZTI5SEJQcVlzWmJzNDRfT1N0RnlMdFhoZ1lGQ2E2aUdzTF9JRk5sb2Zqbk1aaXZwXzF6a2ZVUHExLWxsYy1UdVd4OUkwWUpvbGFYT0JLV0t4dTY3NXBXSXp1UU9QZENoVW9YZXYtb2hsVnUwUXhBbXRXd0tyb2ExbWs4eEhHME5XTk5WSmc?oc=5", "summary": "News or commentary from The New York Times. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The New York Times", "displayDate": "Apr 21, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers It’s an Obscure Psychedelic Used to Treat Trauma. Could It Help Me?.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "it’s an obscure psychedelic used to treat trauma. could it help me? - the new york times news or commentary from the new york times. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the new york times media cataloged source primary-source record" }, { "id": "latest_scan-VHJ1bXDigJlzIH", "title": "Trump’s psychedelics executive order and how Texas inspired (and may benefit from) it - The Microdose", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBsanJJZk9QOXZMd0xsZUJqUXpvN2l6V0d4em8yeHVMMUIyc2tHeU41MDlGdElyem1FXzdtTzY2UTJqUHNUNUxNd3h2Y1dkcU4tOUg5TUl3ZnpJdll4TVBaRFhrYjNPZDVhMU5GdnJrWVhIWkptQTJzaE5pNA?oc=5", "summary": "News or commentary from The Microdose. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "Apr 24, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Trump’s psychedelics executive order and how Texas inspired (and may benefit from) it.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "trump’s psychedelics executive order and how texas inspired (and may benefit from) it - the microdose news or commentary from the microdose. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the microdose media cataloged source primary-source record" }, { "id": "latest_scan-VGhlIEdyaXBwaW", "title": "The Gripping Story Behind Netflix's In Waves and War - Time Magazine", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Time Magazine", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1kak5uRndBbDhjWFI1bmdqRF9Rb3B3YmR2NlBTcTM3MmpvS2ZhTndEVXNmSnBZbDdJeVJVSlRSM3BJUmsycWZxblAzQ0VsOFlpa1JBaFdWMUtHZjhHRmVuZEhud29hVXktMVZ0TTFidw?oc=5", "summary": "News or commentary from Time Magazine. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 03 Nov 2025 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Time Magazine", "displayDate": "Nov 3, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers The Gripping Story Behind Netflix's In Waves and War.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "the gripping story behind netflix's in waves and war - time magazine news or commentary from time magazine. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism time magazine media cataloged source primary-source record" }, { "id": "latest_scan-VGhlIExvbmcsIF", "title": "The Long, Strange Trip of Rick Perry - The New York Times", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The New York Times", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOdExKaTlOUTNBdFdDR1E0Qjc1MmhKdzdHTVdkNGxSdXFkSUxWd1hHNzV0RndzM2dua2dBT1lsOF9BWFFRczRiR21Zem9qN0doV0xteHRrYUlENk5hYmV0R0x0X3p1dVhsSy1YMWVKaV9HNGkzZlFGaXk5LTA4YUxWYURXeGhnM0JYd05DLVp6dXB5ZnM?oc=5", "summary": "News or commentary from The New York Times. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 12 Aug 2025 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The New York Times", "displayDate": "Aug 12, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers The Long, Strange Trip of Rick Perry.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "the long, strange trip of rick perry - the new york times news or commentary from the new york times. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the new york times media cataloged source primary-source record" }, { "id": "latest_scan-V2l0aCBSaWNrIF", "title": "With Rick Perry’s backing and $50 million from the state, Texas set to become a leader in psychedelics research - The Texas Tribune", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Texas Tribune", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUW0wYU9ReUxrYS1aWlpkZE5xSUMzaENMT25PSktXRERBcGRhdjlHdjRnTGw0aWdpbTBRUU5zT0FNb2VmMDJrMTRxUDNnVWl5eU9iM1lqTjE3dUxnajB4SFVJNGlMc19OWlh5WVF6WERuRG82R3dZeXlvT01PemxXZWNrR2N3MkpfSHFZSWVGbkk2WUdYeWUwb3oxX1JxUzRVY1l0bmJrNXR5c2M?oc=5", "summary": "News or commentary from The Texas Tribune. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 11 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Texas Tribune", "displayDate": "Jun 11, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers With Rick Perry’s backing and $50 million from the state, Texas set to become a leader in psychedelics research.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "with rick perry’s backing and $50 million from the state, texas set to become a leader in psychedelics research - the texas tribune news or commentary from the texas tribune. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the texas tribune media cataloged source primary-source record" }, { "id": "latest_scan-aGFtaWx0b24tbW", "title": "hamilton-morris-headshot-1 - Multidisciplinary Association for Psychedelic Studies – MAPS", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Multidisciplinary Association for Psychedelic Studies – MAPS", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9kTGJTTzVQbm54MkJ0dGowdmtMVE9fVEhJdVVReV9BVWc1VFBPTWJobVUtdTlIS0RhQjFCZmhUdVE5cnI5NnpBenUwR2dsTmFFWU5zRnJyRQ?oc=5", "summary": "News or commentary from Multidisciplinary Association for Psychedelic Studies – MAPS. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 29 Jun 2024 10:57:34 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Multidisciplinary Association for Psychedelic Studies – MAPS", "displayDate": "Jun 29, 2024", "whatItIs": "News or commentary.", "conversationContext": "Covers hamilton-morris-headshot-1.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "hamilton-morris-headshot-1 - multidisciplinary association for psychedelic studies – maps news or commentary from multidisciplinary association for psychedelic studies – maps. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism multidisciplinary association for psychedelic studies – maps media cataloged source primary-source record" }, { "id": "latest_scan-TGl2ZSBmcm9tIF", "title": "Live from Psychedelic Science 2025 - The Microdose", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE8yR0JGUTNORFRxSmNoZ1N1dEU0VkFCSWdHVjFzVFlxYWZDOTlNd19DRW42Q0xpTGRFMFNMbXpDeU10VFpFSm5jVUxoYmlIOGh3V2psbHdIY1o4LWVvOG9RU2hjTldYZDJCSF9OU3Q5dVVaUkw3TlN5aFowRHhHWVE?oc=5", "summary": "News or commentary from The Microdose. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 20 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "Jun 20, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers Live from Psychedelic Science 2025.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "live from psychedelic science 2025 - the microdose news or commentary from the microdose. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the microdose media cataloged source primary-source record" }, { "id": "latest_scan-SGFtaWx0b24gTW", "title": "Hamilton Morris On Mistakes, 5-MeO-DMT And Preserving Psychedelic Toads - Forbes", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Forbes", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQkQ1U1VXRHlwWTVZZXVmQ3ZpbzhnNUdmLVdmMWxMbHJIbmVuc2tfbnBFSE90dkNOX05FQWdOcnQ1VU9UZm9ZWng1Zi1aTE4xNjlOMWdORHhlN3dKWXNGd0JTZHZZOG5tVGMwRUlpY2JXZ3V2Q044T2duUUhEZERxVk96Nl9BNnZDUXVXWGN6Yk9GR25PWFZad2RMY2E2VFFDYXNDcjhPMHl0Mk1kam5NZmtqVzlmNVdPaFVhYWVTWUx1OFE?oc=5", "summary": "News or commentary from Forbes. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 09 Jan 2021 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Forbes", "displayDate": "Jan 9, 2021", "whatItIs": "News or commentary.", "conversationContext": "Covers Hamilton Morris On Mistakes, 5-MeO-DMT And Preserving Psychedelic Toads.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "hamilton morris on mistakes, 5-meo-dmt and preserving psychedelic toads - forbes news or commentary from forbes. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism forbes media cataloged source primary-source record" }, { "id": "latest_scan-QmV0dGVyIExpdm", "title": "Better Living Through Chemistry: A Discussion with Hamilton Morris - lucid.news", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "lucid.news", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPS1c5TDAyb3BodVV0WTdwVVB5dkM0Q2ROcEMtdmZtcHpMa2JQVWNXR0xKcXp2WlhlMHpoelU1U1FtdGF6WnFwVkRRYzk1NkxlWUxnT1d0S1VpMmRuRGRyV1lNRGRUOV9yNVE0VVNKbDlIeGFHeThDSHppakotbGxlYnNETFdXd0Q3cFQySUlzYVo3WFE?oc=5", "summary": "News or commentary from lucid.news. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 28 Jan 2021 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "lucid.news", "displayDate": "Jan 28, 2021", "whatItIs": "News or commentary.", "conversationContext": "Covers Better Living Through Chemistry: A Discussion with Hamilton Morris.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "better living through chemistry: a discussion with hamilton morris - lucid.news news or commentary from lucid.news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism lucid.news media cataloged source primary-source record" }, { "id": "latest_scan-RW52aXNpb25pbm", "title": "Envisioning a psychedelic future for Philadelphia’s USciences as it pairs with Compass Pathways for a Drug Discovery Center - Inquirer.com", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Inquirer.com", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPdlZZNk1INjFvNzczUF9EVHV4ZmQ0dmV6UVhUdncxdG1nMk5hM1NPd3FJWVZpRXFsaU1WVE5CR0tRQjYzWkxscVEwU3NVTk9vb0NtRWNKNjY3dEM1bk9sbVlvUlRRb2xtM3ZWOFgycVJlS0o1bkhWcDZoMmlqU3U5OUlzTXhLV2N0Z2Nac01rNnhodlY2ZEM2YXVoT0g2aEpSNXdiNVhZdnJtTDNmNV9mUTJQa2pFSnVBaE8wMkktZDVQMEt2RzEw?oc=5", "summary": "News or commentary from Inquirer.com. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 15 Feb 2021 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Inquirer.com", "displayDate": "Feb 15, 2021", "whatItIs": "News or commentary.", "conversationContext": "Covers Envisioning a psychedelic future for Philadelphia’s USciences as it pairs with Compass Pathways for a Drug Discovery Center.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "envisioning a psychedelic future for philadelphia’s usciences as it pairs with compass pathways for a drug discovery center - inquirer.com news or commentary from inquirer.com. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism inquirer.com media cataloged source primary-source record" }, { "id": "latest_scan-SW4gcmFjZSB0by", "title": "In race to develop psychedelic drug, Texas officials trip at starting line - San Antonio Express-News", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "San Antonio Express-News", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdnRhbHo5SWQ4NU0xYUFNWmMwMkk3S0pTU0NQSm93bjYtOWtWd290MjhOaGlZTkRxaEhTaENGWXFOWXlIVUdUQ19oRkxiNUFiLXZ6TkgxWEZ1ZkZoVjNaeDBkakxIZjJTdGotVnBfUHdhR21rVDQzZk9jLU1GaF9yN2tQeHNGQXowOS14VEJNWFNDN2dHNWpWN0R5cUJlbENDcmlYRkR3ZjhYTVgz?oc=5", "summary": "News or commentary from San Antonio Express-News. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "San Antonio Express-News", "displayDate": "Apr 24, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers In race to develop psychedelic drug, Texas officials trip at starting line - San Antonio Express-News.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "in race to develop psychedelic drug, texas officials trip at starting line - san antonio express-news news or commentary from san antonio express-news. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism san antonio express-news media cataloged source primary-source record" }, { "id": "latest_scan-Rm9ybWVyIFRleG", "title": "Former Texas Gov. Rick Perry is betting on a psychedelic drug. Here’s why - Austin American-Statesman", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Austin American-Statesman", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNTkx5QXMzVUZRNUx1eDhvQU50bkExLTVQdXpPdXJxRElWZFhHTUE3V21GMTdCekpmblJEeEI5QVZzaE05R05WLWZ6NHRjRmxNYmNqV1hXSkxXWEFFbmxBVGxQYnB5bVRxcC10bDZINndLcmluMUZqSkhZd3Jvb085Yzdua29mMU1BUDlIWVRGUW1oUkVKMHQ1TzJB?oc=5", "summary": "News or commentary from Austin American-Statesman. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 18 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "media" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Austin American-Statesman", "displayDate": "Mar 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers Former Texas Gov. Rick Perry is betting on a psychedelic drug. Here’s why - Austin American-Statesman.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "former texas gov. rick perry is betting on a psychedelic drug. here’s why - austin american-statesman news or commentary from austin american-statesman. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism austin american-statesman media cataloged source primary-source record" }, { "id": "latest_scan-QSBOZXcgRXhlY3", "title": "A New Executive Order on Psychedelics: Q&A with I. Glenn Cohen and Mason Marks - Petrie-Flom Center", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "Petrie-Flom Center", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMXhXLVp2ZThnNHgxX2Q4b0tyOG5iRmQ1RnhlWjlsc0JyODl2QTI1dzR5bk9UM1lKZW5rSWI2QzdXcE40ZUo4eVpGOU14MkxWMVBlM0ZkTHJwdHpNN3N1Z0RXNjNTUWwxaVhYMk1NbVljMW0xb2QwYVpNSzBCWU5jZzVVM2xNU1F0ZjhDT3JJN0w1RWVPb2NkVVlSVWk0blV5YkNjaFByMF9EZlhoMHR1eGE5TGZzZnVVZ3FOTlkwWVQ?oc=5", "summary": "News or commentary from Petrie-Flom Center. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 18 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "Petrie-Flom Center", "displayDate": "Apr 18, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "a new executive order on psychedelics: q&a with i. glenn cohen and mason marks - petrie-flom center news or commentary from petrie-flom center. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism petrie-flom center blogs cataloged source primary-source record" }, { "id": "latest_scan-U2NpZW50aXN0cy", "title": "Scientists engineered plants to produce five psychedelics at once; ‘Mega-analysis’ shows brain responses to five psychedelics share a “signature” - The Microdose", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Microdose", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQTVVidXJuNURWcUdxRnp1cDlFVXRzeXUtOWhlM3RicmNmazhCMW5yVTRRcDVBV3BWUWFFNlJSU21EUUhNTGowdVJnOGNyR3Z0akdQNzRrS0lXQ3J3Nzluem1mejE0LWxWanpjdGN0bnUwa09uSlRFUTBDU2xIcnpWYQ?oc=5", "summary": "News or commentary from The Microdose. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 10 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "blogs" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Microdose", "displayDate": "Apr 10, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers blogs.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "scientists engineered plants to produce five psychedelics at once; ‘mega-analysis’ shows brain responses to five psychedelics share a “signature” - the microdose news or commentary from the microdose. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the microdose blogs cataloged source primary-source record" }, { "id": "latest_scan-V2h5IFRleGFzIG", "title": "Why Texas is spending millions to research an illegal psychedelic - The Washington Post", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The Washington Post", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNM1YwUlVpSU81NUh3ZUdGQTI0bERweS04OG5qT3JYX2tVX2JJZjZOTGRJMUs2VHFkWGRtbDZIN0U3UW5pWXAtUlctZ0t4MVEtUzVlSUpXRmRPSVozWGt2MDZ4b2ZCeGxjc2FKcXpfd3lzV1JZdlc0bXlxQkdiMENCd1ZGd2N3eXlyZjhGNQ?oc=5", "summary": "News or commentary from The Washington Post. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 09 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "companies" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The Washington Post", "displayDate": "Jun 9, 2025", "whatItIs": "News or commentary.", "conversationContext": "Covers companies.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "why texas is spending millions to research an illegal psychedelic - the washington post news or commentary from the washington post. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the washington post companies cataloged source primary-source record" }, { "id": "latest_scan-UG93ZXJmdWwgUH", "title": "Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction (Published 2024) - The New York Times", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The New York Times", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNemZra3UzMEpyY21MT2tnS3FpcnNkVUJlV2xXenkteU1qUV96YS1KRGt5MS1WbXh2TkRIX08tTlMwclNaME1neEhqVnA0UVdlNU5rQVRRcktMNkFtMDE3Skh2ZWxYNWtySXBwUXdVMnI1TU9RbWVmak00WThMclo2T3NacFQyRGxNNUJpYQ?oc=5", "summary": "News or commentary from The New York Times. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 05 Mar 2024 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "safety" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The New York Times", "displayDate": "Mar 5, 2024", "whatItIs": "News or commentary.", "conversationContext": "Covers safety.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "powerful psychedelic gains renewed attention as a treatment for opioid addiction (published 2024) - the new york times news or commentary from the new york times. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the new york times safety cataloged source primary-source record" }, { "id": "latest_scan-TmV3IEV4ZWN1dG", "title": "New Executive Order Fast-Tracks the Use of Psychedelics to Treat Mental Health Disorders in Veterans - U.S. Medicine", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "U.S. Medicine", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxOeGJGTVlxSjJIUFprenpUOFJBaGU1a0tpSDRmYVhvNnNKeldvd1VsdnRWamtmeVpLMUdKbnpDNDJZYmdEdkFvSDU1ZEhaZTZvcjdhT3huc2ZkRXIwdzF0S0JtX0tJSWF6djZkMVVUU2pVSHNWTURUd3hPdzgyX0paQk9XMTZQOXBIWEFfSUxZNXh6MnBTUXhJWGo0OVhuS1B0X0ZHWHczU0djWFdQTTg1MEYzZ0hWX3c2Z3ZrdzhieEhHY2JLRm5neTNsaU5VSmZTV1FNQU1FOV96aUxERUwwalo5ZDhQc0pkWnduTk5fbw?oc=5", "summary": "News or commentary from U.S. Medicine. Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 13 May 2026 08:17:15 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "U.S. Medicine", "displayDate": "May 13, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "new executive order fast-tracks the use of psychedelics to treat mental health disorders in veterans - u.s. medicine news or commentary from u.s. medicine. use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism u.s. medicine conditions cataloged source primary-source record" }, { "id": "latest_scan-UHJlc2lkZW50IF", "title": "President Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans - The White House (.gov)", "category": "news_articles_blogs", "sourceType": "journalism", "sourceName": "The White House (.gov)", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPblR2UkN1dkR0QXUyeUJuSDgxTEJhWWlfUlRsRG9EeXM4QlBFY0VPbm1EbDUwOEM3aFZ0eHJNamQ4YUVaOFBtNGtpMTZPMjhDYUo2V0xlUFBqSjNNYXVUSzhFUHRSSnc3SnVPYnE0WHVBN1hpSVBqTmVfZXg1cWFlUnJOWmlwa1ZsamZCeTdCTDFhMG51UXNjQVotMmUxSDBpNTBzaE5PdmRlNVByV1NuUktJdkZrbDZEQzQzSlNZYVY0ekVHZHh1aW5iZ2ZZUDlQbkJNZklLRkVuNjZ4NS16a2d6cV93dHV0OVBJ?oc=5", "summary": "News or commentary from The White House (.gov). Use it to understand public discussion and timing; verify important claims against primary sources.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 20 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "conditions" ], "displayCategory": "News and commentary", "displaySourceType": "Journalism", "displaySourceName": "The White House (.gov)", "displayDate": "Apr 20, 2026", "whatItIs": "News or commentary.", "conversationContext": "Covers conditions.", "whyListed": "Useful for public context and timelines. Confirm important claims with primary sources.", "searchText": "president trump’s landmark order advances breakthrough mental health treatments — delivering new hope to veterans - the white house (.gov) news or commentary from the white house (.gov). use it to understand public discussion and timing; verify important claims against primary sources. news_articles_blogs journalism the white house (.gov) conditions cataloged source primary-source record" }, { "id": "source_radar-U2lsbyBQaGFybW", "title": "Silo Pharma files provisional patent for ibogaine-based TBI therapeutic", "category": "companies_patents", "sourceType": "company_release", "sourceName": "source_radar", "url": "https://www.globenewswire.com/news-release/2026/05/07/3289971/0/en/silo-pharma-files-provisional-patent-for-ibogaine-based-therapeutic-targeting-traumatic-brain-injury.html", "summary": "Track as commercial activity. Do not treat forward-looking therapeutic claims as evidence.", "confidence": "Claim record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-07", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "commercial", "tbi", "patent" ], "displayCategory": "Companies and patents", "displaySourceType": "Company release", "displaySourceName": "globenewswire.com", "displayDate": "May 7, 2026", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial, tbi, patent.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "silo pharma files provisional patent for ibogaine-based tbi therapeutic track as commercial activity. do not treat forward-looking therapeutic claims as evidence. companies_patents company_release source_radar commercial tbi patent cataloged source claim record" }, { "id": "source_radar_archive-SXMgSWJvZ2Fpbm", "title": "Is Ibogaine the Next Miracle Drug? - by Josh Code - The Free Press", "category": "companies_patents", "sourceType": "journalism", "sourceName": "The Free Press", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE5oTnh2a2gzNjFOYzVGOTdOWnRLUnRONU9FWVBSaHN1WGJxV2hHckU3aS1QWG9sZy1aVWlIVzJ6Y1ZfbzhoVERjOEVNQUpLRWVNYkpoam5mZG1lUU9Kd2FaN2w3TGp6QWQ3?oc=5", "summary": "Company, patent, or biotech-field source from The Free Press. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 27 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "The Free Press", "displayDate": "Apr 27, 2026", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "is ibogaine the next miracle drug? - by josh code - the free press company, patent, or biotech-field source from the free press. commercial claims need independent verification. companies_patents journalism the free press commercial cataloged source primary-source record" }, { "id": "source_radar_archive-SW5zaWRlIElib2", "title": "Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction - Time Magazine", "category": "companies_patents", "sourceType": "journalism", "sourceName": "Time Magazine", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE45bVIxRzdLWnVBWWc2V3o5T2F0LTROMzNwbUcteUwxV1FhRHFmMnZkYk16dzJHY2EyOG5xc1h4dEZYbDk3TU83ODcxRU1MTVQ3ZU43OEtKdU5wY1JSWC1FbGg4VGhiZ1p5Yks0?oc=5", "summary": "Company, patent, or biotech-field source from Time Magazine. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 05 Apr 2021 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "Time Magazine", "displayDate": "Apr 5, 2021", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "inside ibogaine, one of the most promising and perilous psychedelics for addiction - time magazine company, patent, or biotech-field source from time magazine. commercial claims need independent verification. companies_patents journalism time magazine commercial cataloged source primary-source record" }, { "id": "source_radar_archive-VGV4YXMgT0vigJ", "title": "Texas OK’s $50 Million for Ibogaine Research - nytimes.com", "category": "companies_patents", "sourceType": "journalism", "sourceName": "nytimes.com", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOck4zMHFBQlUxeHZBMXA2ekhYeXFvUzhPRG83QjY4clFITzdmeTl1bnI0RUdySVBNOXZhR3ZCZmFFbXBIUERPU19pdE5uUE9XbWk5UnhENTF1eDROZ3FSREVjMUQ5aHdyZ3RtUGZpNC1iRFRzUFljOEczdEZRT0Y3NEI2czhUNjBWcnlJ?oc=5", "summary": "Company, patent, or biotech-field source from nytimes.com. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 14 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-27T12:32:12.524Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "nytimes.com", "displayDate": "Jun 14, 2025", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "texas ok’s $50 million for ibogaine research - nytimes.com company, patent, or biotech-field source from nytimes.com. commercial claims need independent verification. companies_patents journalism nytimes.com commercial cataloged source primary-source record" }, { "id": "source_radar_archive-U3VyZU5hbm8gbW", "title": "SureNano maps weight-loss drug safety studies, explores ibogaine IP - Stock Titan", "category": "companies_patents", "sourceType": "journalism", "sourceName": "Stock Titan", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPM2VMMU41N2VVUjFvdUpBX2JhSkI4a0RLMWcydExhNjB0aFZwQWRQY0VIOEpIVzRtM0VhbWU3cTBlaUdhUFZMNmRnV0N1Z0RNVzhfZ3NsMkdNakVIRi1EQmd5ckVsSHZVaFpKSnpLdXdJU2h1aWlNNGFQYU9DdnhQdWUtQlM2V3pSeDR0TUNGODJ2WlpPVExTczVlU2p3ZklNb2VnN3hjaTNSOEp0bUgtamdR?oc=5", "summary": "Company, patent, or biotech-field source from Stock Titan. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 24 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-12T02:40:43.482Z", "sourceOrigin": "source_radar_archive", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "Stock Titan", "displayDate": "Apr 24, 2026", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "surenano maps weight-loss drug safety studies, explores ibogaine ip - stock titan company, patent, or biotech-field source from stock titan. commercial claims need independent verification. companies_patents journalism stock titan commercial cataloged source primary-source record" }, { "id": "source_radar_archive-VGV4YXMgbGF1bm", "title": "Texas launching ibogaine research program after failing to find drug company partner - KVUE", "category": "companies_patents", "sourceType": "journalism", "sourceName": "KVUE", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNMVlVTVI2ZUUzZG94TV9zNF9PZHo4eXF0MVZMT2lSWjVzZ3dnWU9RUU5XcWhwYWNyTHBwZ1lFNnhXLWNrX3F4RlEtbjBReUFLMjhNckZUVFM0bks5cGlVWnVHZl8tN05KVXZfQTNWbnY2SDhmbUJpS29sZmstdHNZb0FnVGJKNFRfQ05QNXFJQ2dlUF8wRmhraHdJaUtkMUVfY2VBWkYzaWFPcWlGeUV6eFI4OUNpc01nejZFVEpRNlctT1pvb1IteEJIbGpSNzVfR3NjYktyemtQdEZWSDBN?oc=5", "summary": "Company, patent, or biotech-field source from KVUE. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 01 Apr 2026 07:00:00 GMT", "foundAt": "2026-05-17T04:17:16.065Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "KVUE", "displayDate": "Apr 1, 2026", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers Texas launching ibogaine research program after failing to find drug company partner.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "texas launching ibogaine research program after failing to find drug company partner - kvue company, patent, or biotech-field source from kvue. commercial claims need independent verification. companies_patents journalism kvue media cataloged source primary-source record" }, { "id": "latest_scan-SGUgVG9vayBhIF", "title": "He Took a Psychedelic to Cure His Addiction. It Was His Last Trip - Rolling Stone", "category": "companies_patents", "sourceType": "journalism", "sourceName": "Rolling Stone", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQanVnRUNqNk9kbTZuQ2JQVU5LaVF4Y2drb2doeFdBdjRhUjFWa1VEYllxc0RHd1hUc2FLc216c2twbkVteS1pOHJyWkJVOFJBekdoYUZmbzRINThQekVJOGtRS2NaOGdKTUtrRndGd1owSUpkNHVVdS1ka3k4enZDaUM4eDl5ZDkxOHlWeDBJcnFZRUJnQlZ3dnM1cloxNUlERlFxNERONHg1azVv?oc=5", "summary": "Company, patent, or biotech-field source from Rolling Stone. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 14 Aug 2024 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "Rolling Stone", "displayDate": "Aug 14, 2024", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "he took a psychedelic to cure his addiction. it was his last trip - rolling stone company, patent, or biotech-field source from rolling stone. commercial claims need independent verification. companies_patents journalism rolling stone commercial cataloged source primary-source record" }, { "id": "latest_scan-SG93IGFuIEludm", "title": "How an Investor Evaluates Five Leading Psychedelic Therapy Companies - lucid.news", "category": "companies_patents", "sourceType": "journalism", "sourceName": "lucid.news", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbzg2aHRBZzhxRnZmSzdCVVVxel9fYUh1ZW9sRE8xc3lTSUhWelJyeWp3QmZSTzk3YVNMRDdFRWVIVDNmdGxGQlowbUJ0NEFyMXRub1NhVU5vNFMyVWcwWHJ5WGphdUkzdkpLMmhhVVlKbzhmZUs3Q255SnhxUlZjSnZEc3ZUQlNFRTZuX2hTcUV1am5TUjM0?oc=5", "summary": "Company, patent, or biotech-field source from lucid.news. Commercial claims need independent verification.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 09 May 2021 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "commercial" ], "displayCategory": "Companies and patents", "displaySourceType": "Journalism", "displaySourceName": "lucid.news", "displayDate": "May 9, 2021", "whatItIs": "Company, patent, or biotech-field source.", "conversationContext": "Covers commercial.", "whyListed": "Useful for tracking commercial activity. Business claims do not prove clinical value.", "searchText": "how an investor evaluates five leading psychedelic therapy companies - lucid.news company, patent, or biotech-field source from lucid.news. commercial claims need independent verification. companies_patents journalism lucid.news commercial cataloged source primary-source record" }, { "id": "ambio-news-globenewswire-neurodegenerative-2025", "title": "Ambio Life Sciences launches clinical ibogaine program for patients with neurodegenerative conditions", "category": "clinics", "sourceType": "company_release", "sourceName": "GlobeNewswire", "url": "https://www.globenewswire.com/news-release/2025/06/09/3095856/0/en/Ambio-Life-Sciences-Launches-World-s-First-Clinical-Ibogaine-Program-for-Patients-With-Neurodegenerative-Conditions.html", "summary": "Company-distributed press release about an Ambio neurodegenerative-conditions program. Use as a commercial/company claim record, not independent evidence of safety, efficacy, or access.", "confidence": "Company release", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "neurodegenerative", "parkinsons", "multiple_sclerosis", "clinic_claims", "company_release" ], "displayCategory": "Clinic claims", "displaySourceType": "Company release", "displaySourceName": "GlobeNewswire", "displayDate": "", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers ambio, ambio life sciences, neurodegenerative, parkinsons.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ambio life sciences launches clinical ibogaine program for patients with neurodegenerative conditions company-distributed press release about an ambio neurodegenerative-conditions program. use as a commercial/company claim record, not independent evidence of safety, efficacy, or access. clinics company_release globenewswire ambio ambio_life_sciences neurodegenerative parkinsons multiple_sclerosis clinic_claims company_release cataloged source company release" }, { "id": "ambio-primary-company-site", "title": "Ambio Life Sciences public clinic and research claims", "category": "clinics", "sourceType": "clinic_company_primary_source", "sourceName": "Ambio Life Sciences", "url": "https://www.ambio.life/", "summary": "Primary company site for Ambio Life Sciences. Use to track Ambio's own claims about locations, programs, safety, research, sourcing, and leadership; do not treat as independent verification or a recommendation.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [ "Jonathan Dickinson", "Trevor Millar", "José Inzunza" ], "publishedAt": "", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "manual_seed", "tags": [ "ambio", "ambio_life_sciences", "clinic_claims", "mexico", "malta", "research", "nagoya", "no_referral" ], "displayCategory": "Clinic claims", "displaySourceType": "Clinic Company Primary Source", "displaySourceName": "Ambio Life Sciences", "displayDate": "", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers ambio, ambio life sciences, clinic claims, mexico.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ambio life sciences public clinic and research claims primary company site for ambio life sciences. use to track ambio's own claims about locations, programs, safety, research, sourcing, and leadership; do not treat as independent verification or a recommendation. clinics clinic_company_primary_source ambio life sciences ambio ambio_life_sciences clinic_claims mexico malta research nagoya no_referral cataloged source primary-source record" }, { "id": "source_radar-R2xvYmFsIElib2", "title": "Global Ibogaine Therapy Alliance clinical guidelines", "category": "clinics", "sourceType": "clinical_guideline", "sourceName": "source_radar", "url": "https://ibogaine.mindvox.com/wp-content/uploads/2020/08/Ibogaine-Assisted-Detoxification-Guidelines.pdf", "summary": "Valuable historical and clinical-practice reference; label age and avoid presenting as current regulatory protocol.", "confidence": "Clinical Guideline", "status": "Cataloged source", "people": [], "publishedAt": "2015-2017", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "safety", "detoxification", "clinical_practice" ], "displayCategory": "Clinic claims", "displaySourceType": "Clinical Guideline", "displaySourceName": "ibogaine.mindvox.com", "displayDate": "2015-2017", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers safety, detoxification, clinical practice.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "global ibogaine therapy alliance clinical guidelines valuable historical and clinical-practice reference; label age and avoid presenting as current regulatory protocol. clinics clinical_guideline source_radar safety detoxification clinical_practice cataloged source clinical guideline" }, { "id": "source_radar_archive-SUJFWDAxMSwgdG", "title": "IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and academic research - The Malaysian Reserve", "category": "clinics", "sourceType": "journalism", "sourceName": "The Malaysian Reserve", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNUXlRU2R6cUZ3Z2xtM0kzcl9IcHJDdFlJc0dnRFBndW5ySXZmaTNqU3ZwcGRoTTYyekptY0JVbkh6YXE3QmUxU2VERDRiSWF6eFJhNkFfR05JYzI1OXByN05fR3gtWHBNSGpEelR1MU85eHh5bjZMdDlFLXUwVzVwNG5YVTc3YU1zWkVLa1BlLXBQRXgyQVVTZkxvc2N1bi1nSGl5MG9WWHl3Y2tFaU1TRUtmOXBSZGhyX2Z1UklSV2NRa0xsN1dTTVJST3hCdl8zSTh5M2x0TmdQcGpYTUF4U2U0TXpESkE?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 21 May 2024 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "culture" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "The Malaysian Reserve", "displayDate": "May 21, 2024", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers culture.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ibex011, the first nagoya-compliant gmp iboga extract, is now available for clinical use and academic research - the malaysian reserve clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism the malaysian reserve culture cataloged source primary-source record" }, { "id": "source_radar_archive-QWZnaGFuaXN0YW", "title": "Afghanistan and Iraq War veteran hopes to heal with Ibogaine - thewarhorse.org", "category": "clinics", "sourceType": "journalism", "sourceName": "thewarhorse.org", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFA1bF9JSEVPVkJHT0IzeXdfZTAzNmUwaTBaN1BGcVA2ZHI4d3JWbUJuS0J6dmZiVXB2dmNKd0ZwNWJMOXVCb21JdmdZVTNUNDN5eWo2cWpKWEQtZ1NVOGlnNFQzcw?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 08 Jan 2026 08:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "thewarhorse.org", "displayDate": "Jan 8, 2026", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "afghanistan and iraq war veteran hopes to heal with ibogaine - thewarhorse.org clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism thewarhorse.org clinics cataloged source primary-source record" }, { "id": "source_radar_archive-QW4gaW4tZGVwdG", "title": "An in-depth look at the bipartisan push for an ibogaine research pilot program in Colorado | Denver7 360 - Denver7", "category": "clinics", "sourceType": "journalism", "sourceName": "Denver7", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOYjNGdEJ5TFVPTXg1VVNLUkl0Vkc5TXNqZUt5bXQ0bUhSVzI1d05UeE9LSlNkR0F6RHFaNE5JTWxjNm5rTk1sZTJvLTRpOWo3VVRRdjNxTTVTendUaUtKdF9qYVJZV2hYNzlRMkk2NzNkNEdkTlVkMEVKcFRYM1dTak5IaW1NWWdXNGdRQnJGZklwSV9leXdKX1c3bVZlMVVVOXJycEFrajV5ZnNoanNMX1ZyZWpkNzUwNUFILWZOdkRBaWFpOTZ4cDI3eXBibE9Z?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 13 Mar 2026 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "Denver7", "displayDate": "Mar 13, 2026", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "an in-depth look at the bipartisan push for an ibogaine research pilot program in colorado | denver7 360 - denver7 clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism denver7 clinics cataloged source primary-source record" }, { "id": "source_radar_archive-VmV0ZXJhbuKAmX", "title": "Veteran’s journey: Ibogaine as a path to healing - DAV : Disabled American Veterans", "category": "clinics", "sourceType": "journalism", "sourceName": "DAV : Disabled American Veterans", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPN1pkVGt3Vm5kS2hhRk5iS1hyZ1YtUmJWc2FnYnFJMkJYZzRiZl9QWnZnMi1yVmFGNHZHTzAtX1BlR0Z2OGlOd0pvd0d3R201RWI2ME9tRDE3SVpMdnAycUhjTXlfSU05TDI1TGNDQm40ZmJldTdtcGdNLV94TDZDQmtyVURFX290dld5eF9CUHVtdw?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 25 Mar 2025 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "DAV : Disabled American Veterans", "displayDate": "Mar 25, 2025", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "veteran’s journey: ibogaine as a path to healing - dav : disabled american veterans clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism dav : disabled american veterans clinics cataloged source primary-source record" }, { "id": "source_radar_archive-TWV4aWNhbiBpYm", "title": "Mexican ibogaine clinic sees increasing number of veteran guests - Mugglehead Investment Magazine", "category": "clinics", "sourceType": "journalism", "sourceName": "Mugglehead Investment Magazine", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOWmZSUHRHelRSZVB2bktQcU04NFcyY0xqLWpwN0lIcVA1ek9ZNEZrclNjR1l6SDdBU3ZiNldBaWl1TWtsQ0h3aG1QUGo4Zkd0VFhyNjgxRXZKUnlOVUV3dktQVEgxSVRubnVJYTJwcVRpWmdpV1VpOXhjS09jSGFWdlpQOWluRG1pSWh3WU5ERQ?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Tue, 12 Aug 2025 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "Mugglehead Investment Magazine", "displayDate": "Aug 12, 2025", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "mexican ibogaine clinic sees increasing number of veteran guests - mugglehead investment magazine clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism mugglehead investment magazine clinics cataloged source primary-source record" }, { "id": "source_radar_archive-T2Zmc2hvcmUgSW", "title": "Offshore Ibogaine Clinics In Mexico, Portugal, and Brazil - lucid.news", "category": "clinics", "sourceType": "journalism", "sourceName": "lucid.news", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOVFlSSWFkMEtkbEg1ckwyVnN5X2NfZkVOTXJ3eFoyWjc3RV9uUmI2SmNfUm1EMHY2d1NyQlJYUTh1NDVKaS1sWENLa0tJcjRPa25rb25JMnJ2d3o0SU9RcjZFT0xMU1hRM0ItTE9iN1FtV2JpNmtwQ3JaT3ktZEJxYVUyZGFudw?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 07 Oct 2024 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "lucid.news", "displayDate": "Oct 7, 2024", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "offshore ibogaine clinics in mexico, portugal, and brazil - lucid.news clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism lucid.news clinics cataloged source primary-source record" }, { "id": "source_radar_archive-VGhlIEhhbGx1Y2", "title": "The Hallucinatory Power of Ibogaine is Surprisingly Gaining Acceptance in Texas - Dallas Observer", "category": "clinics", "sourceType": "journalism", "sourceName": "Dallas Observer", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOY0I0Y0FDVk16ZWM1RUFIRHRDRkdSQTJmclNRdHQ0cFAxVW15ODJtS21XWlcxOWIyaWhydHFhbVFPUkJYY0wwNlQ1R2Q4ZUkyWmFzU3Ixb1ZNWGJ0V0xhc2pTTkNoVjJkdm40SWh0bThHc1ZlcUNTNHZCYkxNaWhGZEs5d2tiQ1JHNlR4NHVMeWttUTB6WU5GOVI4YmZDQ3hp?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 06 Aug 2025 07:00:00 GMT", "foundAt": "2026-05-17T10:41:04.449Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "Dallas Observer", "displayDate": "Aug 6, 2025", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "the hallucinatory power of ibogaine is surprisingly gaining acceptance in texas - dallas observer clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism dallas observer clinics cataloged source primary-source record" }, { "id": "source_radar_archive-QW1iaW8gTGlmZS", "title": "Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions - BioSpace", "category": "clinics", "sourceType": "journalism", "sourceName": "BioSpace", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQOVVURExEYzZfTGpOcnBrTFJQLVZZWTEtUnlVRmpBLVMyXzhnVVF4eEZrUVVoNjNQWDJpOUdwRjdrdGxpUklHT2d3U1hELUl2QzRHWnVoSzBCWTN5S2dVMzBEQ3VaXzdubkNZWUZySGFEbGI1V0JwU1NnUEtSdkVPVkpUUGZ2QnNPaWRHeGRUQ0RLT0tDalJPS0Z6VjFHWXdIakhHUkJqcHROdk1WZGViLVJkQkgtNTRhTy1XazNqNWFiSGxuQ0FJbGF0alRHU185SU9sZFdXUTlFLXBUeHUwcHZvQnByVTNfRWc?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 09 Jun 2025 07:00:00 GMT", "foundAt": "2026-05-17T16:41:12.918Z", "sourceOrigin": "source_radar_archive", "tags": [ "companies" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "BioSpace", "displayDate": "Jun 9, 2025", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers companies.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ambio life sciences launches world's first clinical ibogaine program for patients with neurodegenerative conditions - biospace clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism biospace companies cataloged source primary-source record" }, { "id": "source_radar_archive-SSBUcmllZCBJYm", "title": "I Tried Ibogaine, the Psychedelic Anti-Addiction Drug - vice.com", "category": "clinics", "sourceType": "journalism", "sourceName": "vice.com", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5qNkswc3ZfU3M4MFp5QkRFcWYwWWpTYTd1RmluNXRSeU9fc2N0akpsUmVyTVJ1UUFENjNRNERlbXFMaGFrMXJwc1NrZlpjQnJVZjRONmdETks3WEFlMFhvQUlnSFRVRnVPdG4xbXp1b0tQUWRlM0Z5bERhNk85anc?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 25 Nov 2022 08:00:00 GMT", "foundAt": "2026-05-20T12:03:39.720Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "vice.com", "displayDate": "Nov 25, 2022", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "i tried ibogaine, the psychedelic anti-addiction drug - vice.com clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism vice.com clinics cataloged source primary-source record" }, { "id": "source_radar_archive-SWJvZ2FpbmUgZW", "title": "Ibogaine eases traumatic brain injury in veterans - Drug Discovery News", "category": "clinics", "sourceType": "journalism", "sourceName": "Drug Discovery News", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQRTh2MHlKYS16VnlEUkdSTGhoVUc5eE5TcmZzWktVMm9rVUxjb3NuYjMzMFRLX0FGdF9renpwSGxNYl8wbFhvWnAzMHk0Z2NYcXlBMTNnRzhVM3VJeHI0dTNfTGlrRnktREl1Y1NwcEZ4YjJudVFWQUI0MUZZUU1Sc1NSRkZxUzVEdGxwR0FGRmNPb3c?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Thu, 14 Mar 2024 04:14:33 GMT", "foundAt": "2026-05-20T03:03:37.779Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "Drug Discovery News", "displayDate": "Mar 14, 2024", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ibogaine eases traumatic brain injury in veterans - drug discovery news clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism drug discovery news clinics cataloged source primary-source record" }, { "id": "source_radar_archive-SW5zaWRlIHRoZS", "title": "Inside the Mexican ibogaine clinic where Conor McGregor ‘saw Jesus’ - The Times", "category": "clinics", "sourceType": "journalism", "sourceName": "The Times", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPM2hhUC1POVpGQUJsalFnZ2dra2s2WjktTWVMZzZoc3VXUi04MnZJR1k2eGJCak9FMVJxWDlHREN1Q3I0dDhMaG00aFo0cUlKSzRGVmFKekRlOVB5cXQyOHFoOHhoNDVnY2hBX1NMdXJsMk1Zb3FNaXp3MUEtXzYzcmN5ak56SGNyZEdxMzhFWmpOUnRHT2h5cW5HeGYwTEVKQ0E?oc=5", "summary": "Clinic-claim monitoring entry. IbogaBase does not endorse clinics or provide referrals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 29 Nov 2025 08:00:00 GMT", "foundAt": "2026-05-21T18:41:56.708Z", "sourceOrigin": "source_radar_archive", "tags": [ "clinics" ], "displayCategory": "Clinic claims", "displaySourceType": "Journalism", "displaySourceName": "The Times", "displayDate": "Nov 29, 2025", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "inside the mexican ibogaine clinic where conor mcgregor ‘saw jesus’ - the times clinic-claim monitoring entry. ibogabase does not endorse clinics or provide referrals. clinics journalism the times clinics cataloged source primary-source record" }, { "id": "source_radar-SUNFRVJTIElib2", "title": "ICEERS Iboga Community Engagement Initiative Phase 3 report", "category": "culture_stewardship", "sourceType": "cultural_stewardship", "sourceName": "source_radar", "url": "https://www.iceers.org/wp-content/uploads/2026/03/ICEERS_IBOGA_Phase-3_-v2_-ENG.pdf", "summary": "Use for cultural context, conservation risk, illegal-poaching concerns, and stewardship framing.", "confidence": "Cultural Stewardship", "status": "Cataloged source", "people": [], "publishedAt": "2026-03", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "culture", "bwiti", "gabon", "conservation", "benefit_sharing" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Cultural Stewardship", "displaySourceName": "iceers.org", "displayDate": "Mar 1, 2026", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture, bwiti, gabon, conservation.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "iceers iboga community engagement initiative phase 3 report use for cultural context, conservation risk, illegal-poaching concerns, and stewardship framing. culture_stewardship cultural_stewardship source_radar culture bwiti gabon conservation benefit_sharing cataloged source cultural stewardship" }, { "id": "source_radar-SW5kaWdlbm91cy", "title": "Indigenous Medicine Conservation Fund iboga conservation overview", "category": "culture_stewardship", "sourceType": "cultural_stewardship", "sourceName": "source_radar", "url": "https://imc.fund/biocultures/iboga", "summary": "Use for conservation strategy, overharvest, access, reciprocity, and alternative-source framing.", "confidence": "Cultural Stewardship", "status": "Cataloged source", "people": [], "publishedAt": "current", "foundAt": "2026-05-31T20:46:51.196Z", "sourceOrigin": "source_radar", "tags": [ "conservation", "bwiti", "nagoya", "fair_trade" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Cultural Stewardship", "displaySourceName": "imc.fund", "displayDate": "current", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers conservation, bwiti, nagoya, fair trade.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "indigenous medicine conservation fund iboga conservation overview use for conservation strategy, overharvest, access, reciprocity, and alternative-source framing. culture_stewardship cultural_stewardship source_radar conservation bwiti nagoya fair_trade cataloged source cultural stewardship" }, { "id": "source_radar_archive-VGhlIHBzeWNob2", "title": "The psychoactive drug ibogaine could save lives—and everyone wants to cash in - National Geographic", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "National Geographic", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNWmt4Z2wwVmRWSTFqa09iZWxFNXJOVWw0cFdUY3VjU1lCbmpxMXJsbXQzQmRWLWd0d1U0MUVSQllnUjkzVzNwUHk4aTRjYWNSbXA0eU9YcnZTckpjRlNMclhjZ0VuOEt5RHdMbXZLZ00xQUhJWjI3c2NzcVpGcmVQZnJCR2RkSVRfcVE1eXZsc0k4dmpzaDBPajFCRE44Zw?oc=5", "summary": "Culture or stewardship source from National Geographic. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Wed, 08 Mar 2023 08:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "culture" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "National Geographic", "displayDate": "Mar 8, 2023", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "the psychoactive drug ibogaine could save lives—and everyone wants to cash in - national geographic culture or stewardship source from national geographic. outsider summaries require humility and source awareness. culture_stewardship journalism national geographic culture cataloged source primary-source record" }, { "id": "source_radar_archive-RnJvbSBTYWNyZW", "title": "From Sacred Root to Strategic Asset: Gabon Races to Protect and Profit from Iboga’s Global Rise - Trendsnafrica", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "Trendsnafrica", "url": "https://news.google.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?oc=5", "summary": "Culture or stewardship source from Trendsnafrica. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sun, 11 May 2025 07:00:00 GMT", "foundAt": "2026-05-11T02:39:25.816Z", "sourceOrigin": "source_radar_archive", "tags": [ "culture" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "Trendsnafrica", "displayDate": "May 11, 2025", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "from sacred root to strategic asset: gabon races to protect and profit from iboga’s global rise - trendsnafrica culture or stewardship source from trendsnafrica. outsider summaries require humility and source awareness. culture_stewardship journalism trendsnafrica culture cataloged source primary-source record" }, { "id": "source_radar_archive-R29kLCBHYWJvbi", "title": "God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next - psychedelicalpha.com", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "psychedelicalpha.com", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQOTZhM0YwWi1PNGhDVWotVTZ6N3locFZ5NVBuRnMwcVlWWG1Ob3pUWWU5b1p2S2J2N0ZSSlRIeVdHNk81cURqRHFMS0k1b3VRRC1qZWl4NFl4OWRyN0RkQ05xdWlocnpLSWpzTEtvWHZ4dWF1MWFDUUVXZEVvMVY5b3BYS24wY1JkZ3ltd3p6SFdyZ3BzQVNfc3ljXzllc1NOaWVvN1l1a2lncTc1c01ZRUpVOTZGdHN2SFBLSEJPSEthSTlDZnc?oc=5", "summary": "Culture or stewardship source from psychedelicalpha.com. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Fri, 01 May 2026 12:47:41 GMT", "foundAt": "2026-05-29T16:41:29.201Z", "sourceOrigin": "source_radar_archive", "tags": [ "media" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "psychedelicalpha.com", "displayDate": "May 1, 2026", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "god, gabon, and government: w. bryan hubbard on ibogaine, the executive order, and what comes next - psychedelicalpha.com culture or stewardship source from psychedelicalpha.com. outsider summaries require humility and source awareness. culture_stewardship journalism psychedelicalpha.com media cataloged source primary-source record" }, { "id": "latest_scan-R2Fib24gbG9uZ3", "title": "Gabon longs to cash in on sacred hallucinogenic remedy - eNCA", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "eNCA", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOOUhGY3pBeGRZdi04bVRZUkdQT1JxVTlrYVVMQ21tQjhlSFYxdWh6Q2tuYVdPeGVvcm80Z0lyUUlFbmFhc2pCc09kdDEzdXBCanY1LVNocnZhb0lULThoQlB1MUUxc1ZDeHp5S0hTdlN3STR0UTY1OFcza0tNejR5RVVn?oc=5", "summary": "Culture or stewardship source from eNCA. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Sat, 10 May 2025 07:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "culture" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "eNCA", "displayDate": "May 10, 2025", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "gabon longs to cash in on sacred hallucinogenic remedy - enca culture or stewardship source from enca. outsider summaries require humility and source awareness. culture_stewardship journalism enca culture cataloged source primary-source record" }, { "id": "latest_scan-SW5kaWdlbm91cy", "title": "Indigenous-led Medicine Conservation - Multidisciplinary Association for Psychedelic Studies – MAPS", "category": "culture_stewardship", "sourceType": "journalism", "sourceName": "Multidisciplinary Association for Psychedelic Studies – MAPS", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5YU0U0RG9mOUdycG80QjlvQ0pWaUZtNnpOMk9LQW1kQnZWZVE2ZWtVckVUbi1CV0tOclcwNGZaY1FHNWZUYXVFVUgtLTlQMmV4bnM4WXpSaE8wUXNnNlBGYjhOeVgxUXdBVlY1NTBnUDNfTFVGb0Nr?oc=5", "summary": "Culture or stewardship source from Multidisciplinary Association for Psychedelic Studies – MAPS. Outsider summaries require humility and source awareness.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "Mon, 05 Feb 2024 08:00:00 GMT", "foundAt": "2026-05-31T20:46:26.257Z", "sourceOrigin": "latest_scan", "tags": [ "culture" ], "displayCategory": "Culture and stewardship", "displaySourceType": "Journalism", "displaySourceName": "Multidisciplinary Association for Psychedelic Studies – MAPS", "displayDate": "Feb 5, 2024", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers culture.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "indigenous-led medicine conservation - multidisciplinary association for psychedelic studies – maps culture or stewardship source from multidisciplinary association for psychedelic studies – maps. outsider summaries require humility and source awareness. culture_stewardship journalism multidisciplinary association for psychedelic studies – maps culture cataloged source primary-source record" }, { "id": "brief-1", "title": "FDA allowed an early-phase noribogaine study to proceed in the U.S.", "category": "weekly_brief", "sourceType": "Regulatory", "sourceName": "FDA", "url": "https://www.fda.gov/news-events/press-announcements/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order", "summary": "FDA announced that DemeRx NB may begin a closely monitored phase I noribogaine hydrochloride study for alcohol use disorder. What it does not mean: This is not drug approval, not a finding of safety or effectiveness, and not patient access guidance.", "confidence": "Primary-source record", "status": "Current brief item", "people": [], "publishedAt": "2026-05-17T06:00:00.000Z", "foundAt": "2026-05-17T06:00:00.000Z", "sourceOrigin": "weekly_brief", "tags": [ "what_changed", "field_brief", "Regulatory" ], "displayCategory": "Weekly brief", "displaySourceType": "Regulatory", "displaySourceName": "FDA", "displayDate": "May 17, 2026", "whatItIs": "Recent field update.", "conversationContext": "FDA announced that DemeRx NB may begin a closely monitored phase I noribogaine hydrochloride study for alcohol use disorder.", "whyListed": "Useful for seeing what changed recently. An update is not the same as a conclusion.", "searchText": "fda allowed an early-phase noribogaine study to proceed in the u.s. fda announced that demerx nb may begin a closely monitored phase i noribogaine hydrochloride study for alcohol use disorder. what it does not mean: this is not drug approval, not a finding of safety or effectiveness, and not patient access guidance. weekly_brief regulatory fda what_changed field_brief regulatory current brief item primary-source record" }, { "id": "brief-2", "title": "Oklahoma HB 3834 was approved by the governor.", "category": "weekly_brief", "sourceType": "State policy", "sourceName": "Oklahoma Legislature", "url": "https://www.oklegislature.gov/BillInfo.aspx?Bill=hb3834&Session=2600", "summary": "Oklahoma's bill page shows HB 3834, the Oklahoma Breakthrough Therapy Act for ibogaine clinical trials, approved by the governor on May 12, 2026. What it does not mean: It does not make ibogaine FDA-approved and does not erase federal Schedule I constraints.", "confidence": "Primary-source record", "status": "Current brief item", "people": [], "publishedAt": "2026-05-17T06:00:00.000Z", "foundAt": "2026-05-17T06:00:00.000Z", "sourceOrigin": "weekly_brief", "tags": [ "what_changed", "field_brief", "State policy" ], "displayCategory": "Weekly brief", "displaySourceType": "State Policy", "displaySourceName": "Oklahoma Legislature", "displayDate": "May 17, 2026", "whatItIs": "Recent field update.", "conversationContext": "Oklahoma's bill page shows HB 3834, the Oklahoma Breakthrough Therapy Act for ibogaine clinical trials, approved by the governor on May 12, 2026.", "whyListed": "Useful for seeing what changed recently. An update is not the same as a conclusion.", "searchText": "oklahoma hb 3834 was approved by the governor. oklahoma's bill page shows hb 3834, the oklahoma breakthrough therapy act for ibogaine clinical trials, approved by the governor on may 12, 2026. what it does not mean: it does not make ibogaine fda-approved and does not erase federal schedule i constraints. weekly_brief state policy oklahoma legislature what_changed field_brief state policy current brief item primary-source record" }, { "id": "brief-3", "title": "Texas remains the central public-funding case study.", "category": "weekly_brief", "sourceType": "State policy", "sourceName": "Texas Legislature Online", "url": "https://capitol.texas.gov/tlodocs/89R/billtext/html/SB02308F.htm", "summary": "Texas SB 2308 created a pathway for a selected consortium to conduct ibogaine drug development clinical trials and includes a subchapter that applies only if FDA approves ibogaine for a medical condition. What it does not mean: Texas law is not proof of efficacy and does not mean treatment is available outside federal law and research controls.", "confidence": "Primary-source record", "status": "Current brief item", "people": [], "publishedAt": "2026-05-17T06:00:00.000Z", "foundAt": "2026-05-17T06:00:00.000Z", "sourceOrigin": "weekly_brief", "tags": [ "what_changed", "field_brief", "State policy" ], "displayCategory": "Weekly brief", "displaySourceType": "State Policy", "displaySourceName": "Texas Legislature Online", "displayDate": "May 17, 2026", "whatItIs": "Recent field update.", "conversationContext": "Texas SB 2308 created a pathway for a selected consortium to conduct ibogaine drug development clinical trials and includes a subchapter that applies only if FDA approves ibogaine for a medical condition.", "whyListed": "Useful for seeing what changed recently. An update is not the same as a conclusion.", "searchText": "texas remains the central public-funding case study. texas sb 2308 created a pathway for a selected consortium to conduct ibogaine drug development clinical trials and includes a subchapter that applies only if fda approves ibogaine for a medical condition. what it does not mean: texas law is not proof of efficacy and does not mean treatment is available outside federal law and research controls. weekly_brief state policy texas legislature online what_changed field_brief state policy current brief item primary-source record" }, { "id": "brief-4", "title": "Tennessee HOPE Act materials describe proposed ibogaine drug-development trials.", "category": "weekly_brief", "sourceType": "State policy", "sourceName": "Tennessee General Assembly Fiscal Review Committee", "url": "https://capitol.tn.gov/Bills/114/Fiscal/HB2075.pdf", "summary": "The Tennessee fiscal note for HB 2075 / SB 2149 describes the Helping Open Pathways to Effective Treatment Act and proposed cohort-based ibogaine drug-development trials. What it does not mean: The fiscal note is not clinical evidence and explicitly frames key activity around FDA approval and state/federal constraints.", "confidence": "Primary-source record", "status": "Current brief item", "people": [], "publishedAt": "2026-05-17T06:00:00.000Z", "foundAt": "2026-05-17T06:00:00.000Z", "sourceOrigin": "weekly_brief", "tags": [ "what_changed", "field_brief", "State policy" ], "displayCategory": "Weekly brief", "displaySourceType": "State Policy", "displaySourceName": "Tennessee General Assembly Fiscal Review Committee", "displayDate": "May 17, 2026", "whatItIs": "Recent field update.", "conversationContext": "The Tennessee fiscal note for HB 2075 / SB 2149 describes the Helping Open Pathways to Effective Treatment Act and proposed cohort-based ibogaine drug-development trials.", "whyListed": "Useful for seeing what changed recently. An update is not the same as a conclusion.", "searchText": "tennessee hope act materials describe proposed ibogaine drug-development trials. the tennessee fiscal note for hb 2075 / sb 2149 describes the helping open pathways to effective treatment act and proposed cohort-based ibogaine drug-development trials. what it does not mean: the fiscal note is not clinical evidence and explicitly frames key activity around fda approval and state/federal constraints. weekly_brief state policy tennessee general assembly fiscal review committee what_changed field_brief state policy current brief item primary-source record" }, { "id": "brief-5", "title": "Podcast and interview discovery is now a standing intake lane.", "category": "weekly_brief", "sourceType": "Media", "sourceName": "IbogaBase public catalog", "url": "data/public-search-index.json", "summary": "The source catalog contains a growing podcast/interview directory and a dedicated Listening Library Curator role. What it does not mean: Interview statements are not treated as facts until converted into claim records and traced to supporting sources.", "confidence": "Media", "status": "Current brief item", "people": [], "publishedAt": "2026-05-17T06:00:00.000Z", "foundAt": "2026-05-17T06:00:00.000Z", "sourceOrigin": "weekly_brief", "tags": [ "what_changed", "field_brief", "Media" ], "displayCategory": "Weekly brief", "displaySourceType": "Media", "displaySourceName": "IbogaBase public catalog", "displayDate": "May 17, 2026", "whatItIs": "Recent field update.", "conversationContext": "The source catalog contains a growing podcast/interview directory and a dedicated Listening Library Curator role.", "whyListed": "Useful for seeing what changed recently. An update is not the same as a conclusion.", "searchText": "podcast and interview discovery is now a standing intake lane. the source catalog contains a growing podcast/interview directory and a dedicated listening library curator role. what it does not mean: interview statements are not treated as facts until converted into claim records and traced to supporting sources. weekly_brief media ibogabase public catalog what_changed field_brief media current brief item media" }, { "id": "policy-1", "title": "United States: 21 CFR 1308.11 federal Schedule I listing for Ibogaine", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Cornell Legal Information Institute / eCFR mirror", "url": "https://www.law.cornell.edu/cfr/text/21/1308.11", "summary": "Federal Schedule I Baseline. Allows: Establishes the federal baseline that Ibogaine is listed in Schedule I under U.S. controlled-substances regulations. Does not allow: Does not authorize medical treatment, prescribing, clinic access, or state-level exceptions that override federal law. Caveat: This remains the starting point for every U.S. state policy row unless and until federal law changes.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "United States", "21 CFR 1308.11 federal Schedule I listing for Ibogaine" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Cornell Legal Information Institute / eCFR mirror", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, united states, 21 cfr 1308.11 federal schedule i listing for ibogaine.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "united states: 21 cfr 1308.11 federal schedule i listing for ibogaine federal schedule i baseline. allows: establishes the federal baseline that ibogaine is listed in schedule i under u.s. controlled-substances regulations. does not allow: does not authorize medical treatment, prescribing, clinic access, or state-level exceptions that override federal law. caveat: this remains the starting point for every u.s. state policy row unless and until federal law changes. laws_policy policy_tracker_row cornell legal information institute / ecfr mirror policy united states 21 cfr 1308.11 federal schedule i listing for ibogaine cataloged source primary-source record" }, { "id": "policy-2", "title": "United States: FDA noribogaine IND-related clinical research action", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "FDA press announcement", "url": "https://www.fda.gov/news-events/press-announcements/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order", "summary": "Early Phase Study Allowed To Proceed. Allows: DemeRx NB may begin a phase I noribogaine hydrochloride study in a closely monitored U.S. clinical setting. Does not allow: Not FDA approval, not proof of safety or effectiveness, and not a general treatment access pathway. Caveat: Noribogaine research language is separate from Ibogaine treatment access.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "United States", "FDA noribogaine IND-related clinical research action" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "FDA press announcement", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, united states, fda noribogaine ind-related clinical research action.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "united states: fda noribogaine ind-related clinical research action early phase study allowed to proceed. allows: demerx nb may begin a phase i noribogaine hydrochloride study in a closely monitored u.s. clinical setting. does not allow: not fda approval, not proof of safety or effectiveness, and not a general treatment access pathway. caveat: noribogaine research language is separate from ibogaine treatment access. laws_policy policy_tracker_row fda press announcement policy united states fda noribogaine ind-related clinical research action cataloged source primary-source record" }, { "id": "policy-3", "title": "Arizona: HB 2871, appropriation for Ibogaine clinical research study", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Arizona House bill summary", "url": "https://www.azleg.gov/legtext/57leg/1R/summary/H.HB2871_022425_CAUCUSCOW.DOCX.htm", "summary": "2025 Bill Dead Or Not Carried Forward In Tracker. Allows: The proposal would have appropriated state funds for a certified clinical research study on Ibogaine for neurological diseases. Does not allow: This tracker does not treat the proposal as current access or an enacted 2026 program without a newer official status source. Caveat: Federal Schedule I and FDA/DEA/IRB requirements would remain controlling.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Arizona", "HB 2871, appropriation for Ibogaine clinical research study" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Arizona House bill summary", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, arizona, hb 2871, appropriation for ibogaine clinical research study.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "arizona: hb 2871, appropriation for ibogaine clinical research study 2025 bill dead or not carried forward in tracker. allows: the proposal would have appropriated state funds for a certified clinical research study on ibogaine for neurological diseases. does not allow: this tracker does not treat the proposal as current access or an enacted 2026 program without a newer official status source. caveat: federal schedule i and fda/dea/irb requirements would remain controlling. laws_policy policy_tracker_row arizona house bill summary policy arizona hb 2871, appropriation for ibogaine clinical research study cataloged source primary-source record" }, { "id": "policy-4", "title": "Colorado: HB26-1325, Natural Medicine / Ibogaine research pilot program", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Colorado General Assembly bill page", "url": "https://leg.colorado.gov/bills/HB26-1325", "summary": "Passed Legislature Awaiting Enactment Check. Allows: Creates an Ibogaine research pilot program lane, allows up to five pilot sites, includes possible rulemaking around administration/manufacturing/use, and adds benefit-sharing language tied to Indigenous communities. Does not allow: Does not make unsupervised Ibogaine use lawful and should not be read as FDA approval, proof of efficacy, or a provider referral pathway. Caveat: Any research or clinical activity remains constrained by federal law and applicable approvals.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Colorado", "HB26-1325, Natural Medicine / Ibogaine research pilot program" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Colorado General Assembly bill page", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, colorado, hb26-1325, natural medicine / ibogaine research pilot program.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "colorado: hb26-1325, natural medicine / ibogaine research pilot program passed legislature awaiting enactment check. allows: creates an ibogaine research pilot program lane, allows up to five pilot sites, includes possible rulemaking around administration/manufacturing/use, and adds benefit-sharing language tied to indigenous communities. does not allow: does not make unsupervised ibogaine use lawful and should not be read as fda approval, proof of efficacy, or a provider referral pathway. caveat: any research or clinical activity remains constrained by federal law and applicable approvals. laws_policy policy_tracker_row colorado general assembly bill page policy colorado hb26-1325, natural medicine / ibogaine research pilot program cataloged source primary-source record" }, { "id": "policy-5", "title": "Kentucky: SB 77, Ibogaine research in the Commonwealth", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Kentucky Legislature bill record", "url": "https://apps.legislature.ky.gov/record/26rs/sb77.html", "summary": "Enacted After Veto Override Acts Ch 158. Allows: Establishes a state framework for Ibogaine research and intellectual-property development through a public-private partnership approach. Does not allow: The enacted framework does not create general treatment access or FDA approval. Caveat: Federal Schedule I status and FDA approval requirements remain central.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Kentucky", "SB 77, Ibogaine research in the Commonwealth" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Kentucky Legislature bill record", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, kentucky, sb 77, ibogaine research in the commonwealth.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "kentucky: sb 77, ibogaine research in the commonwealth enacted after veto override acts ch 158. allows: establishes a state framework for ibogaine research and intellectual-property development through a public-private partnership approach. does not allow: the enacted framework does not create general treatment access or fda approval. caveat: federal schedule i status and fda approval requirements remain central. laws_policy policy_tracker_row kentucky legislature bill record policy kentucky sb 77, ibogaine research in the commonwealth cataloged source primary-source record" }, { "id": "policy-6", "title": "Louisiana: SB 43, psychedelic-assisted therapy / clinical research language", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Louisiana Legislature bill page", "url": "https://legis.la.gov/Legis/BillInfo.aspx?i=249751", "summary": "Passed House Returned For Senate Action Check. Allows: The bill record describes psychedelic-assisted therapy legislation and has included Ibogaine-related clinical-study discussion in public tracking. Does not allow: Do not treat this as final law or treatment access until final enrollment/signature status is confirmed. Caveat: Federal law, FDA authorization, and state implementation details remain controlling.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Louisiana", "SB 43, psychedelic-assisted therapy / clinical research language" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Louisiana Legislature bill page", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, louisiana, sb 43, psychedelic-assisted therapy / clinical research language.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "louisiana: sb 43, psychedelic-assisted therapy / clinical research language passed house returned for senate action check. allows: the bill record describes psychedelic-assisted therapy legislation and has included ibogaine-related clinical-study discussion in public tracking. does not allow: do not treat this as final law or treatment access until final enrollment/signature status is confirmed. caveat: federal law, fda authorization, and state implementation details remain controlling. laws_policy policy_tracker_row louisiana legislature bill page policy louisiana sb 43, psychedelic-assisted therapy / clinical research language cataloged source primary-source record" }, { "id": "policy-7", "title": "Maryland: SB 527 / HB 1477, Ibogaine Clinical Research Grant Program", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Maryland General Assembly bill text", "url": "https://www.mgaleg.maryland.gov/2026RS/bills/sb/sb0527F.pdf", "summary": "Introduced With Hearing Activity. Allows: Would establish an Ibogaine Clinical Research Grant Program and include it as an authorized use of Opioid Restitution Fund money. Does not allow: Introduced/hearing activity is not enactment and does not authorize treatment access. Caveat: Any funded research would still need applicable federal authorization.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Maryland", "SB 527 / HB 1477, Ibogaine Clinical Research Grant Program" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Maryland General Assembly bill text", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, maryland, sb 527 / hb 1477, ibogaine clinical research grant program.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "maryland: sb 527 / hb 1477, ibogaine clinical research grant program introduced with hearing activity. allows: would establish an ibogaine clinical research grant program and include it as an authorized use of opioid restitution fund money. does not allow: introduced/hearing activity is not enactment and does not authorize treatment access. caveat: any funded research would still need applicable federal authorization. laws_policy policy_tracker_row maryland general assembly bill text policy maryland sb 527 / hb 1477, ibogaine clinical research grant program cataloged source primary-source record" }, { "id": "policy-8", "title": "Mississippi: HB 314, Ibogaine Drug Development Clinical Trial Act", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Mississippi Legislature bill text as sent to governor", "url": "https://billstatus.ls.state.ms.us/documents/2026/html/HB/0300-0399/HB0314SG.htm", "summary": "Approved By Governor Effective 2026 07 01. Allows: Creates a state framework for an Ibogaine drug-development clinical trial consortium and coordination with a lead consortium in another state. Does not allow: Does not provide routine clinical access; treatment-administration provisions depend on FDA approval or lawful federal authorization. Caveat: Federal waiver, authorization, IND, and FDA approval language remains central.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Mississippi", "HB 314, Ibogaine Drug Development Clinical Trial Act" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Mississippi Legislature bill text as sent to governor", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, mississippi, hb 314, ibogaine drug development clinical trial act.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "mississippi: hb 314, ibogaine drug development clinical trial act approved by governor effective 2026 07 01. allows: creates a state framework for an ibogaine drug-development clinical trial consortium and coordination with a lead consortium in another state. does not allow: does not provide routine clinical access; treatment-administration provisions depend on fda approval or lawful federal authorization. caveat: federal waiver, authorization, ind, and fda approval language remains central. laws_policy policy_tracker_row mississippi legislature bill text as sent to governor policy mississippi hb 314, ibogaine drug development clinical trial act cataloged source primary-source record" }, { "id": "policy-9", "title": "Ohio: Ibogaine Treatment Study Committee", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Ohio Legislative Service Commission board record", "url": "https://www.lsc.ohio.gov/publications/boards-and-commissions/ibogaine-treatment-study-committee", "summary": "Study Committee Current Report Due 2027 12 31. Allows: Creates and maintains a temporary study committee to evaluate Ibogaine treatment issues and make legislative recommendations. Does not allow: A study committee is not legalization, treatment access, a clinical trial authorization, or FDA approval. Caveat: Federal Schedule I status remains unchanged.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Ohio", "Ibogaine Treatment Study Committee" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Ohio Legislative Service Commission board record", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, ohio, ibogaine treatment study committee.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "ohio: ibogaine treatment study committee study committee current report due 2027 12 31. allows: creates and maintains a temporary study committee to evaluate ibogaine treatment issues and make legislative recommendations. does not allow: a study committee is not legalization, treatment access, a clinical trial authorization, or fda approval. caveat: federal schedule i status remains unchanged. laws_policy policy_tracker_row ohio legislative service commission board record policy ohio ibogaine treatment study committee cataloged source primary-source record" }, { "id": "policy-10", "title": "Oklahoma: HB 3834, Oklahoma Breakthrough Therapy Act", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Oklahoma Legislature bill history", "url": "https://www.oklegislature.gov/BillInfo.aspx?Bill=hb3834&Session=2600", "summary": "Approved By Governor. Allows: Creates a state framework related to Ibogaine clinical trials and drug-development requirements. Does not allow: Does not make Ibogaine FDA-approved and does not by itself authorize unsupervised treatment or provider referral. Caveat: Federal Schedule I status and FDA/DEA/IRB requirements remain central.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Oklahoma", "HB 3834, Oklahoma Breakthrough Therapy Act" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Oklahoma Legislature bill history", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, oklahoma, hb 3834, oklahoma breakthrough therapy act.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "oklahoma: hb 3834, oklahoma breakthrough therapy act approved by governor. allows: creates a state framework related to ibogaine clinical trials and drug-development requirements. does not allow: does not make ibogaine fda-approved and does not by itself authorize unsupervised treatment or provider referral. caveat: federal schedule i status and fda/dea/irb requirements remain central. laws_policy policy_tracker_row oklahoma legislature bill history policy oklahoma hb 3834, oklahoma breakthrough therapy act cataloged source primary-source record" }, { "id": "policy-11", "title": "Oklahoma: HB 4293, Veterans Mental Health Innovation Act", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Oklahoma Legislature bill history", "url": "https://www.oklegislature.gov/BillInfo.aspx?Bill=HB4293&Session=2600&Tab=0", "summary": "Introduced Referred To Rules. Allows: Would authorize scientific research and clinical trials related to Ibogaine with registration and immunity language. Does not allow: Introduced/referred language is not enactment and does not create general treatment access. Caveat: Federal authorization and controlled-substance constraints remain central.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Oklahoma", "HB 4293, Veterans Mental Health Innovation Act" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Oklahoma Legislature bill history", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, oklahoma, hb 4293, veterans mental health innovation act.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "oklahoma: hb 4293, veterans mental health innovation act introduced referred to rules. allows: would authorize scientific research and clinical trials related to ibogaine with registration and immunity language. does not allow: introduced/referred language is not enactment and does not create general treatment access. caveat: federal authorization and controlled-substance constraints remain central. laws_policy policy_tracker_row oklahoma legislature bill history policy oklahoma hb 4293, veterans mental health innovation act cataloged source primary-source record" }, { "id": "policy-12", "title": "Oregon: HB 4110, physician-supervised Ibogaine proposal", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Oregon Legislative Information System", "url": "https://olis.oregonlegislature.gov/liz/2026R1/Measures/Overview/HB4110", "summary": "In House Committee. Allows: Would allow an attending physician to provide Ibogaine to a patient for specified disorders and exempt specified use from controlled-substance definition if enacted. Does not allow: As an in-committee bill, it does not create current legal access or override federal law. Caveat: DEA/FDA constraints and federal Schedule I status remain unresolved.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Oregon", "HB 4110, physician-supervised Ibogaine proposal" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Oregon Legislative Information System", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, oregon, hb 4110, physician-supervised ibogaine proposal.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "oregon: hb 4110, physician-supervised ibogaine proposal in house committee. allows: would allow an attending physician to provide ibogaine to a patient for specified disorders and exempt specified use from controlled-substance definition if enacted. does not allow: as an in-committee bill, it does not create current legal access or override federal law. caveat: dea/fda constraints and federal schedule i status remain unresolved. laws_policy policy_tracker_row oregon legislative information system policy oregon hb 4110, physician-supervised ibogaine proposal cataloged source primary-source record" }, { "id": "policy-13", "title": "Tennessee: HB 2075 / SB 2149, HOPE Treatment Act", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Tennessee General Assembly bill information", "url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=SB2149", "summary": "Passed Both Chambers Senate Concurred House Amendment. Allows: Authorizes Tennessee research institutions to participate in federally authorized clinical trials involving Ibogaine under specified safety and compliance conditions. Does not allow: Does not authorize routine clinical treatment, non-research possession, or self-directed access. Caveat: Clinical work must comply with a valid FDA IND or other federal authorization when required.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Tennessee", "HB 2075 / SB 2149, HOPE Treatment Act" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Tennessee General Assembly bill information", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, tennessee, hb 2075 / sb 2149, hope treatment act.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "tennessee: hb 2075 / sb 2149, hope treatment act passed both chambers senate concurred house amendment. allows: authorizes tennessee research institutions to participate in federally authorized clinical trials involving ibogaine under specified safety and compliance conditions. does not allow: does not authorize routine clinical treatment, non-research possession, or self-directed access. caveat: clinical work must comply with a valid fda ind or other federal authorization when required. laws_policy policy_tracker_row tennessee general assembly bill information policy tennessee hb 2075 / sb 2149, hope treatment act cataloged source primary-source record" }, { "id": "policy-14", "title": "Texas: SB 2308, Ibogaine drug development clinical trials", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Texas Legislature enrolled bill text", "url": "https://capitol.texas.gov/tlodocs/89R/billtext/html/SB02308F.htm", "summary": "Enrolled Law Effective 2025. Allows: Creates a pathway for a selected consortium and interagency contract for Ibogaine drug development clinical trials. Does not allow: Treatment-administration provisions apply only if FDA approves Ibogaine to treat a medical condition. Caveat: Implementation may require federal waiver or authorization; clinical work remains subject to federal law.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Texas", "SB 2308, Ibogaine drug development clinical trials" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Texas Legislature enrolled bill text", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, texas, sb 2308, ibogaine drug development clinical trials.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "texas: sb 2308, ibogaine drug development clinical trials enrolled law effective 2025. allows: creates a pathway for a selected consortium and interagency contract for ibogaine drug development clinical trials. does not allow: treatment-administration provisions apply only if fda approves ibogaine to treat a medical condition. caveat: implementation may require federal waiver or authorization; clinical work remains subject to federal law. laws_policy policy_tracker_row texas legislature enrolled bill text policy texas sb 2308, ibogaine drug development clinical trials cataloged source primary-source record" }, { "id": "policy-15", "title": "Texas: State-funded IMPACT Ibogaine clinical trials program", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Texas Tribune reporting with state-program context", "url": "https://www.texastribune.org/2026/03/31/texas-ibogaine-research-clinical-trials-psychedelics/", "summary": "State Research Program Announced After Partner Search. Allows: Tracks Texas' move toward state-run or state-funded clinical trials after difficulty finding a drug-company partner. Does not allow: Reporting about implementation does not mean treatment access, FDA approval, or proof that trials are already enrolling. Caveat: Federal law and trial authorization remain central.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Texas", "State-funded IMPACT Ibogaine clinical trials program" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Texas Tribune reporting with state-program context", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, texas, state-funded impact ibogaine clinical trials program.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "texas: state-funded impact ibogaine clinical trials program state research program announced after partner search. allows: tracks texas' move toward state-run or state-funded clinical trials after difficulty finding a drug-company partner. does not allow: reporting about implementation does not mean treatment access, fda approval, or proof that trials are already enrolling. caveat: federal law and trial authorization remain central. laws_policy policy_tracker_row texas tribune reporting with state-program context policy texas state-funded impact ibogaine clinical trials program cataloged source primary-source record" }, { "id": "policy-16", "title": "Vermont: H.859, psychedelic therapy and Ibogaine clinical drug development trials", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "Vermont Legislature bill text", "url": "https://legislature.vermont.gov/Documents/2026/Docs/BILLS/H-0859/H-0859%20As%20Introduced.pdf", "summary": "Introduced. Allows: Would establish a Psychedelic Therapy Advisory Board and require the Department of Health to contract with a Vermont entity for Ibogaine clinical drug-development trials. Does not allow: Introduced bill language is not enactment and does not authorize treatment access. Caveat: Federal authorization remains required for clinical drug-development work.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "Vermont", "H.859, psychedelic therapy and Ibogaine clinical drug development trials" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "Vermont Legislature bill text", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, vermont, h.859, psychedelic therapy and ibogaine clinical drug development trials.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "vermont: h.859, psychedelic therapy and ibogaine clinical drug development trials introduced. allows: would establish a psychedelic therapy advisory board and require the department of health to contract with a vermont entity for ibogaine clinical drug-development trials. does not allow: introduced bill language is not enactment and does not authorize treatment access. caveat: federal authorization remains required for clinical drug-development work. laws_policy policy_tracker_row vermont legislature bill text policy vermont h.859, psychedelic therapy and ibogaine clinical drug development trials cataloged source primary-source record" }, { "id": "policy-17", "title": "West Virginia: HB 4626, grant program for FDA drug-development trials with Ibogaine", "category": "laws_policy", "sourceType": "policy_tracker_row", "sourceName": "West Virginia Legislature bill history", "url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?input=4626&sessiontype=RS&year=2026", "summary": "Vetoed. Allows: Would have established a grant program to fund FDA drug-development trials with Ibogaine. Does not allow: Because it was vetoed, it should not be treated as current law or active access. Caveat: Federal Schedule I and FDA approval constraints remain unchanged.", "confidence": "Primary-source record", "status": "Cataloged source", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "policy_tracker", "tags": [ "policy", "West Virginia", "HB 4626, grant program for FDA drug-development trials with Ibogaine" ], "displayCategory": "Law and policy", "displaySourceType": "Policy record", "displaySourceName": "West Virginia Legislature bill history", "displayDate": "May 31, 2026", "whatItIs": "Law, policy, agency, or public-affairs source.", "conversationContext": "Covers policy, west virginia, hb 4626, grant program for fda drug-development trials with ibogaine.", "whyListed": "Useful for understanding policy movement. Current law depends on jurisdiction and exact source text.", "searchText": "west virginia: hb 4626, grant program for fda drug-development trials with ibogaine vetoed. allows: would have established a grant program to fund fda drug-development trials with ibogaine. does not allow: because it was vetoed, it should not be treated as current law or active access. caveat: federal schedule i and fda approval constraints remain unchanged. laws_policy policy_tracker_row west virginia legislature bill history policy west virginia hb 4626, grant program for fda drug-development trials with ibogaine cataloged source primary-source record" }, { "id": "state-policy-alabama", "title": "Alabama Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Alabama as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Alabama", "AL" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Alabama as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "alabama ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for alabama as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga alabama al no state specific record in tracker state policy coverage row" }, { "id": "state-policy-alaska", "title": "Alaska Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Alaska as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Alaska", "AK" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Alaska as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "alaska ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for alaska as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga alaska ak no state specific record in tracker state policy coverage row" }, { "id": "state-policy-arizona", "title": "Arizona Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Arizona: HB 2871, appropriation for Ibogaine clinical research study (2025 Bill Dead Or Not Carried Forward In Tracker). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Arizona", "AZ", "HB 2871, appropriation for Ibogaine clinical research study", "2025_bill_dead_or_not_carried_forward_in_tracker" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Arizona: HB 2871, appropriation for Ibogaine clinical research study (2025 Bill Dead Or Not Carried Forward In Tracker). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "arizona ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for arizona: hb 2871, appropriation for ibogaine clinical research study (2025 bill dead or not carried forward in tracker). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga arizona az hb 2871, appropriation for ibogaine clinical research study 2025_bill_dead_or_not_carried_forward_in_tracker tracked state specific activity state policy coverage row" }, { "id": "state-policy-arkansas", "title": "Arkansas Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Arkansas as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Arkansas", "AR" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Arkansas as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "arkansas ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for arkansas as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga arkansas ar no state specific record in tracker state policy coverage row" }, { "id": "state-policy-california", "title": "California Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for California as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "California", "CA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for California as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "california ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for california as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga california ca no state specific record in tracker state policy coverage row" }, { "id": "state-policy-colorado", "title": "Colorado Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Colorado: HB26-1325, Natural Medicine / Ibogaine research pilot program (Passed Legislature Awaiting Enactment Check). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Colorado", "CO", "HB26-1325, Natural Medicine / Ibogaine research pilot program", "passed_legislature_awaiting_enactment_check" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Colorado: HB26-1325, Natural Medicine / Ibogaine research pilot program (Passed Legislature Awaiting Enactment Check). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "colorado ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for colorado: hb26-1325, natural medicine / ibogaine research pilot program (passed legislature awaiting enactment check). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga colorado co hb26-1325, natural medicine / ibogaine research pilot program passed_legislature_awaiting_enactment_check tracked state specific activity state policy coverage row" }, { "id": "state-policy-connecticut", "title": "Connecticut Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Connecticut as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Connecticut", "CT" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Connecticut as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "connecticut ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for connecticut as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga connecticut ct no state specific record in tracker state policy coverage row" }, { "id": "state-policy-delaware", "title": "Delaware Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Delaware as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Delaware", "DE" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Delaware as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "delaware ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for delaware as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga delaware de no state specific record in tracker state policy coverage row" }, { "id": "state-policy-district-of-columbia", "title": "District of Columbia Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for District of Columbia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "District of Columbia", "DC" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for District of Columbia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "district of columbia ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for district of columbia as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga district of columbia dc no state specific record in tracker state policy coverage row" }, { "id": "state-policy-florida", "title": "Florida Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Florida as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Florida", "FL" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Florida as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "florida ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for florida as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga florida fl no state specific record in tracker state policy coverage row" }, { "id": "state-policy-georgia", "title": "Georgia Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Georgia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Georgia", "GA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Georgia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "georgia ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for georgia as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga georgia ga no state specific record in tracker state policy coverage row" }, { "id": "state-policy-hawaii", "title": "Hawaii Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Hawaii as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Hawaii", "HI" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Hawaii as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "hawaii ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for hawaii as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga hawaii hi no state specific record in tracker state policy coverage row" }, { "id": "state-policy-idaho", "title": "Idaho Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Idaho as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Idaho", "ID" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Idaho as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "idaho ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for idaho as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga idaho id no state specific record in tracker state policy coverage row" }, { "id": "state-policy-illinois", "title": "Illinois Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Illinois as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Illinois", "IL" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Illinois as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "illinois ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for illinois as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga illinois il no state specific record in tracker state policy coverage row" }, { "id": "state-policy-indiana", "title": "Indiana Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Indiana as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Indiana", "IN" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Indiana as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "indiana ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for indiana as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga indiana in no state specific record in tracker state policy coverage row" }, { "id": "state-policy-iowa", "title": "Iowa Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Iowa as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Iowa", "IA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Iowa as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "iowa ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for iowa as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga iowa ia no state specific record in tracker state policy coverage row" }, { "id": "state-policy-kansas", "title": "Kansas Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Kansas as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Kansas", "KS" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Kansas as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "kansas ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for kansas as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga kansas ks no state specific record in tracker state policy coverage row" }, { "id": "state-policy-kentucky", "title": "Kentucky Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Kentucky: SB 77, Ibogaine research in the Commonwealth (Enacted After Veto Override Acts Ch 158). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Kentucky", "KY", "SB 77, Ibogaine research in the Commonwealth", "enacted_after_veto_override_acts_ch_158" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Kentucky: SB 77, Ibogaine research in the Commonwealth (Enacted After Veto Override Acts Ch 158). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "kentucky ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for kentucky: sb 77, ibogaine research in the commonwealth (enacted after veto override acts ch 158). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga kentucky ky sb 77, ibogaine research in the commonwealth enacted_after_veto_override_acts_ch_158 tracked state specific activity state policy coverage row" }, { "id": "state-policy-louisiana", "title": "Louisiana Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Louisiana: SB 43, psychedelic-assisted therapy / clinical research language (Passed House Returned For Senate Action Check). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Louisiana", "LA", "SB 43, psychedelic-assisted therapy / clinical research language", "passed_house_returned_for_senate_action_check" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Louisiana: SB 43, psychedelic-assisted therapy / clinical research language (Passed House Returned For Senate Action Check). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "louisiana ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for louisiana: sb 43, psychedelic-assisted therapy / clinical research language (passed house returned for senate action check). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga louisiana la sb 43, psychedelic-assisted therapy / clinical research language passed_house_returned_for_senate_action_check tracked state specific activity state policy coverage row" }, { "id": "state-policy-maine", "title": "Maine Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Maine as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Maine", "ME" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Maine as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "maine ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for maine as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga maine me no state specific record in tracker state policy coverage row" }, { "id": "state-policy-maryland", "title": "Maryland Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Maryland: SB 527 / HB 1477, Ibogaine Clinical Research Grant Program (Introduced With Hearing Activity). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Maryland", "MD", "SB 527 / HB 1477, Ibogaine Clinical Research Grant Program", "introduced_with_hearing_activity" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Maryland: SB 527 / HB 1477, Ibogaine Clinical Research Grant Program (Introduced With Hearing Activity). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "maryland ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for maryland: sb 527 / hb 1477, ibogaine clinical research grant program (introduced with hearing activity). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga maryland md sb 527 / hb 1477, ibogaine clinical research grant program introduced_with_hearing_activity tracked state specific activity state policy coverage row" }, { "id": "state-policy-massachusetts", "title": "Massachusetts Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Massachusetts as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Massachusetts", "MA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Massachusetts as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "massachusetts ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for massachusetts as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga massachusetts ma no state specific record in tracker state policy coverage row" }, { "id": "state-policy-michigan", "title": "Michigan Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Michigan as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Michigan", "MI" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Michigan as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "michigan ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for michigan as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga michigan mi no state specific record in tracker state policy coverage row" }, { "id": "state-policy-minnesota", "title": "Minnesota Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Minnesota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Minnesota", "MN" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Minnesota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "minnesota ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for minnesota as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga minnesota mn no state specific record in tracker state policy coverage row" }, { "id": "state-policy-mississippi", "title": "Mississippi Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Mississippi: HB 314, Ibogaine Drug Development Clinical Trial Act (Approved By Governor Effective 2026 07 01). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Mississippi", "MS", "HB 314, Ibogaine Drug Development Clinical Trial Act", "approved_by_governor_effective_2026_07_01" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Mississippi: HB 314, Ibogaine Drug Development Clinical Trial Act (Approved By Governor Effective 2026 07 01). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "mississippi ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for mississippi: hb 314, ibogaine drug development clinical trial act (approved by governor effective 2026 07 01). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga mississippi ms hb 314, ibogaine drug development clinical trial act approved_by_governor_effective_2026_07_01 tracked state specific activity state policy coverage row" }, { "id": "state-policy-missouri", "title": "Missouri Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Missouri as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Missouri", "MO" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Missouri as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "missouri ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for missouri as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga missouri mo no state specific record in tracker state policy coverage row" }, { "id": "state-policy-montana", "title": "Montana Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Montana as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Montana", "MT" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Montana as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "montana ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for montana as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga montana mt no state specific record in tracker state policy coverage row" }, { "id": "state-policy-nebraska", "title": "Nebraska Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Nebraska as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Nebraska", "NE" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Nebraska as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "nebraska ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for nebraska as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga nebraska ne no state specific record in tracker state policy coverage row" }, { "id": "state-policy-nevada", "title": "Nevada Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Nevada as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Nevada", "NV" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Nevada as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "nevada ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for nevada as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga nevada nv no state specific record in tracker state policy coverage row" }, { "id": "state-policy-new-hampshire", "title": "New Hampshire Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Hampshire as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "New Hampshire", "NH" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Hampshire as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "new hampshire ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for new hampshire as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga new hampshire nh no state specific record in tracker state policy coverage row" }, { "id": "state-policy-new-jersey", "title": "New Jersey Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Jersey as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "New Jersey", "NJ" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Jersey as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "new jersey ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for new jersey as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga new jersey nj no state specific record in tracker state policy coverage row" }, { "id": "state-policy-new-mexico", "title": "New Mexico Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Mexico as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "New Mexico", "NM" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New Mexico as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "new mexico ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for new mexico as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga new mexico nm no state specific record in tracker state policy coverage row" }, { "id": "state-policy-new-york", "title": "New York Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New York as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "New York", "NY" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for New York as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "new york ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for new york as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga new york ny no state specific record in tracker state policy coverage row" }, { "id": "state-policy-north-carolina", "title": "North Carolina Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for North Carolina as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "North Carolina", "NC" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for North Carolina as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "north carolina ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for north carolina as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga north carolina nc no state specific record in tracker state policy coverage row" }, { "id": "state-policy-north-dakota", "title": "North Dakota Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for North Dakota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "North Dakota", "ND" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for North Dakota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "north dakota ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for north dakota as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga north dakota nd no state specific record in tracker state policy coverage row" }, { "id": "state-policy-ohio", "title": "Ohio Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Ohio: Ibogaine Treatment Study Committee (Study Committee Current Report Due 2027 12 31). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Ohio", "OH", "Ibogaine Treatment Study Committee", "study_committee_current_report_due_2027_12_31" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Ohio: Ibogaine Treatment Study Committee (Study Committee Current Report Due 2027 12 31). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "ohio ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for ohio: ibogaine treatment study committee (study committee current report due 2027 12 31). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga ohio oh ibogaine treatment study committee study_committee_current_report_due_2027_12_31 tracked state specific activity state policy coverage row" }, { "id": "state-policy-oklahoma", "title": "Oklahoma Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 2 state-specific Iboga/Ibogaine policy record(s) for Oklahoma: HB 3834, Oklahoma Breakthrough Therapy Act (Approved By Governor); HB 4293, Veterans Mental Health Innovation Act (Introduced Referred To Rules). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Oklahoma", "OK", "HB 3834, Oklahoma Breakthrough Therapy Act", "HB 4293, Veterans Mental Health Innovation Act", "approved_by_governor", "introduced_referred_to_rules" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 2 state-specific Iboga/Ibogaine policy record(s) for Oklahoma: HB 3834, Oklahoma Breakthrough Therapy Act (Approved By Governor); HB 4293, Veterans Mental Health Innovation Act (Introduced Referred To Rules). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "oklahoma ibogaine policy coverage ibogabase tracks 2 state-specific iboga/ibogaine policy record(s) for oklahoma: hb 3834, oklahoma breakthrough therapy act (approved by governor); hb 4293, veterans mental health innovation act (introduced referred to rules). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga oklahoma ok hb 3834, oklahoma breakthrough therapy act hb 4293, veterans mental health innovation act approved_by_governor introduced_referred_to_rules tracked state specific activity state policy coverage row" }, { "id": "state-policy-oregon", "title": "Oregon Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Oregon: HB 4110, physician-supervised Ibogaine proposal (In House Committee). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Oregon", "OR", "HB 4110, physician-supervised Ibogaine proposal", "in_house_committee" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Oregon: HB 4110, physician-supervised Ibogaine proposal (In House Committee). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "oregon ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for oregon: hb 4110, physician-supervised ibogaine proposal (in house committee). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga oregon or hb 4110, physician-supervised ibogaine proposal in_house_committee tracked state specific activity state policy coverage row" }, { "id": "state-policy-pennsylvania", "title": "Pennsylvania Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Pennsylvania as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Pennsylvania", "PA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Pennsylvania as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "pennsylvania ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for pennsylvania as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga pennsylvania pa no state specific record in tracker state policy coverage row" }, { "id": "state-policy-rhode-island", "title": "Rhode Island Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Rhode Island as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Rhode Island", "RI" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Rhode Island as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "rhode island ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for rhode island as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga rhode island ri no state specific record in tracker state policy coverage row" }, { "id": "state-policy-south-carolina", "title": "South Carolina Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for South Carolina as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "South Carolina", "SC" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for South Carolina as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "south carolina ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for south carolina as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga south carolina sc no state specific record in tracker state policy coverage row" }, { "id": "state-policy-south-dakota", "title": "South Dakota Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for South Dakota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "South Dakota", "SD" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for South Dakota as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "south dakota ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for south dakota as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga south dakota sd no state specific record in tracker state policy coverage row" }, { "id": "state-policy-tennessee", "title": "Tennessee Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Tennessee: HB 2075 / SB 2149, HOPE Treatment Act (Passed Both Chambers Senate Concurred House Amendment). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Tennessee", "TN", "HB 2075 / SB 2149, HOPE Treatment Act", "passed_both_chambers_senate_concurred_house_amendment" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Tennessee: HB 2075 / SB 2149, HOPE Treatment Act (Passed Both Chambers Senate Concurred House Amendment). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "tennessee ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for tennessee: hb 2075 / sb 2149, hope treatment act (passed both chambers senate concurred house amendment). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga tennessee tn hb 2075 / sb 2149, hope treatment act passed_both_chambers_senate_concurred_house_amendment tracked state specific activity state policy coverage row" }, { "id": "state-policy-texas", "title": "Texas Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 2 state-specific Iboga/Ibogaine policy record(s) for Texas: SB 2308, Ibogaine drug development clinical trials (Enrolled Law Effective 2025); State-funded IMPACT Ibogaine clinical trials program (State Research Program Announced After Partner Search). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Texas", "TX", "SB 2308, Ibogaine drug development clinical trials", "State-funded IMPACT Ibogaine clinical trials program", "enrolled_law_effective_2025", "state_research_program_announced_after_partner_search" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 2 state-specific Iboga/Ibogaine policy record(s) for Texas: SB 2308, Ibogaine drug development clinical trials (Enrolled Law Effective 2025); State-funded IMPACT Ibogaine clinical trials program (State Research Program Announced After Partner Search). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "texas ibogaine policy coverage ibogabase tracks 2 state-specific iboga/ibogaine policy record(s) for texas: sb 2308, ibogaine drug development clinical trials (enrolled law effective 2025); state-funded impact ibogaine clinical trials program (state research program announced after partner search). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga texas tx sb 2308, ibogaine drug development clinical trials state-funded impact ibogaine clinical trials program enrolled_law_effective_2025 state_research_program_announced_after_partner_search tracked state specific activity state policy coverage row" }, { "id": "state-policy-utah", "title": "Utah Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Utah as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Utah", "UT" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Utah as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "utah ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for utah as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga utah ut no state specific record in tracker state policy coverage row" }, { "id": "state-policy-vermont", "title": "Vermont Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Vermont: H.859, psychedelic therapy and Ibogaine clinical drug development trials (Introduced). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Vermont", "VT", "H.859, psychedelic therapy and Ibogaine clinical drug development trials", "introduced" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for Vermont: H.859, psychedelic therapy and Ibogaine clinical drug development trials (Introduced). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "vermont ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for vermont: h.859, psychedelic therapy and ibogaine clinical drug development trials (introduced). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga vermont vt h.859, psychedelic therapy and ibogaine clinical drug development trials introduced tracked state specific activity state policy coverage row" }, { "id": "state-policy-virginia", "title": "Virginia Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Virginia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Virginia", "VA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Virginia as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "virginia ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for virginia as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga virginia va no state specific record in tracker state policy coverage row" }, { "id": "state-policy-washington", "title": "Washington Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Washington as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Washington", "WA" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Washington as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "washington ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for washington as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga washington wa no state specific record in tracker state policy coverage row" }, { "id": "state-policy-west-virginia", "title": "West Virginia Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for West Virginia: HB 4626, grant program for FDA drug-development trials with Ibogaine (Vetoed). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "Tracked State Specific Activity", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "West Virginia", "WV", "HB 4626, grant program for FDA drug-development trials with Ibogaine", "vetoed" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "IbogaBase tracks 1 state-specific Iboga/Ibogaine policy record(s) for West Virginia: HB 4626, grant program for FDA drug-development trials with Ibogaine (Vetoed). This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "west virginia ibogaine policy coverage ibogabase tracks 1 state-specific iboga/ibogaine policy record(s) for west virginia: hb 4626, grant program for fda drug-development trials with ibogaine (vetoed). this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga west virginia wv hb 4626, grant program for fda drug-development trials with ibogaine vetoed tracked state specific activity state policy coverage row" }, { "id": "state-policy-wisconsin", "title": "Wisconsin Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Wisconsin as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Wisconsin", "WI" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Wisconsin as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "wisconsin ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for wisconsin as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga wisconsin wi no state specific record in tracker state policy coverage row" }, { "id": "state-policy-wyoming", "title": "Wyoming Ibogaine policy coverage", "category": "state_policy_coverage", "sourceType": "state_policy_coverage_row", "sourceName": "IbogaBase state policy coverage", "url": "#policy-tracker-table", "summary": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Wyoming as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "confidence": "State policy coverage row", "status": "No State Specific Record In Tracker", "people": [], "publishedAt": "2026-05-31", "foundAt": "2026-05-31", "sourceOrigin": "state_policy_coverage", "tags": [ "policy", "state_policy", "ibogaine", "iboga", "Wyoming", "WY" ], "displayCategory": "State policy coverage", "displaySourceType": "State policy coverage row", "displaySourceName": "IbogaBase state policy coverage", "displayDate": "May 31, 2026", "whatItIs": "State policy coverage marker.", "conversationContext": "No state-specific Iboga/Ibogaine policy record is currently in the IbogaBase tracker for Wyoming as of 2026-05-31. This is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent.", "whyListed": "Useful for state-by-state searching. It flags tracked activity and makes untracked states visible without pretending absence is certainty.", "searchText": "wyoming ibogaine policy coverage no state-specific iboga/ibogaine policy record is currently in the ibogabase tracker for wyoming as of 2026-05-31. this is legal information tracking, not legal advice; untracked does not mean legally impossible or definitively absent. state_policy_coverage state_policy_coverage_row ibogabase state policy coverage policy state_policy ibogaine iboga wyoming wy no state specific record in tracker state policy coverage row" }, { "id": "condition-oud", "title": "Opioid use disorder evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: early human and observational. Human evidence: Observational detoxification reports, follow-up studies, and registered oral Ibogaine withdrawal research. Main limitation: Durability, relapse denominator data, missing follow-up, concurrent supports, and adverse-event denominator data remain incomplete. Safety: Cardiac risk, concurrent substances, withdrawal physiology, electrolyte issues, psychiatric status, and medication interactions. Not proven: Ibogaine is not proven to cure opioid addiction.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Opioid use disorder", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "oud" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, oud.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "opioid use disorder evidence page evidence level: early human and observational. human evidence: observational detoxification reports, follow-up studies, and registered oral ibogaine withdrawal research. main limitation: durability, relapse denominator data, missing follow-up, concurrent supports, and adverse-event denominator data remain incomplete. safety: cardiac risk, concurrent substances, withdrawal physiology, electrolyte issues, psychiatric status, and medication interactions. not proven: ibogaine is not proven to cure opioid addiction. evidence_pages condition_evidence_template ibogabase evidence framework opioid use disorder evidence condition oud evidence framework evidence framework" }, { "id": "condition-aud", "title": "Alcohol use disorder evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: investigational. Human evidence: FDA allowed an early phase U.S. Noribogaine hydrochloride study to proceed after an IND submission in April 2026. Main limitation: Noribogaine, Ibogaine, plant Iboga, alcohol-withdrawal risk, and clinic claims are separate subjects. Safety: Alcohol withdrawal, liver health, medications, QT/QTc, electrolytes, and monitoring requirements. Not proven: Noribogaine is not FDA-approved for alcohol use disorder.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Alcohol use disorder", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "aud" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, aud.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "alcohol use disorder evidence page evidence level: investigational. human evidence: fda allowed an early phase u.s. noribogaine hydrochloride study to proceed after an ind submission in april 2026. main limitation: noribogaine, ibogaine, plant iboga, alcohol-withdrawal risk, and clinic claims are separate subjects. safety: alcohol withdrawal, liver health, medications, qt/qtc, electrolytes, and monitoring requirements. not proven: noribogaine is not fda-approved for alcohol use disorder. evidence_pages condition_evidence_template ibogabase evidence framework alcohol use disorder evidence condition aud evidence framework evidence framework" }, { "id": "condition-tbi", "title": "Traumatic brain injury evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: notable open label human signal. Human evidence: A 30-person veteran prospective observational study and later neurophysiology work drew attention and require side-by-side design-limit explanation. Main limitation: Small sample, male veteran population, Mexico treatment setting, concurrent supports, selection effects, and short follow-up. Safety: Screening, cardiac monitoring, magnesium context, psychiatric history, and follow-up. Not proven: Ibogaine is not proven as a general TBI treatment.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Traumatic brain injury", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "tbi" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, tbi.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "traumatic brain injury evidence page evidence level: notable open label human signal. human evidence: a 30-person veteran prospective observational study and later neurophysiology work drew attention and require side-by-side design-limit explanation. main limitation: small sample, male veteran population, mexico treatment setting, concurrent supports, selection effects, and short follow-up. safety: screening, cardiac monitoring, magnesium context, psychiatric history, and follow-up. not proven: ibogaine is not proven as a general tbi treatment. evidence_pages condition_evidence_template ibogabase evidence framework traumatic brain injury evidence condition tbi evidence framework evidence framework" }, { "id": "condition-ptsd", "title": "PTSD and trauma symptoms evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: secondary outcomes and observational. Human evidence: PTSD-related signals often appear within veteran or substance-use populations rather than standalone PTSD trials. Main limitation: Confounding, expectation effects, integration/support differences, psychiatric exclusions, and concurrent interventions. Safety: Psychiatric destabilization, suicidality screening, medications, acute monitoring, and post-session support. Not proven: Ibogaine is not proven as a PTSD treatment.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "PTSD and trauma symptoms", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "ptsd" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, ptsd.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "ptsd and trauma symptoms evidence page evidence level: secondary outcomes and observational. human evidence: ptsd-related signals often appear within veteran or substance-use populations rather than standalone ptsd trials. main limitation: confounding, expectation effects, integration/support differences, psychiatric exclusions, and concurrent interventions. safety: psychiatric destabilization, suicidality screening, medications, acute monitoring, and post-session support. not proven: ibogaine is not proven as a ptsd treatment. evidence_pages condition_evidence_template ibogabase evidence framework ptsd and trauma symptoms evidence condition ptsd evidence framework evidence framework" }, { "id": "condition-depression", "title": "Depression and mood symptoms evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: secondary outcomes and small reports. Human evidence: Mood improvements appear in some Ibogaine-related observational and veteran studies, usually as secondary outcomes. Main limitation: Expectation effects, concurrent treatment, post-acute recovery, integration, and regression to the mean can affect mood measures. Safety: Suicidality, bipolar disorder, psychosis risk, serotonergic medications, sleep disruption, and cardiac risk. Not proven: Ibogaine is not proven as a depression treatment.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Depression and mood symptoms", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "depression" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, depression.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "depression and mood symptoms evidence page evidence level: secondary outcomes and small reports. human evidence: mood improvements appear in some ibogaine-related observational and veteran studies, usually as secondary outcomes. main limitation: expectation effects, concurrent treatment, post-acute recovery, integration, and regression to the mean can affect mood measures. safety: suicidality, bipolar disorder, psychosis risk, serotonergic medications, sleep disruption, and cardiac risk. not proven: ibogaine is not proven as a depression treatment. evidence_pages condition_evidence_template ibogabase evidence framework depression and mood symptoms evidence condition depression evidence framework evidence framework" }, { "id": "condition-anxiety", "title": "Anxiety symptoms evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: secondary outcomes. Human evidence: Anxiety outcomes are usually measured within TBI, PTSD, or substance-use populations rather than as a standalone indication. Main limitation: Anxiety can change with withdrawal relief, sleep, expectation, setting, or integration support. Safety: Acute distress, panic, psychiatric destabilization, benzodiazepines, serotonergic drugs, and cardiac monitoring. Not proven: Ibogaine is not proven as an anxiety treatment.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Anxiety symptoms", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "anxiety" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, anxiety.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "anxiety symptoms evidence page evidence level: secondary outcomes. human evidence: anxiety outcomes are usually measured within tbi, ptsd, or substance-use populations rather than as a standalone indication. main limitation: anxiety can change with withdrawal relief, sleep, expectation, setting, or integration support. safety: acute distress, panic, psychiatric destabilization, benzodiazepines, serotonergic drugs, and cardiac monitoring. not proven: ibogaine is not proven as an anxiety treatment. evidence_pages condition_evidence_template ibogabase evidence framework anxiety symptoms evidence condition anxiety evidence framework evidence framework" }, { "id": "condition-parkinsons", "title": "Parkinson's disease evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: case report watchlist. Human evidence: A 2026 peer-reviewed case report describes one patient treated with low-dose Ibogaine hydrochloride over 80 days using validated Parkinson's instruments. Main limitation: One-patient evidence is highly uncertain and vulnerable to placebo, expectation, medication changes, and disease variability. Safety: Age, cardiac status, neurological comorbidity, drug interactions, sleep worsening, and medication changes. Not proven: Ibogaine is not proven as a Parkinson's treatment.", "confidence": "Case report", "status": "Evidence framework", "condition": "Parkinson's disease", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "parkinsons" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, parkinsons.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "parkinson's disease evidence page evidence level: case report watchlist. human evidence: a 2026 peer-reviewed case report describes one patient treated with low-dose ibogaine hydrochloride over 80 days using validated parkinson's instruments. main limitation: one-patient evidence is highly uncertain and vulnerable to placebo, expectation, medication changes, and disease variability. safety: age, cardiac status, neurological comorbidity, drug interactions, sleep worsening, and medication changes. not proven: ibogaine is not proven as a parkinson's treatment. evidence_pages condition_evidence_template ibogabase evidence framework parkinson's disease evidence condition parkinsons evidence framework case report" }, { "id": "condition-withdrawal_craving", "title": "Withdrawal and cravings evidence page", "category": "evidence_pages", "sourceType": "condition_evidence_template", "sourceName": "IbogaBase evidence framework", "url": "#evidence-matrix", "summary": "Evidence level: early human signal by context. Human evidence: Withdrawal and craving findings appear in OUD studies, observational detoxification reports, and substance-use reviews. Main limitation: Concurrent medications, setting, expectation, follow-up loss, and substance-specific withdrawal risks can change interpretation. Safety: Withdrawal physiology, dehydration, electrolytes, cardiac risk, benzodiazepines, alcohol, stimulants, opioids, and polysubstance use. Not proven: Craving reduction or withdrawal relief is not the same as a cure.", "confidence": "Evidence framework", "status": "Evidence framework", "condition": "Withdrawal and cravings", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "evidence_pages", "tags": [ "evidence", "condition", "withdrawal_craving" ], "displayCategory": "Evidence pages", "displaySourceType": "Evidence framework", "displaySourceName": "IbogaBase evidence framework", "displayDate": "", "whatItIs": "IbogaBase evidence page.", "conversationContext": "Covers evidence, condition, withdrawal craving.", "whyListed": "Useful for condition-specific summaries, limitations, and unknowns.", "searchText": "withdrawal and cravings evidence page evidence level: early human signal by context. human evidence: withdrawal and craving findings appear in oud studies, observational detoxification reports, and substance-use reviews. main limitation: concurrent medications, setting, expectation, follow-up loss, and substance-specific withdrawal risks can change interpretation. safety: withdrawal physiology, dehydration, electrolytes, cardiac risk, benzodiazepines, alcohol, stimulants, opioids, and polysubstance use. not proven: craving reduction or withdrawal relief is not the same as a cure. evidence_pages condition_evidence_template ibogabase evidence framework withdrawal and cravings evidence condition withdrawal_craving evidence framework evidence framework" }, { "id": "clinic-observatory-1", "title": "Clinic claim monitoring", "category": "clinics", "sourceType": "clinic_observatory_schema", "sourceName": "IbogaBase Clinic Observatory", "url": "#clinics", "summary": "Clinic entries track public claims, locations, safety statements, outcome language, and adverse-event signals. IbogaBase does not rank clinics or provide referrals.", "confidence": "Claim record", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "clinic_observatory", "tags": [ "clinics", "claims", "no_referrals" ], "displayCategory": "Clinic claims", "displaySourceType": "Clinic-claim record", "displaySourceName": "IbogaBase Clinic Observatory", "displayDate": "", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics, claims, no referrals.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "clinic claim monitoring clinic entries track public claims, locations, safety statements, outcome language, and adverse-event signals. ibogabase does not rank clinics or provide referrals. clinics clinic_observatory_schema ibogabase clinic observatory clinics claims no_referrals cataloged source claim record" }, { "id": "clinic-observatory-2", "title": "Ambio Life Sciences", "category": "clinics", "sourceType": "clinic_observatory_schema", "sourceName": "IbogaBase Clinic Observatory", "url": "#clinics", "summary": "Ambio is included as a clinic/company/research-site claim record because it appears in peer-reviewed research and public reporting. This is not a referral, ranking, endorsement, or provider recommendation.", "confidence": "Peer-reviewed source", "status": "Cataloged source", "people": [], "publishedAt": "", "foundAt": "", "sourceOrigin": "clinic_observatory", "tags": [ "clinics", "claims", "no_referrals" ], "displayCategory": "Clinic claims", "displaySourceType": "Clinic-claim record", "displaySourceName": "IbogaBase Clinic Observatory", "displayDate": "", "whatItIs": "Clinic-claim monitoring entry.", "conversationContext": "Covers clinics, claims, no referrals.", "whyListed": "Useful for non-promotional claim monitoring only. IbogaBase does not rank, recommend, or refer to clinics.", "searchText": "ambio life sciences ambio is included as a clinic/company/research-site claim record because it appears in peer-reviewed research and public reporting. this is not a referral, ranking, endorsement, or provider recommendation. clinics clinic_observatory_schema ibogabase clinic observatory clinics claims no_referrals cataloged source peer-reviewed source" }, { "id": "site-topic-bwiti-history", "title": "Bwiti history and public cultural context", "category": "culture_stewardship", "sourceType": "culture_context", "sourceName": "IbogaBase culture reference", "url": "#history", "summary": "Public-facing orientation to Iboga's Central African context, Gabon, Bwiti/Bwete, Misoko/Missoko, Fang contexts, stewardship, and protected knowledge boundaries.", "confidence": "Culture context", "status": "Cataloged source", "tags": [ "bwiti", "bwete", "history", "gabon", "misoko", "missoko", "fang", "culture", "stewardship" ], "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:57.488Z", "sourceOrigin": "ibogabase_reference", "displayCategory": "Culture and stewardship", "displaySourceType": "Culture context", "displaySourceName": "IbogaBase culture reference", "displayDate": "", "whatItIs": "Culture, stewardship, conservation, or reciprocity source.", "conversationContext": "Covers bwiti, bwete, history, gabon.", "whyListed": "Useful for cultural, ecological, and stewardship context. Community voices carry more authority than outsider summaries.", "searchText": "bwiti history and public cultural context public-facing orientation to iboga's central african context, gabon, bwiti/bwete, misoko/missoko, fang contexts, stewardship, and protected knowledge boundaries. culture_stewardship culture_context ibogabase culture reference bwiti bwete history gabon misoko missoko fang culture stewardship cataloged source culture context" }, { "id": "site-topic-cyp2d6", "title": "CYP2D6, medication interactions, and Ibogaine safety", "category": "reference_pages", "sourceType": "safety_topic", "sourceName": "IbogaBase safety reference", "url": "#safety", "summary": "Safety orientation for CYP2D6 metabolism, QT/QTc risk, polypharmacy, serotonergic and stimulant risks, electrolyte issues, exclusions, and emergency-readiness standards.", "confidence": "Safety topic", "status": "Cataloged source", "tags": [ "cyp2d6", "medication_interactions", "qt", "qtc", "polypharmacy", "safety", "cardiac" ], "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:57.488Z", "sourceOrigin": "ibogabase_reference", "displayCategory": "Reference pages", "displaySourceType": "Safety topic", "displaySourceName": "IbogaBase safety reference", "displayDate": "", "whatItIs": "Safety topic", "conversationContext": "Covers cyp2d6, medication interactions, qt, qtc.", "whyListed": "Useful for orientation and search routing. Follow linked sources before relying on a claim.", "searchText": "cyp2d6, medication interactions, and ibogaine safety safety orientation for cyp2d6 metabolism, qt/qtc risk, polypharmacy, serotonergic and stimulant risks, electrolyte issues, exclusions, and emergency-readiness standards. reference_pages safety_topic ibogabase safety reference cyp2d6 medication_interactions qt qtc polypharmacy safety cardiac cataloged source safety topic" }, { "id": "site-topic-claim-cures-addiction", "title": "Claim check: Ibogaine cures addiction", "category": "reference_pages", "sourceType": "claim_check", "sourceName": "IbogaBase claim check", "url": "#claims", "summary": "Verdict: overstated. Human evidence suggests possible effects on opioid withdrawal and craving in some settings, but cure language is unsupported and ignores relapse, safety risk, selection bias, and incomplete long-term data.", "confidence": "Claim record", "status": "Cataloged source", "tags": [ "ibogaine", "cures_addiction", "claim_check", "opioid_use_disorder", "withdrawal", "relapse", "limitations" ], "people": [], "publishedAt": "", "foundAt": "2026-05-31T20:46:57.488Z", "sourceOrigin": "ibogabase_reference", "displayCategory": "Reference pages", "displaySourceType": "Claim check", "displaySourceName": "IbogaBase claim check", "displayDate": "", "whatItIs": "Claim check", "conversationContext": "Covers cures addiction, claim check, opioid use disorder, withdrawal.", "whyListed": "Useful for orientation and search routing. Follow linked sources before relying on a claim.", "searchText": "claim check: ibogaine cures addiction verdict: overstated. human evidence suggests possible effects on opioid withdrawal and craving in some settings, but cure language is unsupported and ignores relapse, safety risk, selection bias, and incomplete long-term data. reference_pages claim_check ibogabase claim check ibogaine cures_addiction claim_check opioid_use_disorder withdrawal relapse limitations cataloged source claim record" } ] }